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ABSTRACT OF THE DISSERTATION
Unraveling Population Heterogeneity using Single-Cell Analysis
by
Wenjun Kong
Doctor of Philosophy in Biology and Biomedical Sciences
Computational and Systems Biology
Washington University in St. Louis, 2022
Dr. Samantha A. Morris, Chair
The human body contains approximately 100 trillion cells, encompassing distinct cell
types that serve diverse functions. Understanding cell population heterogeneity is vital for
uncovering different biological functions and mechanisms. In addition, cells at transition during
continual processes, such as development, reprogramming, and disease, are essential for painting
the entire blueprint and highlighting critical stages of the progression trajectory. For instance,
cell fate engineering holds much promise for generating clinically valuable cell types from
mature somatic cells. Nonetheless, current reprogramming protocols are inefficient, and charting
the changes in cell identity during such processes can help design strategies to mitigate the offtarget and increase efficiency. RNA-sequencing allows us to study transcript abundance and
dissect different genetic features. Prior to single-cell level sequencing, bulk-level transcriptomics
have demonstrated power at a lower resolution to distinguish populations and identify
differential gene markers. The advent of single-cell RNA-sequencing technologies has brought
us a new era of exploring the small world inside individual cells via their transcriptome profiles.
Single-cell RNA-sequencing takes a snapshot of individual cells, enabling the dissection of
population composition and capture of cells at different states in complex biological systems.
viii

Cell type annotation has been a long-standing interest in understanding cell identities from gene
profiles. Yet, manual annotations require prior knowledge of cell-type-specific gene signatures
and are labor-intensive and time-consuming. Automated annotation approaches are in demand
for exponentially growing single-cell datasets.
In response to such demand, many computational approaches have been developed.
However, they classify cells in a discrete, categorical manner, limiting their application in
continuous biological systems. Focusing on continual processes, we designed a computational
tool, 'Capybara,' to measure cell identity as a continuum at a single-cell resolution. This approach
enables the classification of discrete cell identities and recognizes cells harboring hybrid
identities, supporting a quantitative cell-fate transition metric. After benchmarking against other
classifiers and validation with "ground-truth" lineage data, we apply Capybara to a diverse range
of cellular programming and reprogramming protocols: The application to direct cardiac
reprogramming uncovers a patterning bias and a hybrid state between atrial and ventricular
cardiomyocytes; Capybara reveals previously uncharacterized patterning deficiencies in motor
neuron programming, instructing a new approach to alleviate the lack of proper patterning;
Further, we apply Capybara to our in-house system, direct reprogramming of fibroblast to
induced endoderm progenitors, and find a putative in vivo correlate for this engineered cell type
that has, to date, remained poorly defined. These findings highlight the utility of Capybara to
dissect cell identity and fate transitions in development, reprogramming, and disease. Finally, we
further explore the direct cardiac reprogramming system using the comprehensive set of tools
developed in the lab. We resolve lineage relationships in this system using CellTagging, find key
regulatory transcription factors using CellOracle, and evaluate small molecules' effect on the
patterning bias using Capybara.
ix

In summary, I have developed a tool to highlight cell fate transitions and reveal insight
into cellular heterogeneity in different continuous biological processes. Further investigation in
the transition states by integration with other data modalities and experimental approaches may
help pinpoint key checkpoints for successful reprogramming, allowing future interventions to
improve the efficiency and fidelity of cell fate engineering.

x

Chapter 1: Introduction
1.1 Background and Motivation
Complex biological systems are composed of many different cell types. These diverse
cellular compositions govern specific functions and mechanisms of these biological systems
(Altschuler and Wu, 2010, Paszek et al., 2010). Understanding such heterogeneity is key to
uncover hidden mechanisms and allow future advancements in medicine and biology, such as
improvement in efficiency of cell regeneration (Takahashi and Yamanaka, 2006, Guo and
Morris, 2017), insight into cell fate decisions (Stegle et al., 2015), and target identification in
tumors (McGranahan and Swaton, 2017). As disparate cell types transcribe unique combinations
of genes, heterogeneity can be analyzed using transcriptome-based approaches (Wit, 2017). The
development of transcriptome profiling technologies has enabled the capture and quantification
of complete sets of transcripts in cells (Wang et al., 2009).
Bulk RNA-sequencing, at the population level, has enabled insights in comparisons
between different tissues, treatments, or cell populations. Yet, concerns, such as loss of cell-tocell variation and the stochastic nature of the single-cell transcriptome (Elowitz et al., 2002),
have emerged with growing demands of decoding cellular heterogeneity at a higher resolution. In
the past decade, single-cell RNA-sequencing (scRNA-seq) techniques have been flourishing,
enabling the field to explore the world inside of an individual cell, increasing the resolution of
sequencing to a new standard (Sandberg, 2014). Starting with techniques that sequence the
transcriptome following the manual isolation of one cell (Tang et al., 2009), researchers have
developed highly parallel scRNA-seq techniques to profile individual cells in a larger population
1

simultaneously (Klein et al., 2015; Macosko et al., 2015; Zheng et al., 2017). This rapidly
evolving technique has brought broad opportunities to assess cell composition and dynamics in
complex systems at an individual-cell resolution. A demand that naturally arises with the broad
adoption of these relatively nascent technologies is to catalog cell identities. Recent endeavors to
create cell atlases across a range of organisms have brought interest in systematic cell type
classification (Han et al., 2018, Regev et al., 2017; Tabula Muris Consortium et al., 2018). With
these atlases primarily focused on defining discrete cell types of tissues under homeostasis,
classifying cell identities in dynamic contexts, such as development, disease, and
reprogramming, poses a challenge as cell types and states are in continual transition (Cahan et
al., 2014).
Inspired by this challenge, this dissertation will focus on dissecting cellular heterogeneity
via application and analysis of scRNA-seq data in complex, continuous biological systems,
particularly development and reprogramming. Specifically, we will develop computational tools
and apply our in-house technologies to understand heterogeneity of in vitro systems, and further
feed into potential improvements of in vitro models.
The following subsections (1.1.1-1.1.4) will include a literature review, focusing on four
major topics: 1) single-cell RNA-sequencing technologies, 2) cell type classification algorithms,
3) cellular reprogramming, with a subsection focusing on direct cardiac reprogramming, and 4)
transition cells in continuous processes.

1.1.1 From Bulk to Single Cell, One Cell to Cell Atlases
As the genetic material being determined in the mid-20th century, efforts have been made
to develop technologies to decipher DNA sequences. Starting with the genome of bacteriophage
2

(Sanger et al., 1982) to the Human Genome Project (Abdellah et al., 2004; Lander et al., 2001),
the fidelity and efficiency of DNA sequencing have been brought to the next scale level. Such
sequencing techniques have enabled the genome assembly of multiple organisms, identification
of genetic variations to benefit different clinical applications, and the initiation of using
sequencers to quantify molecules (Shendure et al., 2017). At the same time as the technology
evolves, the definition of “gene” has grown to be more complex over the years – from the unit of
heredity to the Central Dogma. The ENCODE project, seeking to interpret the human DNA
sequence, revealed that protein-encoding genes occupy 1% of the entire genome while over 80%
were responsible for gene activity regulation (Birney et al., 2007). In addition, quantification of
RNA molecules has expanded the vision of RNA beyond single protein-coding transcripts to
include multiple isoforms from one gene and non-coding RNAs, such as miRNAs, snoRNAs,
etc. (Gerstein et al., 2007).
Early years of transcriptomic studies have largely relied on probe-based microarray
approaches, where cDNA was hybridized to custom-made oligo probes and expression was
measured via scanning of the fluorescent signal. The probes can be designed to hybrid at splicing
junctions, allowing detailed mapping of transcript isoforms (Z. Wang et al., 2009). Yet, the
hybridization probes rely on prior knowledge regarding the genome sequence, limiting its ability
to capture the full range of transcripts. In addition, quantification of hybridization-based
fluorescence can be obscured by high-background cross-hybridization (F Ozsolak, 2011; Wang
et al., 2009). In 2008, RNA-sequencing (RNA-seq) was introduced via shortgun sequencing of
the cDNA using next-generation DNA sequencing (NGS). The introduction of this approach
allows massive scale-up in RNA molecules at test and detection of nascent transcripts without
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prior knowledge to the genomic regions, offering a comprehensive view of gene expression for
various cell types (F Ozsolak, 2011; Shendure et al., 2017; Z. Wang et al., 2009).
The development of RNA-seq warrants new applications in understanding cellular
functions and molecular mechanisms via the lens of gene expression, such as cell growth and
differentiation and regulation under different stimuli. Further, it introduced potential clinical
application, such as biomarker detection or gene fusion for disease diagnosis and treatment
improvements (X. Li & Wang, 2021). Studies of RNA-seq at the population level provides the
opportunity to study expression patterns across different populations or species and adds
information in genetic modification at the transcription layer. Yet, as bulk RNA-seq takes the
average expression across the population, cell types in heterogeneous environment can be
challenging to distinguish and rare cell populations can be masked (Elowitz et al., 2002; X. Li &
Wang, 2021). Such concerns sparked the initiation of the new era to profile individual cells.
Single-cell RNA-sequencing (scRNA-seq) started with the capture of the entire
transcriptome of a single mouse blastomere cell manually isolated from 4-cell stage. The
transcriptome was reverse-transcribed and double-stranded cDNA was synthesized, amplified,
sheared, and ligated with an adaptor to be sequenced on a NGS system. Using this approach,
transcripts of more genes and nascent splicing junctions were detected compared to previous
microarray attempts, demonstrating promising results in analyzing complex profiles of individual
cells (Tang et al., 2009). In the last decade, highly parallel scRNA-seq techniques have been
developed to profile individual cells in a large population simultaneously. These techniques can
be broadly categorized based on isolation methods employed. Droplet-based microfluidic
techniques use individual droplets as reaction chambers, where a cell is encapsulated in an oil
droplet together with lysis buffer and a bead. The bead is primed with oligos including PCR
4

primer, cell barcode, unique molecular identifier, and poly-T capture sequence. As the individual
cell lyse, it releases its mRNA within the droplet, hybridizing to the oligos on the bead. The
samples are further collected, washed, and processed to produce the final libraries (X. Zhang, Li,
et al., 2019). Three representative droplet-based systems include Drop-seq (Macosko et al.,
2015), inDrop (Klein et al., 2015), and 10X Genomics Chromium (Zheng et al., 2017). All three
strategies share similar designs to incorporate microfluidics but differ in their design of beads
and primed oligos leading to different experimental processing of the library. For instance, Dropseq uses small, inflexible beads, while inDrop and 10X use hydrogel beads, enabling higher
pairing between the cells and the beads, allowing higher capture efficiency. With detachable
priming oligos, 10X and inDrop enable higher capture efficiency of mRNA molecules (X.
Zhang, Li, et al., 2019).
Another major type of scRNA-seq technology uses wells as reaction chambers for
individual cells, such as CytoSeq (Fan et al., 2015), Microwell (J. Yuan & Sims, 2016), and SeqWell (Gierahn et al., 2017). The wells are first loaded with a cell suspension, during which cells
settle into individual wells by gravity. The barcoded and primed beads are then loaded by a
similar mechanism. Microfluid and semi-permeable membranes have been used in combination
with the wells to avoid cross-contamination between wells and loss of transcripts in individual
wells (Gierahn et al., 2017). To further improve the throughput, split-pool combinatorial
barcoding strategies have been developed, such as SPLiT-seq (Rosenberg et al., 2018) and sciRNA-seq (Cao et al., 2017). Using the split-pool approach, cells are not required to be
encapsulated in their own reaction chamber, but multiple cells are allowed in each well of 96- or
384-well plates. In brief, with each well labelled with a unique barcode, cells are fixed and first
randomly split into wells and labelled with first set of barcoded primers. The cells are then
5

pooled and re-distributed into another well-plate to be labelled with a second set of primers. With
repeating rounds of split-pool, cells are uniquely labelled with combinations of barcodes. In
SPLiT-seq, four rounds of spilt and pool were performed, producing over 21 million barcode
combinations, enabling the profiles of over 100,000 single cells to be captured (Rosenberg et al.,
2018). While in sci-RNA-seq, the re-distribution of cells is performed with fluorescence
activated cell sorting (FACS) on DAPI, ensuring 10 to 100 cells per well, before further barcode
indexing (Cao et al., 2017).
Technology development and advancement lays the foundation of scientific discoveries.
The rapidly improving scRNA-seq technologies enable researchers to further address the longstanding interest of understanding biology from the cells. As the basic building blocks of life,
cells of different types play unique and pivotal roles in the overall function of each organ to
further support essential functions of life. Leveraging scRNA-seq technologies, comprehensive
sequencing of cells from different organs at homeostatic conditions in Mus Musculus has been
flourishing since 2018, empowering the identification of cell types and subtypes and global
analysis of same cell types across tissues (X. Han et al., 2018; Schaum et al., 2018). In addition
to the adult mouse map, continuous effort has been made to chart transcriptomic changes
sampling at multiple time points during gastrulation and organogenesis, mapping out major
developmental trajectories (Cao et al., 2019; Pijuan-Sala et al., 2019). Beyond mouse, the
Human Cell Atlas (HCA) was first proposed in 2017 (Regev et al., 2017). Since then,
collaborative efforts have been made to sequence different cells in various human systems, such
as lung (Schupp et al., 2021), heart (Litviňuková et al., 2020), intestine (Elmentaite et al., 2021),
pancreas (Tosti et al., 2021), immune system (Suo et al., 2022) etc. In light of the COVID-19
pandemic, the meta-analysis of these single-cell data has shed light in understanding the
6

pathology, venue and target of infection, and immune responses (Loske et al., 2021; Melms et
al., 2021; Stephenson et al., 2021). In addition to adult cells, the HCA was further expanded to
the Human Development Cell Atlas (HDCA), empowering the molecular basis for human
organogenesis and development (Cao et al., 2020; Haniffa et al., 2021).
Accompanying the advancement in technologies and exploration of many systems using
single-cell sequencing (scRNA-seq), the volume of data generated has escalated exponentially.
Compared to gene expression profile in bulk, transcriptomes within individual cells posed new
challenges in analysis. Due to the low number of starting transcripts, scRNA-seq data is usually
noisy and shallow (Cao et al., 2019; X. Han et al., 2018). To allow detection of low
transcriptome levels, the mRNA is reversed transcribed, and the cDNA is amplified for them to
be detected, leading to potential distortions and bias (Sandberg, 2014). In addition, lowabundance transcripts, such as those encoded by transcription factors and regulatory genes, fail
to be detected in scRNA-seq dataset, presenting large proportion of zero values and sparse
matrices. These unique features of single-cell data posed a demand in development of statistical
and computational frameworks (Andrews et al., 2021).
To tackle potential quantitative bias introduced during cDNA synthesis and
amplification, unique molecular identifiers (UMIs) were introduced to become a direct and more
accurate measurement of gene expression compared to RNA reads. The usage and incorporation
of UMI barcodes in the bead-primed oligos assists the quality of downstream analysis (Andrews
et al., 2021; Islam et al., 2014). After the libraries are sequenced, the data was processed to
produce the cell-barcode matrices, which is analyzed to further uncover the biological relevance.
While multiple frameworks have been developed over the years, this work mainly used the 10x
Genomics Cell Ranger pipeline to process the raw sequencing data (Zheng et al., 2017). In
7

general, data is filtered for correct cell barcodes, aligned to transcriptome using STAR aligner,
further filtered to include unique-hit genes and correct UMI sequences, and counted to create the
final UMI count matrices (Zheng et al., 2017). The matrices generated are next preprocessed to
reduce noise and support further biological interpretation of the data.
Single-cell RNA-seq matrices are analyzed via the general five steps, including quality
control (QC), normalization, feature selection, dimensional reduction, and clustering. Quality
control steps involves addition selection of the genes as well as cells. Genes and cells are
selected based on the thresholds of minimum number of cells expressing the gene and minimum
number of genes detect per cell, respectively (Andrews et al., 2021). Further, mitochondria gene
percentage is used to remove potential damaged or dying cells.
A critical next step in analyzing RNA-seq data is normalization. RNA-seq data needs to
be normalized and scaled against different factors, such as library size and depth of reads, prior
to further analysis. As a result of the intrinsic stochasticity of single-cell gene expression
(Elowitz et al., 2002), single-cell datasets show high cell-to-cell variability, making
normalization a particularly important step in analysis. Bulk transcriptome data is usually
normalized to a size factor, determined based on the sequencing depth of each sample. Though a
similar approach may apply to single cells, single cell data is more prone to variation due to
multiple factors, such as diverse gene expression levels in different cell types, uneven
sequencing depths among cells, cell cycle stages, and high sparsity, etc. One approach to
normalization is to robustly estimate the size factor by pooling across cells (Lun et al., 2016). An
alternative involves the usage of synthetic spike-in RNAs, External RNA Control Consortium
(ERCC) (Jiang et al., 2011), or expression of housekeeping genes (Anders & Huber, 2010;
Robinson & Oshlack, 2010). Yet, to have known and controlled concentration, synthetic spike-in
8

RNAs are mostly amenable to well-based single-cell technologies while hard to adapt for
droplet-based approaches. In addition to normalizing across the entire dataset, other approaches,
such as scTransform (Hafemeister & Satija, 2019), account for the expression of each gene to
take in the differences between highly and lowly expressed genes (Andrews et al., 2021).
Single-cell matrices demonstrate the feature of high dimensionality, represented by the
inclusion of ~20,000 genes. Yet, a lot of genes are not expressed or captured in an experiment
depending on different cell types, protocols, or technologies. Such highly sparse datasets make
downstream analysis challenging, such as inaccurate distance metrics and uncomfortable matrix
calculations. To alleviate such challenges, feature selection is a key step to select genes of strong
biological relevance to reduce noise and simplify further analysis (Andrews et al., 2021). The
common approach used in the field is to choose highly variable genes based on cell-to-cell
variations. However, focusing solely on the variance of expression profile could overlook the
technical noise and dependence between the variance and mean of the data. Thus, methods, such
as Seurat, fit a mean-variance relationship in the data to compute expected variances, which is
then used as the metric for gene selection (Stuart et al., 2019). With such feature selection, the
data is then scaled to the standard normal and processed for the proceeding dimensional
reduction step.
With the initial dimensional reduction using feature selection, additional dimensional
reduction steps are performed to further remove the challenges posed by high dimensionality.
The feature-selected dataset first undergoes principal component analysis (PCA) and components
that explain significant fractions of variance are chosen for the next step (Peres-Neto et al., 2005;
S. Sun et al., 2019). Further dimensional reduction approaches, such as Uniform Manifold
Approximation and Projection (UMAP; McInnes et al., 2018) and t-distributed Stochastic
9

Neighbor Embedding (t-SNE; van der Maaten & Hinton, 2008), are applied for visualization in
two-dimensions. UMAP first constructs a manifold, a particular weighted k-neighbor graph,
where the data is approximately uniformly distributed. The graph is then simplified and projected
on the lower dimensional space. As the goal of UMAP algorithm is to preserve the structure of
the manifold, UMAP performs better at maintaining the connected global structure of the data
compared to t-SNE (McInnes et al., 2018), whose focus is to capture the local structure and
separate clusters in the global space (van der Maaten & Hinton, 2008). The application of either
UMAP or t-SNE can be dependent on the emphasis of the analysis. Yet, as neither preserve the
cell-to-cell distances, the projection results should be used with caution in downstream analysis,
such as clustering (Andrews et al., 2021).
Clustering is an essential step in analyzing scRNA-seq data to group and distinguish cells
based on the similarity in expression profiles. Cells can be separated into different clusters driven
by various reasons, such as similar cell types or cell cycle states. Starting with the k-means
clustering algorithm (SC3; Kiselev et al., 2017), the single-cell field has moved to adopt graphbased clustering algorithms, such as Louvain (Blondel et al., 2008) and Leiden algorithms (Traag
et al., 2019). This category of algorithms constructs a graph network among the cells and based
on connectivity, identify distinct cell-modules in the graph. Identified cell groups can be
projected on the two-dimensional space for visualization and a preliminary interpretation.
Downstream analyses post clustering includes three major categories: 1) differential gene
expression analysis, 2) pseudotime analysis or trajectory inferences, and 3) cell type annotation.
Differential expression (DE) analysis is an essential analysis to distinguish the genes that
separate different cell groups. Yet, traditional methods comparing averaged populational
expressions in bulk RNA-seq are challenging as single-cells represent gene expression across
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cells as a distribution. From the non-parametric Wilcoxon rank sum test to scRNA-seq specific
method (e.g., MAST; Finak et al., 2015), different statistical tests have been proposed and
evaluated to identify significant expression differences in distributions between populations.
Another approach is to average the gene expression across cell populations such that the
averaged profiles can be compared, similarly to bulk RNA-seq data (Baran et al., 2019). As
diverse methods emerge, DE analysis enables further biological interpretation of the data, such
as identification of potential markers or perturbation targets to specific populations.
During a continuous biological process, it is potentially inappropriate to place cells into
distinct buckets of cell types as they follow a continual trajectory. Pseudotime analysis concerns
cells collected from such biological processes, such as development and reprogramming. A
common approach used in trajectory inference methods includes two steps: 1) construction of a
manifold of the data in a lower dimensional space, and 2) identify a graph that best capture the
topology of the manifold (Andrews et al., 2021; Saelens et al., 2019). For instance, Monocle
reduces the data to lower dimensionality, build a minimum-spanning tree (MST), and orders the
cells following the MST (Trapnell et al., 2014). Over the years, trajectory inference methods
have been flourishing to produce better representations of continuous biological processes (e.g.,
PAGA, Wolf et al., 2019; Slingshot, Street et al., 2018; etc.). Evaluation of these methods has
offered comprehensive criteria based on the data to choose the appropriate algorithm for optimal
inference (Saelens et al., 2019).
A natural question that follows the clustering step is to ask “What are these cells? What
are their in vivo correlates?” Starting from manual annotation focusing on marker expression,
many automated cell-type classification algorithms have emerged over the past years. In the next
section, I will review the current existing algorithms and the challenges to be tackled.
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1.1.2 Classification Algorithms
Before annotating cell identity, a key question needs to be discussed: what is the
definition of cell type or cell identity? It has been a long-lasting interest to break down and
decipher the cells that constitute living organisms. Starting from histological approaches, the idea
of cell identity has been constantly growing with the advancement of technologies to include
multiple facets that define cell type. The identity of a cell has been expanded and proposed in
recent years to include its phenotype and function, lineage, and present states. Phenotype and
function widely include different aspects of a cell, such as molecular composition, morphology,
spatial context in vivo, functionality, differentiation potential, and so on. The lineage aspect
reveals where the cell starts, its potential destination, and its timestamp in a continuous
biological process, such as development. The present cell state describes the response of a cell to
its environmental stimuli, such as if it is perturbed or in homeostasis (Morris, 2019; Savulescu et
al., 2020). With a complex definition of cell identity, it is worth noting that single-cell RNAsequencing enables us to decode cell identity from the molecular angle of RNA. Yet, it might not
exactly correlate to the interpretation of cellular function (Morris, 2019; Pasquini et al., 2021;
Savulescu et al., 2020). Future consideration to incorporate multi-omics data could lead us to a
more comprehensive blueprint of a cell’s identity.
The exploration of cell identity based on RNA-seq data started in bulk. A few methods,
such as over-representation analysis (ORA) and gene set enrichment analysis (GSEA), were
developed to look for genotype-phenotype relations (Diaz-Mejia et al., 2019; Pasquini et al.,
2021). The unique features, such as high sparsity and noise, of single-cell dataset posed new
challenges and demand for annotation algorithms. Current methodologies can be broadly
categorized to two types: reference-based or reference-free classification. Reference-based
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algorithms normally relies on a reference dataset, such as cell atlas and marker databases. These
approaches further break down to four types based on the choice of their essential building
blocks, including marker gene, statistical test, tree-like relationship, and machine learning
(Pasquini et al., 2021; Y. Zhang et al., 2022). Reference-free classification does not rely on a
reference but tries to group cells sharing similar transcriptional patterns. In the following
subsections, a selection of reference-based methods will be discussed, followed by a brief
discussion of reference-free methods.

1.1.2.1 Reference-Based Methods
Inspired by bulk analysis, initial approaches to annotate single-cell datasets is based on
gene markers. As aforementioned, general analysis of single-cell RNA-sequencing (scRNA-seq)
data involves preprocessing, dimensional reduction, and clustering. Differentially expressed
genes (DEGs) for each cluster can be identified. One approach to categorize cells is to compare
the DEGs for each cluster with known cell-type specific gene set in a marker gene dataset. As
scRNA-seq datasets grow and become publicly available, the cell type markers used in manual
annotation in each dataset have been analyzed and deposited into available databases, such as
CellMarker (X. Zhang, Lan, et al., 2019), PanglaoDB (Franzén et al., 2019), and CancerSEA (H.
Yuan et al., 2019). These databases are generally constructed from extensive mining of public
resources, such as PubMed and Gene Expression Omnibus (GEO). For instance, CellMarker is
curated based on extensive search on PubMed, cross-confirmation across literature, and further
unification by comparison to public resources, such as UniProt (Bateman et al., 2021), Human
Cell Atlas (Regev et al., 2017), etc. Via exhaustive search and careful construction, CellMarker
contains 9,148 markers for 389 cell types of 81 tissues in mouse and 13,605 markers for 467 cell
types from 158 tissues in human (X. Zhang, Lan, et al., 2019). These databases provide valuable
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resources for manual comparison and annotation of single-cell datasets using gene signatures and
lay the foundation for further development of automated classification tools. Yet, manual search
and comparison for marker genes can be labor-intensive and time consuming, with limited
reproducibility (Diaz-Mejia et al., 2019; Pasquini et al., 2021).
Methods, such as scCATCH (Shao et al., 2020) and SCINA (Z. Zhang et al., 2019), that
automate the usage of marker genes have been developed to alleviate the limitations of such
manual annotation. ScCATCH gathers markers from different databases and unifies them to
assemble a tissue specific cell type-marker database, CellMatch. Next, it identifies clusterspecific marker genes of the single-cell dataset and uses evidence-based scoring with CellMatch
to score each cluster for each cell type. The clusters are then annotated based on the scores (Shao
et al., 2020). SCINA employs a probabilistic framework based on expectation-maximization
algorithm. This approach performs clustering on the sample data and assign known cell types to
clusters by fitting a bimodal distribution to the expression of known gene signatures in public
marker databases. In addition to known cell types, SCINA defines and captures novel cell types
for clusters without high expression of any known signatures (Z. Zhang et al., 2019).
Moving away from prior knowledge of marker genes, other approaches have been
developed to annotate clusters based on statistical metrics. The intuitive metric at choice is
correlation assuming profile similarity between single-cell clusters and the reference. CIPR (Ekiz
et al., 2020) and ClustifyR (R. Fu et al., 2020) calculate the centroids of the clusters and the
average expression of each cluster as its pseudo-bulk expression. Clusters are then annotated
based on correlation between the pseudo-bulk expression and the reference datasets (Ekiz et al.,
2020; R. Fu et al., 2020). These approaches improve the automation and enable more accurate
classification. Nonetheless, they are bounded by the definition of the clusters, which can be
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affected by user-defined resolutions that potentially create within cluster heterogeneity (Pasquini
et al., 2021).
Independent of clustering, methods are developed to evaluate cell identity using the
transcriptome on a cell-by-cell basis. SingleR performs differential expression analysis in the
bulk reference set and identifies the top variable genes. Correlation is then computed between
each single-cell profile and each cell type in the bulk reference. Top correlated cell types are
selected to iterate through the steps until only one top cell type remains to be the cell type of the
cell (Aran et al., 2019). With cell atlases becoming publicly available, scmap leverages the high
resolution of single-cell atlases, aiming to map individual cells to cells or clusters in the
reference. Scmap first identifies biologically relevant features and using those features, computes
similarity metrics, including cosine similarity, Pearson, and Spearman correlation. Scmap-cluster
maps individual cells in the sample to centroids of clusters in the reference, while scmap-cell
maps sample cells to cells in the reference. For a cell to be assigned a cell type, scmap-cell
requires agreement in at least two of the similarity metrics, and such similarities hold for at least
three nearest neighbors around the reference cell (Kiselev et al., 2018). Considering the
correlation can be unreliable under the circumstance of high sparsity, more complex statistical
metrics have been employed. For instance, SciBet selects features based on statistical entropy,
where features are more cell-type specific with larger entropy. It then models the expression of
each selected feature as well as expression across genes. Each sample cell profile is evaluated
based on the likelihood over all models and cell type with maximum likelihood estimation is
assigned to the test cell (C. Li et al., 2020).
Tree-based approaches concern the hierarchical relationships within the reference and
cell types are assigned via searches traversing through the tree. These approaches share a similar
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initial step to construct a hierarchical tree of the reference based on distance metrics, such as
correlation or average linkage, across reference cell-type profiles (de Kanter et al., 2019; Lin et
al., 2020; Pliner et al., 2019). Post tree construction, sample cells will travel from top to bottom
through the tree and receive classifications. CHETAH finds the gene signatures for each cell type
at evaluation in the tree, scores the input cell for each cell type, measures the confidence of the
scores, and assigns a cell type (de Kanter et al., 2019). ScClassify takes a different approach of
ensemble learning, taking advantages from different methods for each step. It takes an ensemble
of gene selection approaches and similarity methods to establish a collection of classifiers,
capturing different characteristics for a cell type. Using the bundle of classifiers collectively
allows the algorithm to give accurate assignments to cells (Lin et al., 2020). Garnett requires user
input that contains gene marker information. With the tree built, it employs an elastic net
classifier to classify cells into different cell types. In addition to scRNA-seq data, Garnett can
also classify single-cell ATAC dataset based on gene activity scores (Pliner et al., 2019).
As machine learning methodologies prosper, it has been adapted and applied in analysis
of single-cell datasets with their increasing dimensionality and complexity. Machine learningbased classification tools are developed on a different basis, such as support vector machine
(SVM), random forest, transfer learning, and so on (Pasquini et al., 2021). To avoid significant
individual gene effect, 16cPred uses PCA-transformed gene expression matrices. It builds a
SVM model on the training data and applies the model to the testing data, computing a
conditional probability. Benchmarked by a threshold, the probabilities calculated allows the
assignment of cell types or unknowns. The incorporation of SVM with radial kernels allows the
capture of multi-collinearity and non-linear relationships in high-dimensional data (AlquiciraHernandez et al., 2019). SingleCellNet, like CellNet (Cahan et al., 2014; Morris, Cahan, Li,
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Zhao, San Roman, et al., 2014), applies a random forest algorithm. It identifies features unique to
each cell type and finds the most discriminating sets of gene pairs to binarize the data. A multiclass random forest model is further trained on the binarized data for final classification.
Uniquely, singleCellNet creates a randomly transformed single-cell profile that differs from any
cell types in the reference, enabling the mapping of unknown cell types (Tan & Cahan, 2019).
ScID utilizes Fisher’s linear discriminant analysis to compute discriminative weights in each cell
for each cell-type specific genes identified from the reference. The scores for gene markers are
collectively evaluated to assign cells to reference clusters (Boufea et al., 2020). With the goal to
achieve accuracy, efficiency, and consistency, CaSTLe implements transfer learning. It performs
feature selection based on multiple filtering criteria internal to the tool and trains a XGBoost
classification model on the selected features. The trained model is applied to sample scRNA-seq
data for cell identity categorization (Lieberman et al., 2018). Finally, ACTINN is established on
a three hidden-layer neural network, trained, and tested using Tabula Muris (Schaum et al.,
2018). It has been demonstrated to have high accuracy in cell subtypes and is robust against
different single-cell profiling techniques (Ma & Pellegrini, 2020).

1.1.2.2 Reference-Free Methods
Compared to reference-based methods, reference-free approaches remove the
dependencies on the previously established data and build solely on the test dataset to identify
patterns of cells or features that separate different groups.
Concerning the limited sequencing depth per cell in scRNA-seq and large proportion of
unmapped reads, scSimClassify is a reference-free and alignment-free annotation tool. Instead of
genes, features are defined as k-mers in the reads, which are further preprocessed and filtered to
include only informative k-mers. The selected k-mers are then used to generate a n-bit fingerprint
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and grouped into compressed k-mer groups (CKGs) based on similar abundances. Rather than
cell-by-gene matrices, scSimClassify creates cell-by-CKG matrices that are further used to
identify cell patterns and correlates to gene features (Q. Sun et al., 2021).
ScCoGAPS considers cell identity as the result from collective effects of diverse
processes, leading to various cell states that may not be found in publicly available references.
Focusing on the decomposition of latent spaces and comparison across multiple datasets,
scCoGAPS employs non-negative matrix factorization (NMF) algorithms and transfer learning to
allow target cells to align with the same latent space learned in the source and learn differential
features represented in identified patterns. Applications to developing retina dataset demonstrates
its ability to capture cell patterns during continual process, aligning with temporal progress
during development (Stein-O’Brien et al., 2019).
Though not an exhaustive demonstration of all current available classifiers, the above
discussion represents the major categories of classification algorithms. The rapid development of
tools to annotate cells opens exciting opportunities for downstream analyses and generates
hypotheses for experimental validations and discoveries.
As most of the classifiers attempt to categorize cells in a discrete manner, limiting their
application in continuous biological processes, such as development, reprogramming, and
disease. In the next subsection, we will focus on the review of cellular reprogramming and lay
the foundation for understanding heterogeneity in these processes.

1.1.3 Cellular Reprogramming
In 1957, Waddington proposed a landscape model to depict development from stem cells
to defined terminal fates. In this landscape, differentiation from stem cells is portrayed as a ball
rolling down from the top of a mountain toward different valleys, where the top defines the
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pluripotent state, and the valleys describes diverse differentiated cell identities. This model
explains embryonic development to be a unidirectional, progressive, and irreversible restriction
of cell fate determination (Waddington, 1957). Yet, the breakthrough in pushing cells “back up
the hill” to a more potent state or “crossing the valleys” to a different fate has expanded the
landscape to be more flexible in directionality and reversibility (Ladewig et al., 2013; Morris,
2019).
The spark of rewiring the cell from a differentiated to a totipotent state was initiated in
1958 by John Gurdon. Prior to this discovery, Robert Briggs and Thomas King have attempted
and succeed in nuclear transfer experiments in single-celled organisms (R. Briggs & King,
1952). Following such endeavor, via somatic cell nuclear transfer (SCNT) – transferring the
nucleus of one cell into an enucleated oocyte, Gurdon and his colleague demonstrated that the
recombinant egg was able to successfully develop into a viable animal. These experiments
demonstrated the possibility of reprogramming the somatic epigenome to pluripotency under
internal cues, challenging the unidirectional Waddington landscape, laying the foundation for
cellular reprogramming (Gurdon et al., 1958; Morris, 2019). In addition to efforts to push
differentiated cells toward to pluripotency, it was found that a differentiated cell can be
reprogrammed to another differentiated fate with the guidance of ectopic expression of
transcription factors. Pioneering the field of cell fate engineering between somatic cell types was
the identification of a transcription factor, Myod1, in 1987. The gene was identified via a
screening of a pool of cDNA probes and overexpression of the transcription factor was shown to
fibroblasts to myoblasts (Davis et al., 1987). Since then, large efforts have been made to identify
sets of factors that can induce pluripotency and conversion across somatic cell types (H. Wang et
al., 2021).
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In 2006, Kazutoshi Takahashi and Shinya Yamanaka identified that overexpression of
four transcription factors, including Oct3/4, Sox2, c-Myc, and Klf4, can reprogram differentiated
cells to an induced pluripotent state, where cells have the potential to differentiate to multiple
cell types. Considering the potential of embryonic stem cells (ESC) in the treatment of diseases,
this Nobel-prize winning discovery of induced pluripotent stem cells (iPSCs) shed light in
regenerative medicine to circumvent the challenges of ESC isolations (Takahashi & Yamanaka,
2006). Under proper exogenous cues with small molecules and growth factors, somatic cellderived iPSCs can be guided to desired cell types, such as spinal motor neurons (Dimos et al.,
2008) and cardiomyocytes (Lian et al., 2012). Yet, this approach is lengthy with potential
tumorigenic risk with intermediate induced pluripotency. In addition, the engineered cells do not
faithfully recapitulate the target cell identities (H. Wang et al., 2021).
As the intermediate pluripotent state introduces uncertainty, the previous identification of
MyoD inspired a series of discoveries to bypass intermediate states and induce direct conversion
between somatic cell types. Compared to going through iPSCs, direct cell fate conversions are
faster with higher fidelity and have unique niche of in vivo tissue repair (ref). Broadly, these
reprogramming protocols can be divided into two categories, including conversions between cell
types originated from different germ layers or from the same germ layers (Ladewig et al., 2013).
In the Morris lab, a relevant process to cell fate reprogramming across germ layers
involves the conversion form fibroblasts to the endoderm lineage, such as hepatocytes (Sekiya &
Suzuki, 2011). Starting from mouse embryonic fibroblasts (MEFs), this protocol overexpresses
two transcription factors, Hnf4 and Foxa1/2/3. The resulting cell type was first reported as an
‘induced hepatocyte’ with the capacity to engraft damaged liver (Sekiya & Suzuki, 2011).
Nonetheless, it was later found that these cells have broader potential to engraft damaged
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intestine, leading to their new name, ‘induced endoderm progenitors’ (Guo et al., 2019; Morris,
Cahan, Li, Zhao, San Roman, et al., 2014). Using lineage tracing and single-cell sequencing,
recent work from the Morris lab has illuminated the bifurcation of the resulting population into
successfully reprogrammed cells and cells that fail to achieve the target identity (Biddy et al.,
2018).
Another illustrative procedure demonstrates the engineering of fibroblasts to the
ectoderm lineage, such as neurons (Ladewig et al., 2013). With screening of transcription factors
(TFs) in the neuronal lineage, a combination of three factors, including Ascl1, Brn2, and Myt1l,
was identified to reprogram MEFs to induced neurons (Pang et al., 2011; Vierbuchen et al.,
2010), The induced neurons adopt neuronal morphology with expression of neural markers and
firing of action potential. Further, modulation with additional neural subtype-specific factors can
further specify different subtypes of neurons, such as motor neurons (Aydin & Mazzoni, 2019;
Son et al., 2011). In addition to TF-mediated reprogramming, other regulatory factors, such as
micro-RNAs, have been demonstrated to induce reprogramming. For instance, the combination
of miR-9/9* and miR-124 can introduce the switch from fibroblast to neuron identity (Yoo et al.,
2011). Though mechanistically distinct between different regulatory factors, the diverse
approaches further support the plasticity of cells and the ability to cross the “long-distance”
barrier created by different developmental history (H. Wang et al., 2021).
Compared to cross germ layer-reprogramming, within germ layer-reprogramming
concerns the trans-differentiation between cell types that are developmentally related (Ladewig
et al., 2013). A relevant example involves such lineage switching is within the hematopoiesis
lineage, from B cells to macrophages. Starting from committed B-cells in the lymphoid lineage,
overexpression of transcription factor, Cebp, can induce macrophage phenotypes within 72 hours
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of induction (H. Xie et al., 2004). Like neural reprogramming, addition of other factors, such as
Gata2, can redirect lymphoid cells to other hematopoietic lineages (Iwasaki et al., 2006).
However, it was found that the converted cell identity was not sustained, with marker expression
of the starting cell type regained over time (Morris, Cahan, Li, Zhao, San Roman, et al., 2014).
Direct cardiac reprogramming exemplifies another protocol that engineers within the
same germ layer. As it serves a major system in the second half of this thesis, I will discuss this
cell fate conversion process in detail in the next subsection.

1.1.3.1 Direct Cardiac Reprogramming
Heart disease is a leading cause of death worldwide. One of the key pathologies
contributing to cardiovascular disease is the loss of functional cardiomyocytes, whose postmitotic nature limits regenerative potential (Ieda et al., 2010; Qian et al., 2012; Song et al.,
2012). Induced pluripotent stem cell (iPSC) reprogramming from somatic cells opened broad
opportunities in direct differentiation of mature cardiomyocytes from a stem-cell like state (Lian
et al., 2012; Takahashi & Yamanaka, 2006). Yet, the inefficient conversion to iPSCs along with
limited differentiation to cardiomyocytes produces a heterogeneous population, hindering the
clinical utility of these cells (Ieda et al., 2010). Direct reprogramming between somatic cell types
is a promising alternative for faster and more efficient production of the target cell types (H.
Wang et al., 2021). Composing 50% of the heart, cardiac fibroblasts serve important structural
and signaling functions in normal heart. Upon injury, cardiac fibroblasts are activated to
proliferate and respond to form the scar tissue. This endogenous source of cells holds much
promise for reprogramming and repair to generate functional cardiomyocytes in vivo (Ieda et al.,
2010; Qian et al., 2013; Song et al., 2012; H. Wang et al., 2021).
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In 2010, without known master regulators, a similar screening approach was employed to
find appropriate transcription factors (TFs) for cardiac conversion. In brief, cardiac fibroblasts
and cardiomyocytes were subject to the microarray assay, and 14 higher expressing factors in
cardiomyocytes were identified as potential factors. Via iterative removal of one factor from the
combination, the combination of three key transcription factors, Gata4, Mef2c, and Tbx5 (GMT),
was found to be sufficient to generate cardiomyocytes with cardiac-specific expression,
sarcomere structure, and electrophysiology. Transplantation of TF-transfected fibroblasts
demonstrates conversion and functional engraftment in vivo (Ieda et al., 2010). Nonetheless, the
overall conversion efficiency remains low, ranging from 1.5% to 3% (Qian et al., 2013; Song et
al., 2012). An optimal set of TFs, including GMT and Hand2 (GHMT), was thus explored and
established to reprogram with an increased efficiency between 7% and 9% (Song et al., 2012).
Taking this protocol beyond in vitro, in vivo reprogramming induced by direct delivery of
TFs into diseased heart is shown to be effective to improve cardiac function in the damaged
myocardium post myocardial infarction (MI). In brief, the TFs are locally delivered to the
infarcted region via retrovirus, and the region is allowed to reprogram and recover. Evaluations
at 12 weeks post MI show significant improvement in cardiac functionality and decrease in scar
size with the TF-delivery compared to control dsRed-delivery. Notably, in contrast to in vitro
induced cardiomyocytes, in vivo reprogrammed cells are reported to achieve more mature
phenotypes, such as contractility, and more closely mimic resident cardiomyocytes in the heart.
It is suggested that cues from the microenvironment in vivo could have facilitate the process to
maturity, inspiring additional approaches to improve the protocol (Qian et al., 2012).
To further enhance reprogramming outcomes, chemical enhancement and additional
factors have been tested to facilitate the reprogramming process. For instance, in GHMT-guided
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reprogramming, addition of Akt1, protein kinase B, enhances cardiomyocyte reprogramming by
2-fold increase in efficiency and enhanced cardiac-specific transcription, structural protein, and
morphology (H. Zhou et al., 2015). Additionally, alternative modulations with GMT, such as a
set of two small molecules that inhibit Wnt and TGF pathways, are found to improve the
efficiency by over three-fold compared to GMT only (Mohamed et al., 2017). Beyond mice,
direct cardiac reprogramming from human skin fibroblast has been explored considering its
potential to improve heart diseases. With further optimization, miR-133 is identified as a key
regulator with MGT to induce efficient conversion in human cells (Y. Zhou et al., 2019).
Though we have seen continuous advancement in reprogramming protocols the
underlying molecular mechanisms driving this process remain unclear. Recent studies have
elucidated important features of this cell fate conversion (de Soysa et al., 2019; Stone et al.,
2019; Y. Zhou et al., 2019). Single-cell transcriptomics has revealed that cells during early
conversion transit through a bifurcation, with one route leading to reprogramming while the
other becomes refractory to cardiac conversion (Y. Zhou et al., 2019). In support of this, in joint
epigenetic and single-cell analysis, transition cells are found to determine their terminal fate in
the first 24-48 hours and take one of the two paths, either to cardiac fate or to non-cardiac
identity resembling fibroblast or vascular developmental cell states (Stone et al., 2019). Analysis
of chromatin landscape changes illustrates enhancers activated at early transition resemble
mostly neonatal cardiac development, gradually moving toward postnatal and adult stages. This
demonstrates that early reprogrammed cells adopt an immature identity, mimicking embryonic
development, before specification and activation of mature cardiac enhancers toward an adult
fate (Hashimoto et al., 2019).
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The development of technologies has expedited the discoveries to understand the
underlying mechanism of cardiac reprogramming, bringing us closer to future clinical
applications. Current studies rely on clustering to identify cellular subpopulations before, during,
and after reprogramming (Y. Xie et al., 2022). As aforementioned, the limitations of clusteringbased approach could miss the identification of rare cells or cells in progress of changing. In
addition, present trajectories established are inferred from gene expression. Based on current
studies, we ask the following questions. Could we systematically identify and annotate these
cells, including cells in transition? Using lineage tracing technologies, could we build a “ground
truth” map of lineage, connecting cell ancestry via heritable cell labeling? In addition, could we
identify putative TFs that assist reprogramming via gene regulatory network construction?
In a nutshell, reprogramming strategies have grown exponentially during the past two
decades, laying the foundation for future regenerative medicine. Yet, the low efficiency and
fidelity of the resulting cell types hinders the application in clinical settings. Understanding such
heterogeneity and dissection of cell identity and state at different stages can facilitate potential
methods for improvement. Laying on a continuum, cells in transition could offer invaluable
insights into key stages along the processes. In the next section, we will briefly focus on
transition cells during continuous biological processes and further develop the questions of
interest in this thesis.

1.1.4 Cells in Transition
The Waddington epigenetic landscape established the idea of continuous development as
well as offering a conceptual framework for mathematical modeling. Flourishing single-cell
sequencing technologies have brought the resolution to the next level and enabled closer
exploration of cells during fate decision-making processes, such as differentiation,
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reprogramming, and disease. Due to the asynchronous nature of captured cells, the data contains
cells in different states, including differentiated fates, primed progenitor or stem states, and
transitions (Brackston et al., 2018; MacLean et al., 2018; Moris et al., 2016). Known fates and
states have been defined based on diverse phenotypes, such as marker expression, morphology,
and protein level, while transition states take a broader definition as any potential intermediates
between different defined states (MacLean et al., 2018). For instance, using hematopoiesis
hierarchical lineage as a model, these transition cells could be bipotent progenitors (e.g.,
granulocyte-monocyte progenitors), states from monocytes to macrophages, or cross-lineage
stages between monocytes and neutrophils (Olsson et al., 2016). This broad concept paints
transition states as a continuous blueprint with less stability but more fluidity, posing new
challenges on inference and modeling (S. Jin et al., 2018).
One approach of addressing such states in continuous processes from single-cell datasets
is based on pseudotemporal ordering algorithms, as previously discussed in section 1.1.1. These
algorithms align the asynchronous cells based on gradual transcriptional changes (Kester & van
Oudenaarden, 2018). Identification of terminal identities on the trajectories connects the cells in
between terminals as transition cells. The other category of approaches is established based on
the concept of the Waddington hierarchical structures (S. Jin et al., 2018). For instance, entropy
is adopted to measure stemness and potency of the current cell state. StemID is a method
developed to identify stem cell state based on an entropy metric. RaceID2 is first applied to
annotate cell types on the single-cell clusters. Lineage tree is then inferred with prior knowledge
regarding topology of the system of interest, where cells are further positioned on the links
between pairs of clusters. Cell states with high connectivity and transcriptome entropy are
predicted to have a stem cell identity. Whereas low entropy states mark the putative
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differentiated states of the system (Grün et al., 2016). Nevertheless, clustering-based methods
tend to separate cells into distinct clusters, overlooking potentially rare transiting cell populations
(P. Zhou et al., 2021).
To directly dissect transition dynamics, other approaches, incorporating interdisciplinary
models from physics, have been proposed to model transition probabilities and infer lineage
trees. ScEpath is an approached based on an energy landscape of single-cell processes. Instead of
an emphasis on variations between different genes, this approach computes the energy estimation
based on the connectivity and interdependence among genes within the gene regulatory network.
Principle component analysis and clustering are further performed on the estimated energy to
place the cells on a landscape. Transition probabilities for each state are computed based on the
energy within each state and the distances in the reduced dimensional space between pairs of
clusters. With the inferred probabilities, lineages are constructed following a probability-directed
graph, further enabling downstream analysis, such as pseudotime calculation and identification
of driver genes in cell fate-decision making (MacLean et al., 2018).
Recently, considering the dynamics within the transition cells, MuTrans took on the idea
dynamic modeling to characterize transition cells. Taking the metaphor of Waddington landscape
on development, MuTrans considers that, in the hilly landscape, valleys are differentiated fates
while peaks are bipotent or multi-potent states. Cells at the peak could have bi-stability or multistability, yet those at the valleys have most stability. Any position in between the peak and valley
is considered as transitions. To identify a path of movement, MuTrans implements random walks
in three scales: 1) to compare cell to cell, 2) to compare cluster to cluster, and 3) to compare cell
to cluster. Iterative modeling in the three scales leads to ultimate identification of a potential path
of the cell from one fate to the other. Application of MuTrans to dynamic systems, such as iPSC
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differentiation, has revealed key cell fate-decision dynamics with their key related driver genes
(P. Zhou et al., 2021).
At the same time as development of inference of transitional cell states, another important
question posed is “what are the roles of these intermediate cell states?” Five putative roles of
these cell states have been proposed. First, these cell states serve as a controlled switch in a
bidirectional relationship between two fates. For instance, in the condition of epithelial-tomesenchymal transition (EMT), the intermediate state is a key transition to push the cells from E
to M (MacLean et al., 2018). Second, cells at this cell state harbors multiple characteristics from
distinct cell types, namely a hybrid phenotype. This hybrid phenomena have been previously
identified in different systems (Farrell et al., 2018; Hong et al., 2012, 2015; Olsson et al., 2016).
Hematopoiesis is one of the examples where bistable cells are found to express both monocytic
and neutrophilic lineage-specific markers (Olsson et al., 2016). The third role proposed is to
maintain the balance of cell populations. Responding environmental cues or changes, cells at
intermediate states can fluctuate to attenuate the fluctuations within the different cell
populations, such as E and M cells during EMT. The next function in consideration is that these
transition states maintain a higher potential to readily expand to their differentiated cell types. An
example demonstrating this is EMT in cancer, where the identified bipotent intermediates are
considered to have higher stemness and ability to generate both E and M cells. Last proposed
function is to serve as a checkpoint during the continual processes, such as checkpoint before full
differentiation to terminal fates (MacLean et al., 2018; Sha et al., 2019). These proposed
functions highlight the potential pivotal roles of transition states and postulate interesting
hypothesis in modulating the dynamics in continuous biological systems.
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Investigation in transition cells during differentiation and disease progression have
unraveled genes that guide the decision-making process. Similarly, we would like to consider
these cell states during transcription factor (TF) -mediated reprogramming. As the current
reprogramming protocols are inefficient with low fidelity, we can ask key questions from the
scope of transition cells. What are the key transition states between the starting population and
target cell types? How can we introduce additional modulation to the core TFs to push the cells
toward the proper transitions toward the target?
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1.2 Key Questions in the Field and Goals
This dissertation will focus on the following challenges in the field: 1) classification in a
continuous biological process, 2) identification of intermediate cells during programming and
reprogramming, and 3) systematic characterization of cellular heterogeneity. With these
challenges in mind, I formulate two specific project goals:
1. I will develop computational tools to better understand heterogeneity in complex,
continuous biological systems.
2. I will apply our in-house technologies and tools in another reprogramming system, direct
reprogramming of cardiomyocytes, to study the heterogeneity, lineage, and underline
mechanism.
To approach these goals, statistical methods, technologies, and biological systems will be
utilized. Major technologies, methods, and systems will include single-cell RNA-sequencing of
various systems as discussed in Subsection 1.1.1, classification algorithms as reviewed in
Subsection 1.1.2, and direct cardiac reprogramming system as discussed in Subsection 1.1.3.
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2.1 Abstract
Transitions in cell identity are fundamental to development, reprogramming, and disease. Singlecell technologies empower the dissection of tissue composition on a cell-by-cell basis in complex
biological systems. Yet highly sparse single-cell RNA-seq data poses challenges for cell-type
annotation algorithms based on bulk RNA-seq data. Furthermore, current methods mostly
require prior biological knowledge regarding gene signatures and classify cells in a discrete,
categorical manner. Here, we present a bioinformatic tool, Capybara, to measure cell identity on
a continuum, at a single-cell resolution. This approach enables the mapping of gradual changes
in cell identity throughout development and reprogramming. Furthermore, Capybara not only
supports the classification of discrete cell entities but also identifies cells in transition, a ‘hybrid’
cell state, representing critical connections during cell identity acquisition. We benchmark the
performance of Capybara against other existing classifiers and demonstrate its efficacy to
accurately annotate cells. Further, we validate Capybara-predicted cell-fate transitions using
“ground-truth” lineage information within a well-characterized differentiation hierarchy,
hematopoiesis. Our application of Capybara to in vitro programming strategies reveals
previously uncharacterized patterning deficiencies, instructing a new approach to alleviate the
lack of appropriate patterning in motor neuron programming. Further, application to the direct
reprogramming of fibroblast to induced endoderm progenitors identifies a putative in vivo
correlate for this engineered cell type that has, to date, remained poorly defined. These findings
prioritize interventions to increase the efficiency and fidelity of these cell engineering strategies,
showcasing the utility of Capybara to dissect cell identity and fate transitions in development,
reprogramming, and disease.
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2.2 Introduction
Cells are the fundamental building blocks of complex biological systems, with each
defined cell type governing specific functions and mechanisms (Altschuler & Wu, 2010; Paszek
et al., 2010). Uncovering cell identities is essential to establish a comprehensive atlas,
standardize cell biology, and allow future advancements in medicine and biology. As genes
encode distinct transcripts in disparate cell types, whole-cell transcriptome profiles serve as a
characterization metric for cell identities (de Wit, 2017). While population RNA-sequencing was
applied to classify a bulk group of cells into categories, concerns, such as loss of cell-to-cell
variation and lack of resolution, have emerged with growing demands of decoding cellular
heterogeneity at a higher resolution (Alquicira-Hernandez et al., 2019; Elowitz et al., 2002).
High-throughput single-cell RNA-sequencing (scRNA-seq) technologies have revolutionized the
cellular resolution of sequencing to a new standard (Klein et al., 2015; Macosko et al., 2015;
Zheng et al., 2017). This rapidly evolving technique opened broad opportunities to portray cell
dynamics in complex processes and decode cellular composition on a cell-by-cell basis.
Nevertheless, scRNA-seq is susceptible to noise and dropout, especially for low-abundance
transcripts, such as cell-type-specific and regulatory genes, resulting in highly sparse data. This
poses challenges for cell-type classification algorithms previously developed for bulk
transcriptome profiles. In recently established atlases (X. Han et al., 2018; Schaum et al., 2018),
cell identities are manually annotated via unsupervised clustering and known cell-type-specific
marker analysis within each cluster. Manual annotation of scRNA-seq data is time-consuming
and labor-intensive as the cell number, especially if prior knowledge of cell type-specific
markers is limited.
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In addition, compared to the homeostatic systems characterized in these atlases, accurate
classification in dynamic systems represents additional challenges as cell states are in a
continuum. For instance, previous approaches built based on bulk transcriptome revealed
incomplete conversion of cell identity during reprogramming, where the resulting cell population
retains the features of the starting cell type, demonstrating continual transition during the process
(Cahan et al., 2014; Morris et al., 2014).
To tackle these challenges, various computational and analytical algorithms have
emerged to support automated annotation of cell identity from single-cell datasets (Abdelaal et
al., 2019). For example, Garnett utilizes both scRNA-seq and scATAC-seq data to classify
single-cell data in three steps: input of gene markers, identification of representative cells, and
classification of other cells (Pliner et al., 2019). In contrast, ScPred builds a prediction model
based on a training scRNA-seq dataset and estimates the probability of each cell belonging to a
cell type, based on which a binary classification is provided (Alquicira-Hernandez et al., 2019).
However, as Garnett is presented as a supervised method, it is limited by the availability of prior
biological knowledge. In addition, discrete and categorical identification of cell type is beneficial
in describing cells with deterministic or defined fates. Yet, it can be challenged upon evaluation
of cells in continuous biological processes, such as early development and reprogramming,
where quantitative and continuous measures of cell identities would be valuable (Tan & Cahan,
2019). SingleCellNet (SCN) is an approach that quantitatively assesses identity via comparison to
reference single-cell datasets using random forests and top-pair transformation. In this approach,
gene selection was first performed to select genes that are preferentially and specifically
expressed in each cell type in the training set. Using the selected genes, the training set is
binarized to train the random forest classifier, which is further used for unknown single-cell cell34

type classification (Tan & Cahan, 2019). While a thorough selection of gene sets that distinguish
cell types, it could be challenging to identify a training set that properly contains all cell types to
map the testing single-cell data without prior information. Moreover, as these approaches
emphasize discrete and categorical cell types, leading to a potential omission of cells at transition
or with mixed identities (Tan & Cahan, 2019).
While cataloging discrete cell types is beneficial in describing cells with deterministic or
defined fates, it is limited for the evaluation of cells in continuous biological processes, such as
early development and reprogramming. Here, we present Capybara, an unsupervised method to
quantitatively assess cell identity as a continuous property against publicly available single-cell
datasets. Considering cell identities as snapshots of the continuum of biological processes, we
compute quantitative scores to measure the likelihood of each cell belonging to a defined cell
class via quadratic programming, a method previously used to evaluate cell identity in
reprogramming processes (Biddy et al., 2018; Cates et al., 2021; Treutlein et al., 2016). Based on
these continuous identities, we further establish a comprehensive classifier that determines the
discrete cell class of each cell. Unlike existing methods, Capybara uses continuous identity
scores to allow multiple identities to be assigned to an individual cell, enabling identification of
hybrid cell types. Building on this unique feature, we develop a ‘transition metric’ to quantify
cell fate transition dynamics.
The efficacy and robustness of Capybara are evaluated against a range of existing cell
type classifiers, demonstrating its accuracy to annotate discrete cell identities (Abdelaal et al.,
2019). We validate hybrid cells via experimental lineage tracing data of hematopoiesis, in
addition to RNA FISH and immunostaining of one of the hybrids during cardiac reprogramming.
We also showcase distinct applications in differentiation, programming, and reprogramming
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processes to diagnose and instruct shortcomings. In direct programming of spinal motor neurons
from embryonic stem cells (ESCs) and reprogramming of cardiomyocytes, Capybara reveals offtarget cell types arising from potential deficiency in patterning. Addition of signaling factors
enhances the generation of motor neurons by over four-fold. Finally, beyond relatively wellcharacterized cell types, analysis of direct reprogramming from fibroblast to induced endoderm
progenitors (iEPs) identifies a potential in vivo correlate to this relatively mysterious
reprogrammed cell type. We further validate this cell type experimentally. Take it together, we
highlight the utility of Capybara to interrogate cell fate transitions in dynamic biological systems,
emphasizing strategies to enhance efficiency and fidelity of cell fate engineering. Capybara code
and documentation are available via https://github.com/morris-lab/Capybara.

2.3 Results
2.3.1 Application of quadratic programming
Quadratic Programming (QP) is a method that has been used to classify single cells into
cell types during various processes, such as reprogramming. It models the transcriptome of a
single cell as a linear combination of bulk gene expression signatures of possible cell types.
Under this model, each single cell receives a set of continuous scores for defined cell classes,
enabling quantitative measurements of cell identity (Methods) (Treutlein et al., 2016).
Previously, we have applied this approach to chart cell identity changes over the time
course of reprogramming from mouse embryonic fibroblasts (MEFs) to induced endoderm
progenitors (iEPs). This reprogramming protocol was first reported to generate induced
hepatocytes, where the cells were evaluated transcriptionally using microarray and functionally
with engraftment in damaged liver (Sekiya & Suzuki, 2011). Leveraging the microarray that
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measures the start and terminal cells, we performed a time course experiment to dissect the
lineage and gradual shift of cell identity during this process. With identified differentially
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expressed genes, QP assigns an identity score between 0 and 1 to each cell. Comparing this
quantitative measure of different time points side-by side, we break the data into fibroblast, early
transition, transition, and reprogrammed populations (Figure 2.1 A, B; (Biddy et al., 2018)).
Although this approach with bulk data grants us a general idea of the cell identities in a
single-cell dataset, its resolution is limited by the gene signature selection and low cellular
resolution of the bulk dataset with masked sub-populations. Therefore, we have adopted this
approach to incorporate single-cell RNA-seq datasets with the whole gene set as a reference to
measure cell identity dynamics in the epithelium of small intestine upon small bowel resection
(SBR). The small intestine is a powerhouse, where different types of nutrients are absorbed from
different regions of the bowel. Upon diseases or injury, such as necrotizing enterocolitis or
gastroschisis, a large portion of the bowel is removed with the remaining bowel anastomosed
together. This procedure is referred as small bowel resection (SBR). The significant loss of the
bowel leads to major loss of absorptive epithelium, resulting in decreased nutrient absorption,
potentially resulting in short bowel syndrome (SBS). One potential venue for treatment of SBS
resides on the adaptation of the remaining intestine regions to absorb a broader range of
nutrients, compensating for the loss of the bowel. To unravel the mechanisms of this adaptation,
single-cell RNA sequencing is adopted to understand the epithelium changes post SBR surgery
in mice. Using QP with a single-cell dataset surveying the epithelium of small intestine, we
categorized the individual cells to detailed intestinal epithelial populations, permitting a higher
resolution in cell-type classification (Figure 2.1 C, D; (Seiler et al., 2019)).
Further, we applied this approach to investigate the developmental transitions and
reprogramming protocols. First, we evaluated fetal-to-adult transitions of hematopoietic stem
cells (HSCs) and lineage-committed hematopoietic progenitor cells (HPCs). HSCs and HPCs
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harbor different phenotypes, such as reduced self-renewal ability and different lineage bias,
between fetal and adult stage. Yet, the mechanistic changes during this process were poorly
characterized. Using QP, we revealed that the transitions of HSCs and HPCs from fetal to adult
are gradual instead of bimodal as turning on a switch (Y. Li et al., 2020). Compared to this
continuous scheme, when applied to neural reprogramming using microRNAs, QP reveals a
stepwise cell-fate determination toward neuron identity (Figure 2.1E-G; (Cates et al., 2021)).

2.3.2 Capybara overview, benchmarking, and validation
In Capybara, we further develop QP to enable systematic reference construction based on
bulk and annotated single-cell atlas datasets as well as identity calculation using reconstructed
references. We enable quantitative evaluation of cell identities based on single-cell datasets,
benefiting cell state evaluation in continuous biological processes. This further supports an
unsupervised classification algorithm in four steps, as follows (Figure 2.2; Methods).

Figure Error! No text of specified style in document..2: Overview of Capybara Workflow.
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First, tissue-level classification is performed prior to assessing cell identity at single-cell
resolution. Identification of relevant tissues is performed based on bulk transcriptomes from
ARCHS4, an exhaustive resource platform comprising the majority of published RNA-seq and
ChIP-seq datasets (Lachmann et al., 2018). This step limits the reference cell types to be
included in downstream analysis, reducing excessive noise and dependencies caused by
correlation across tissues. Then, using the tissue of choice, a reference at higher resolution is
constructed from subsetting a larger atlas, such as the Mouse Cell Atlas (MCA; (X. Han et al.,
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2018)). To alleviate the effect of gene expression dropout, we sample cells from each defined
cell type to create a ‘pseudo-bulk’ reference. Application of QP using this constructed reference
provides continuous measurements of cell identity as a linear combination of all cell types within
the reference. In the third step, we categorize the cells into three broad buckets: 1) discrete, 2)
hybrid, and 3) unknown, leveraging QP quality metrics (Figure 2.3A; Methods). Lastly, a
statistical framework is applied to assign discrete identities to cells. In addition, during this step,
we characterize cells that resemble multiple cell types, representing potential hybrid cells.
Annotations of hybrid cells distinguishes Capybara from other classifiers and allows us to
explore the dynamics as well as maintenance of cell identity in complex systems.
To assess the efficacy and robustness of this approach, we first evaluate the sufficiency of
this established bulk reference. Accuracy of tissue classification is pivotal as it helps tease apart
excessive information and noise from other cells. We evaluate the validity of the tissue reference
transcriptome based on the identity scores of annotated single-cell atlases. Though variations are
observed within each cohort of cells, we identify a unique pattern of identity scores for each
matching tissue, suggesting that this bulk reference is sufficient to imply the correct tissues at
relevance (Figure 2.3B).
Next, we assess the classification functionality via an automatic evaluation algorithm
used in a recent study that benchmarked 20 single-cell classification approaches against various
public available datasets (Abdelaal et al., 2019). In brief, 10-fold cross validation is performed
using various datasets. We assess predictions from the methods using the multiclass area under
the receiver operating characteristic (AUROC), and classification runtime. Based on 5 human
pancreatic datasets and the Allen Mouse Brain Atlas, the performance of Capybara suggests a
similar and nearly perfect AUROC performance (average = 0.95; rank 5 out of 11) with
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reasonable runtime (Figure 2.4A). In this automatic benchmarking method, cross-validation
provides a relatively large training set compared to the test set. A key feature of Capybara is its
flexibility on the size of training set. We identified that a minimum number of 90 cells sampled
from each cell type are required to perform classification. Using the minimum number of cells,
we evaluate our performance using a recent mouse cell atlas, Tabula Muris (Schaum et al.,
2018). Using AUROC scores, we benchmark our method against two top-performing
classification approaches, scmap (Kiselev et al., 2018) and SingleCellNet (Tan & Cahan, 2019).
Here, 90 cells are sampled for each cell type with the remaining cells assessed quantitatively and
classified against pseudo-bulk generated. In this manner, we demonstrate the comparable
performance of Capybara with almost perfect AUROC scores (Figure 2.4B).

Figure Error! No text of specified style in document..4: Benchmarking of Capybara using Established
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Moreover, we evaluate Capybara’s ability to classify between datasets from different
sequencing platforms. Here, we showcase using two of the human pancreatic islet datasets,
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Baron et al (inDrop, (Baron et al., 2016)) and Muraro et al (CEL-seq2, test, (Muraro et al.,
2016)). Cross-platform validation presents a diagonal pattern across matching cell types in the
two datasets, suggesting agreement between annotation and classification. Nevertheless, four
major off-target cell-type classifications are observed. Investigating these cells, we separate them
into two categories. One category includes cell types that are annotated in the test set but not in
reference. The other includes cell types that are misclassified. In the former, we explore the
markers used in the reference for labeling to check if the cells annotated differently in the test set
can map the other type in the reference. From Capybara, mesenchymal cells in the test are
classified as activated stellate cells. Mesenchymal cells are broadly defined, potentially including
stellate cells in the pancreas. Expression of PDGFRA shows significant enrichment in the
classified activated stellate cells compared to other groups. Similarly, PP cells are determined as
gamma cells, whose marker genes, including PPY, SERTM1 and CARTPT, presents upregulation
in the classified cells. We further determine cells with unknown cell types to be ductal cell-like.
In the latter category, it is interesting to note that Capybara identifies heterogeneity in the
annotated acinar cells. Using three acinar cell marker genes, including REG3A, PRSS1 and
CPA1, we cannot isolate expression differences between labeled acinar cells and ductal cells.

Figure Error! No text of specified style in document..5: Validation of Capybara for Datasets generated
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While KRT19, a ductal cell marker, reveals a significant upregulation in the labeled ductal cells,
indicating that KRT19 might play a key role in classification of ductal cells (Figure 2.5).
Additionally, it is worth noting that the original studies use slightly different marker selection for
cell type annotation, potentially leading to mismatch between datasets. Overall, we believe this
cross-platform analysis demonstrates promising application of Capybara across different
sequencing techniques.
As a next step performance validation, we simulate a single-cell dataset comprising
different differentiation paths to assess if Capybara can: 1) Capture cells with discrete identities;
2) Identify cells that do not correlate with any cell types in the reference; 3) Characterize hybrid
cells that are in transition between discrete identities. We use Splatter, a simulation framework
based on gamma-Poisson distribution (Methods; (Zappia et al., 2017)), to simulate distinct
differentiation paths from a progenitor state (P1), bifurcating toward two discrete states (E1 and
P2). P2 progenitor cells bifurcate further toward end states #2 and #3 (E2 and E3, respectively;
Figure 2.6A, B). We include E1, P2, and E2 in the reference with the remaining cells from, such
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as P1 and E3, to be tested. Capybara accurately classifies cells in the three different identity
categories, distinguishing between known discrete identities and cells in transition between them
(AUROC = 1; Figure 2.6A-D). Further, Capybara can distinguish unknown cell types with
100% accuracy and potentially isolate unknown progenitor states from unknown terminal states,
using QP quality metrics with 81% and 65% accuracy, respectively (Figure 2.6C-D; Methods).
We benchmark our hybrid cell classification against scMap to illustrate how existing cell type
classifiers cannot resolve mixed identity cells (Figure 2.6E).
Together, our benchmarking and simulation demonstrate the efficacy of our method for
cell-type classification of discrete and hybrid cell identities. We next showcase move to evaluate
Capybara in a well-characterized continuous differentiation process: hematopoiesis.

2.3.3 Capybara accurately captures cell identity and fate transitions in
hematopoiesis
Cells in many biological processes, such as development and reprogramming, reside on a
continuous landscape, gradually transitioning from one state to another. Understanding these
transition states is essential to uncover the comprehensive overview of dynamic biological
systems. Cell fate determination during developmental processes is an important question to be
addressed to reveal mechanisms and lineages of development (MacLean et al., 2018). In this
process, a single cell differentiates into populations of cells with distinct identities and
committed functions. Apart from the cells with dedicated fate, some cells are in progress, where
the routes are chosen while the ultimate identities are not attained. These cells, we consider,
embrace an intermediate state or in transit, enabling them to be characterized with multiple
identities. Variations in the transcriptome profiles of these cells allow us to analyze transitions
via single-cell RNA-sequencing data, snapshots of individual cells at different time points of the
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continuum. Hematopoiesis provides a well-characterized example of continuous cell state
transition and serves as a valuable model to understand cell fate specification (Orkin & Zon,
2008). Even before birth, hematopoiesis has already started transitioning from a fetal clock to an
adult clock. As aforementioned, HSCs have distinct self-renewal rate, lineage bias, and
transcriptome profiles at fetal stages compared to those in adults. Leveraging single-cell profiling
and continuous identity measurements, we identified gradual and synchronous transition from
fetal to adult stages. Beyond transcriptome, further analysis in epigenome remodeling uncovers
gradual and discordant reprogramming of neonatal landscape in addition to the continuous
accessible fetal chromatin regions after adulthood. Yet, it was found that conversion to adult
states is initiated before birth and is potentially driven by interferon signaling pathway (Y. Li et
al., 2020). In the body of an adult, blood cells are renewed at a rate of seconds through
hematopoiesis. In this process, self-renewing hematopoietic stem cells (HSCs) differentiate
gradually into their mature cell fate in specific lineages, including erythroid, myeloid and
lymphoid lineage. Development of fluorescence-assisted cell sorting (FACS) and identification
of key surface markers in distinct lineages enable the establishment of a hierarchical tree of
hematopoiesis with a root of HSC growing the leaves of mature blood cells through specific
progenitor stages. This lineage paradigm serves as a valuable model in understanding blood
formation and, further, the general mechanism of lineage specification in developmental biology
(Orkin & Zon, 2008; Paul et al., 2015).
Addition of single-cell RNA-sequencing in this system elevates the cellular resolution,
enabling a more comprehensive illustration of the process and demonstrates high heterogeneity
in hematopoiesis. Here, we demonstrate an application of Capybara on a massively parallel
single-cell RNA-seq (MARS-seq) dataset, containing 2,730-cell snapshot of myeloid progenitor
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differentiation (Paul et al., 2015). We first use partition-based graph abstraction (PAGA; (Wolf
et al., 2019)) and identify a total of 24 clusters, which we annotate according to Paul et al. Initial
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tissue-level classification using Capybara corresponds mainly to single-cell bone marrow. Using
the Mouse Cell Atlas (MCA; (X. Han et al., 2018)), we generate the high-resolution reference,
containing two major tissue types: bone marrow, bone marrow (c-Kit), primary mesenchymal
stem cells, and peripheral blood (Figure 2.7A: Step 1). Continuous measurement of cell identity
further returns populations from two major tissues: bone marrow and peripheral blood (Figure
2.7A: Step 2). Discrete cell-type classification suggests 0% unknown population and 16.3% (n =
445) received high identities (Figure 2.7A: Step 3). Doublet analysis in the single-cell dataset
using DoubleFinder (McGinnis et al., 2019) and DoubleDecon (DePasquale et al., 2019)
suggests that 7-9% of the hybrid cell population as cell doublets, relative to 4.3-16.9% of the
discrete population, ruling out doubles as the source of hybrid signals.
Overall, Capybara classifies the expected myeloid progenitor populations, including
erythrocytes, megakaryocytes, hematopoietic stem and progenitor cells (HSPCs), monocytes,
and neutrophils (Figure 2.7A: Step 4). 13 major populations, identified via PAGA and annotated
according to Paul et al., agree with Capybara classification (Weighted Cohen’s Kappa = 0.95;
Figure 2.7B-C). Further, each classified population shows enrichment of established cell-type
marker expression (Cd34, Itga2b, Cebpe, Csf1r, and Car2; P < 2.2E-16, Wilcoxon rank-sum test,
Figure 2.7D).
Next, we assess the classification using modified diffusion pseudotime estimated by
PAGA (Wolf et al., 2019). We first evaluate the identified discrete populations, where Capybaraclassified HSPCs coincide with early pseudotime, as expected for this relatively undifferentiated
cell population (Figure 2.8A-B). Then, we focus on the identified five major hybrid populations
(>= 0.5% of the overall population): erythroblast–erythrocyte progenitors, megakaryocyte
progenitor–erythrocyte progenitors, monocyte progenitor–neutrophils, megakaryocyte
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progenitor–eosinophil progenitors, and monocyte progenitor–eosinophil progenitors (Figure
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2.7A; Step 4). The largest hybrid population contains cells sharing identities between
erythrocyte progenitors and more differentiated erythroblast, representing a putative transition
state. Leveraging PAGA pseudotime, we evaluate these hybrid cells considering hybrids would
likely occupy intermediate pseudotime between defined identities. Comparisons of pseudotime
between hybrids and their discrete counterparts demonstrates that the hybrids are located midpseudotime. For instance, the hybrids, erythroblast–erythrocyte progenitors, are in between the
discrete and erythroblast states (Figure 2.8C-E). Further, clusters enriched for hybrid cells are
connected based on PAGA connectivity (Figure 2.8F). Taken together, this application
demonstrates the ability of Capybara to accurately identify major hematopoietic cell populations,
in addition to hybrid populations.

2.3.4 Lineage tracing reveals the multi-lineage potential of hybrid-classified
cells
To examine hybrid cells, we leverage a single-cell data that simultaneously captures
lineage and transcriptome of hematopoiesis (Weinreb et al., 2020). In this previous study, LinSca1+ Kit+ (LSK) cells were isolated and labeled with random lentiviral-delivered barcodes. The
cells were allowed to differentiate in vitro and collected for single-cell RNA sequencing at Days
2, 4, and 6, yielding 72,946 single-cell transcriptomes. The barcoding strategy allows early cell
state to be linked to later hematopoietic fate and provides a ground truth dataset to assess the
biological relevance of our hybrid cell assignments (Figure 2.9A). We first construct a highresolution reference based on the major Day 6 differentiated myeloid populations, excluding
undifferentiated cells due to potential heterogeneity (Figure 2.10A-B). Capybara identifies of
seven major hybrid cell types, including three largest populations: monocyte-neutrophil,
basophil-mast, and basophil-eosinophil hybrids, who contain clones spanning early and late time
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points (Figure 2.9B). We assessed these hybrid cells via a close look at their cell-type
composition of clonal relatives across all time points. This analysis reveals that these clones are
significantly enriched for the discrete cell types that constitute each hybrid identity (*: P < 0.05;
randomized test; Figure 2.9C).

Figure Error! No text of specified style in document..9: Evaluation of Hybrid Cells using Ground-Truth
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Particularly, we showcase monocyte-neutrophil and basophil-mast hybrid identities, two
major hybrid populations in Day 4 and Day 6. Using Capybara classification, we identified
clones on Day 4 that strictly contains discrete cell identities (i.e., monocyte, neutrophil,
basophils, or mast cells only) and found that their Day 6 siblings are significantly lineage
restricted (P < 0.05, randomization test; Figure 2.9D-E). Next, we investigate into Day 4 clones
containing hybrid cells. To assess the accuracy of hybrid classification, we evaluate if Day 4
clones with hybrid cells would be related to or give rise to significant discrete-identity
populations, reflecting the mixed identities. In monocyte-neutrophil containing Day 4 clones, we

Figure Error! No text of specified style in document..10: Discrete Identities in Ground-Truth
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identified a significant population of both monocyte and neutrophil on Day 6 (Figure 2.9D, left;
Figure 2.9E). Further, via integration of single-cell datasets, we found that these identified
monocyte-neutrophil hybrids are similar to previously identified bistable intermediate cell states
that can yield both monocytes and neutrophils (Figure 2.10C-E; (Olsson et al., 2016)).
Similarly in Day 4 clones with basophil-mast hybrid cells, there is a significance mast cell
population but not basophil on Day 4, yet both discrete basophil and mast cells are identified as
significant populations on Day6 (Figure 2.9D, right). Finally, we compare these results of
hybrid cells to trajectory inference approach using PAGA (Wolf et al., 2019). From PAGA, we
obtain the connectivity measure between different clusters of cells identified using Louvain
algorithm, revealing connected and disconnected regions. Applying similar statistical test as
described as above on the Weinreb dataset fails to uncover the hybrid cell states we identified
(Figure 2.10F). Altogether, using ‘ground truth’ lineage tracing data, we validate the hybrid
cells identified through Capybara to be biologically relevant.

2.3.5 A metric to quantify cell fate transition dynamics
From our application of Capybara to hematopoiesis, the identification of cells harboring
hybrid identities represent intermediate transition states (MacLean et al., 2018). Furthermore, the
identities and states that these cells are connected to help define the cell transition milestones
within a differentiation hierarchy. We leverage this capacity of Capybara to identify hybrid cells
to develop a 'transition metric.' Briefly, for each discrete cell identity, we define in a population,
we measure the strength and frequency of its connections to hybrid identity states (Methods;
Figure 2.11A). This generates a metric we define as a 'transition score,' where a high score
represents a high information state where identities converge, identifying a putative cell fate
transition. This aspect of Capybara is distinct from approaches such as StemID (Grün et al.,
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2016) and CytoTrace (Gulati et al., 2020) in that our transition score does not aim to quantify
potential. Instead, this score aims to identify those cell fate transitions that are central to a
developmental/reprogramming process and is helpful to identify the stages at which a biological
system is in flux.

Figure Error! No text of specified style in document..11: Transition Score and Its Validation.

We first validate the concept of transition scores via comparison to cell-to-cell
connectivity based on PAGA in hematopoiesis (Paul et al., 2015). From PAGA analysis, we
computed the total connections of cells from each cell type to other cell types. Using Pearson’s
correlation, we observed a strong correlation (r = 0.84) between the total connectivity and
transition score (Figure 2.8G). Further, we apply RNA Velocity (la Manno et al., 2018) to
identify actively transitioning cell states in cardiomyocyte reprogramming (Stone et al., 2019).
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Comparing the number of velocity vectors within each defined cell state and transition scores,
we observe strong correlation between the two (Figure 2.11C-D). We apply the transition score
metric to published datasets charting the early development to terminal differentiation (Klein et
al., 2015; Pijuan-Sala et al., 2019; Stone et al., 2019). As development progresses and cells
specialize, transition scores gradually decrease (Figure 2.11B).
Via our validation in hematopoiesis and other systems, we highlight the ability of
Capybara to, in an unbiased manner, accurately distinguish discrete cell identity and cell fate
transitions. We next apply Capybara to characterize less defined, non-physiological systems,
such as reprogramming, to identify key fate specification events and propose potential strategies
to improve the protocols.

2.3.6 Characterizing off-target and hybrid cell identity in cardiac lineage
reprogramming
The identification of transcription factors to convert somatic cells back to a pluripotent
state open new potentials in regenerative medicine to generate therapeutic cells in vitro
(Takahashi & Yamanaka, 2006). Despite the premise of differentiation from stem cells, limited
differentiation to target cell types produces a heterogeneous population, hindering the clinical
utility of these cells. Lineage reprogramming with ectopic expression of transcription factors,
such as direct cardiac conversion, bypassing progenitor or stem cell states, holds much promise
for the generation of clinically valuable cell types from mature somatic cells (H. Wang et al.,
2021). A key question in direct reprogramming concerns the overall efficiency, i.e., percentages
of successful conversion, and fidelity, i.e., similarity to their in vivo counterparts (Guo & Morris,
2017; Morris et al., 2014). Here, we take direct cardiac reprogramming as an example to
demonstrate an application of Capybara to provide some insights.
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The direct conversion of fibroblast to cardiomyocyte-like cells is introduced via
overexpression of three transcription factors: Gata4, Mef2c, and Tbx5 (GMT) (Ieda et al., 2010;
Qian et al., 2013; Song et al., 2012). We select a recently published 30,729-cell transcriptome
dataset that profiled cardiac reprogramming on day -1, 1, 2, 3, 7, and 14, where transcription
factors were added on Day -1 followed by TGFb inhibitor and Wnt inhibitor treatments on Day 0
and Day 1, respectively (Figure 2.12A). On day 14, cells were sorted based on cardiac reporter
gene, a-Myosin Heavy Chain (Gulick et al., 1991), before single-cell processing (Stone et al.,
2019).
Via Capybara, initial tissue classification, followed by refinement using the MCA,
highlights two major tissues, including neonatal skin and neonatal heart (Figure 2.12B). Within
neonatal skin, we identified two major populations, including macrophages and muscle cells,
both of which are mesodermal and resident in the heart (de Soysa et al., 2019). With this
reference, 65.1% of cells are assigned with a discrete identity with 19.7% assigned hybrid
identities (Figure 2.12C). Based on our classification, we identify gradually decreasing trends in
non-cardiomyocyte populations across time points with increasing trends in cardiomyocytes
population. Cell type composition analysis shows enrichment of atrial and left ventricular
cardiomyocytes on Day 7 (39.4%) and Day 14 (83.7%) (Figure 2.12C). Interestingly, we find a
bias of cardiomyocyte population generated to be more atrial like instead of a balanced
distribution between atrial (76%) and ventricular (7.7%) (Figure 2.12C-D). We further validate
this via examination of expression of some regional specific markers, suggesting a potentially
chamber-specific reprogramming (Figure 2.12G).
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Transition score analysis of this process reveals a significant increase at Day 1 and Day 2
with a progressive decrease on day 3 and further on day 7 to day 14 (P < 0.0001, Wilcoxon ranksum Test; Figure 2.13A), implying an active cell fate transition before deterministic
commitment. Identification of such a trend reinforces previous findings, where transition cells
were found to determine their terminal fate in the first 48hr before they bifurcate into two routes
(Stone et al., 2019). Next, we take a close look at hybrid cells in the day 14 sorted population to

Figure Error! No text of specified style in document..13: Transition Scores and Hybrid Identities of
Direct Cardiac Reprogramming.

identify potential intermediate states after commitment to defined fates. Atrial-ventricular (AV)
cardiomyocyte occupies a dominant proportion of the hybrid cells (55.9%) with a second major
population between brown adipose tissue and cardiac fate (Figure 2.12C; 2.13B-C). We
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consider the cells with brown adipose tissue fate could be derived from cardiac resident
adipogenic progenitor that have been previously reported to repair the heart upon injury (H. J.
Chen et al., 2021; K. Wu et al., 2010; Yamada et al., 2006).
To construct a more comprehensive blueprint of the off-target cell types, we performed
cardiac reprogramming according to the Stone protocol, without cardiac reporter sorting at day
14. We obtain a total of 5,107 cells across two independent biological replicates. The queality of
the data is first assessed via integration with the Stone et al. data, where we observe a cosine
similarity of 0.71-0.82, noting the successful recapitulation of the protocol (Figure 2.13D).
Capybara reveals a similar off-target cell profile to the Stone dataset and an enrichment of atrial
cardiomyocytes (Figure 2.13E). AV hybrid cells are also present in this dataset, though at a
much lower frequency (<1%). We consider that this low occurrence could be a result of not
sorting the cells.
To further validate the dominant AV hybrids, we performed RNA fluorescent in situ
hybridization (FISH) at day 14 of our reprogramming scheme to evaluate canonical markers,
Myh6 (atrial myosin heavy chain) and Myh7 (ventricular myosin heavy chain). In addition to
discrete cells expressing one marker or the other, hybrid cells co-expressing both markers are
found (Figure 2.14B). Using our own scRNA-seq data, we further select another canonical atrial
marker, Myl4, along with ventricular enriched expression markers, Actc1 and Tnnc1, to perform
RNA FISH, where other AV hybrids are identified (Figure 2.14A, C). Interestingly, these hybrid
cells are binucleated or have irregular nuclear morphology. Beyond expression, we performed
immunostaining (IF) for canonical markers MYL7 (atrial) and MYL2 (ventricular), supporting
AV hybrids at the protein level (Figure 2.14E). Moreover, the proportion of hybrid cells
identified through IF, scRNA-seq, and RNA FISH are consistent with each other (Figure 2.14F).
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Application of Capybara to direct cardiac reprogramming unravels critical chamberspecification dynamics and off-target cell types, suggesting potential modulations with additional
TFs or signaling molecules are necessary to refine reprogramming outcomes.

60

2.3.7 Capybara reveals a dorsal-ventral patterning deficiency in motor
neuron reprogramming
In vitro culture of embryonic stem cells (ESC) and the discovery of induced pluripotent
stem cells (iPSC) provide opportunities for disease modeling and hold much promise for
generation of clinically valuable cell types to replace damaged tissues (Takahashi & Yamanaka,
2006). To derive specific cell types of interest from stem cells, two major approaches – standard
differentiation or direct programming – are employed. Standard differentiation involves
sequential induction of developmental signals, mimicking embryonic intermediate states during
development, while direct programming introduces exogenous expression of transcription factors
following different routes (Briggs et al., 2017). Both protocols have been reported to recapitulate
the target cell type efficiently and faithfully. Yet, the relationship between cell types produced in
vitro procedures and their counterparts in vivo development remains in the fog. Recent
application of single-cell RNA-sequencing on motor neuron differentiation from mouse ESC
(mESC) unveils that both approaches achieve the same cell state resembling MNs but through
different paths.
With the experiments performed side-by-side, this dataset provides valuable insights and
a venue for direct comparison of the protocols (Figure 2.15A; (Briggs et al., 2017)). Specifically
in MN generation, direct programming (DP) induces MN fate via overexpression of three
transcription factors, Ngn2, Isl1, and Lhx3 (NIL), bypassing developmental progenitor stages
(Mazzoni et al., 2013; Velasco et al., 2017). On the other hand, direct differentiation (DD)
utilizes sequential induction of Fibroblast Growth Factors (FGFs), Retinoic Acid (RA), and
Sonic Hedgehog (SHH) (Wichterle et al., 2002; C. Y. Wu et al., 2012). Here, we primarily focus
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on the TF-mediated DP protocol and apply Capybara to compare the cell fate determination to
mouse spinal cord development.

Figure Error! No text of
specified style in document..15:
Capybara Analysis of Spinal
Motor Neuron Differentiation
and Programming. (Briggs et al.,
2017)
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With prior knowledge regarding the system, we start with the construction of highresolution reference, using a recent single-cell atlas of mouse embryonic spinal cord
development (Figure 2.15B; (Delile et al., 2019)). This reference contains a total of 118 cell
types and states across five different time points from E9.5 to E13.5, including non-neuronal cell
types around the spinal cord, such as blood, mesoderm, and neural crest. In combination with the
embryonic stem cell profile from the MCA, the aggregated dataset is ideal for our analysis of
MN generation, allowing initial tissue selection to be bypassed (Figure 2.15C).
With Capybara, 87.8% of cells (n = 4,136/4,704 cells) are classified with discrete
identities while 12.2% are classified as hybrids with no cells unclassified (Figure 2.15D). We
observe a gradual emergence of neuronal identities from the dominant ESC population at day -1,
with 63.8% of day 11 cells classified as neurons. Nonetheless, only 3% of this population are
classified as motor neurons with majority of them classifying as neurons across the dorsal and
ventral regions of the spinal cord (Figure 2.15D-E). On the other hand, in direct differentiation,
MN generation peaks at 13.4% at the early-stage (day 5), decreasing to 3.4% by the end of the
protocol (day 12), concomitant with an increase in off-target mesoderm identity (1% to 32.9%)
(Figure 2.15D-E). Transition scores significantly decrease as TF-mediated programming
progresses (P < 2.2E-16; Wilcoxon Test; Figure 2.15F) with hybrid cell generation peaking at
day 4 (Figure 2.15G). Within these hybrid states, we observe very few states that map to known
developmental progression, particularly in DP compared to DD, suggesting the cells with
multiple identities arise potentially from non-physiological cell fate specification. Altogether, the
observed distribution of neurons across the spinal cord raises the possibility of potential
deficiency in dorsal-ventral patterning in the in vitro systems, particularly direct programming,
instructing addition of potential patterning signals could enhance MN production.
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2.3.8 Retinoic Acid treatment alleviates off-target identities to enhance MN
generation
Regionalization of the spinal cord integrates complex spatial and temporal patterning
events (Delile et al., 2019), involving different signaling molecules, such as RA and SHH (LaraRamírez et al., 2013; Ribes et al., 2009). Therefore, we hypothesize that these signals could
potentially fine-tune dorsal-ventral patterning to increase MN production in vitro. We directly
programmed ESCs using the original protocol (Mazzoni et al., 2013) with or without 1 μM alltrans RA and/or 0.5 μM smoothened agonist (SAG - a hedgehog pathway activator) (Figure
2.16C). Single-cell RNA-sequencing was performed four days following embryoid body (EB)
formation and doxycycline-induced reprogramming, capturing 17,163 cells from two
independent biological replicates (cosine similarity = 0.988; Figure 2.16A). Using Seurat V4, we
further integrated our TF-only sample with previous data (DP Days 4 and 11) from Briggs et al.,
2017. Compositional analysis in between the two datasets shows that our sample recapitulates
the published data (cosine similarity = 0.912). Classification using the same reference as
described above reveals 11.6 ± 2.9% of cells as MNs in our dataset, representing at least a threefold increase than the Briggs protocol. We speculate that this could be an effect due to the initial
EB formation. In addition, Capybara annotates 13.7 ± 1.7% dorsal and 10.3 ± 1.2% ventral
neurons, mirroring similar results with the Briggs protocol. Apart from cells with discrete
identities, 35.4% of cells are classified as hybrids with a major representation by ESC-MN (22.7
± 0.5%) (Figure 2.16B).
Next, we evaluate if the addition of RA and/or SAG is capable of increasing the MN
population by reducing off-target cell generation. Breaking down the classifications to each
treatment, we observed that RA treatment significantly increases MN generation over four-fold,
64

from 7.5 ± 1.6% to 33.4 ± 4.9% (P < 2.2E-16, randomization test), and significantly depletes the
off-target dorsal population, mainly dl3, from 13.7 ± 2.0% to 5.8 ± 0.9% (P < 2.2E-16,

Figure Error! No text of specified style in document..16: Experimental Validation with Modulation
of Retinoic Acid and Sonic Hedgehog in MN Programming.
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randomization test) (Figure 2.16B-D). In addition to the dorsal population, the major off-target
ventral (mainly V2a) population is significantly depleted, from 10.7 ± 1.2% to 6.1 ± 0.5% (P <
2.2E-16, randomization test). Addition of only SAG slightly enriches for MN generation and
provides no additional yields when added together with RA. A detailed exploration on the hybrid
identities uncovers a significant enrichment upon the addition of RA (P < 2.2E-16,
randomization test), whereas a significant depletion of the ESC-dl3 population (P < 2.2E-16,
randomization test; Figure 2.16E). Furthermore, using scRNA-seq data, we assess the coexpression of MN marker, Mnx1, and dorsal neuron marker, Pou4f1, under different treatment
conditions, and in vivo (Delile et al., 2019). When treated with RA, the percentage of the coexpressing population decreases by over 6-fold, more in line with the 1% co-expressing cells
observed in vivo. Treatment with SAG reduced this population by more than half to 4.8% but
provides no additional reductions in combination with RA (Figure 2.16F-G).
This exploration manifests the ability of Capybara to inspect aberrant dorsal-ventral
patterning in MN programming and instruct the addition of signaling, such as RA, to enhance the
efficiency and fidelity of MN generation in vitro.

2.3.9 An in vivo correlate for fibroblast to induced endoderm progenitor
reprogramming
To further explore the application of Capybara, we turned our focus to interrogate a
relatively uncharacterized direct conversion protocol, from mouse embryonic fibroblasts (MEFs)
to induced endoderm progenitors (iEPs). It was first reported that, via the overexpression of two
transcription factors, Hnf4a and Foxa1, MEFs can be reprogrammed to yield hepatocyte-like
cells (Sekiya & Suzuki, 2011). Yet, more systematic characterization with CellNet with bulk data
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as well as functional studies revealed the capability of these cells to engraft damaged colon and
small intestine (Guo et al., 2019; Morris et al., 2014). Based on this potential, these cells have
been suggested to resemble an endoderm progenitor-like state. Nevertheless, the in vivo correlate
to these reprogrammed cells remains unclear.

Figure Error! No text of specified style in document..17: Capybara Analysis of fibroblast to induced
Endoderm Progenitor (iEP) Reprogramming.
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To characterize these cells, we apply Capybara to our previous 85,010 single-cell RNAsequencing dataset spanning eight time points during the 4-week reprogramming process
(Figure 2.17A; (Biddy et al., 2018)). Initial tissue selection with the high-resolution continuous
measurement suggests major tissues, including embryonic mesenchyme and several endodermal
populations (Figure 2.17B). Across the time course, epithelial cells gradually emerge to 5.9% at
day 28, with few classified hepatocytes, mirroring previous findings using bulk transcriptome
information (Figure 2.17C-D; (Morris et al., 2014)). Compared to the previously discussed
systems, a substantial percentage of cells (35%) remain undetermined, indicating a potential
missing cell type in the reference.
As iEPs have progenitor characteristics, we hypothesize that they represent a putative
developmental progenitor. Therefore, we constructed an embryonic atlas containing endoderm
and foregut tissues across a time course between E3.5 to E9.5 (L. Han et al., 2020; Nowotschin
et al., 2019). However, iEPs remain largely unclassified using this reference (Figure 2.17D-E).
An alternative hypothesis is that iEPs may represent a regenerative cell type considering their
capacity to repair liver and colon (Guo et al., 2019; Morris et al., 2014; Sekiya & Suzuki, 2011).
Further, it is found that the Hippo signaling effector, Yap1, plays a pivotal role in iEP generation
(Kamimoto et al., 2020), resembling injured liver regeneration (Pepe-Mooney et al., 2019). Thus,
we built a high-resolution reference based on both homeostatic and regenerative liver epithelial
single-cell atlas, containing two main regenerative cell types: hepatocytes and biliary epithelial
cells (BECs) (Pepe-Mooney et al., 2019). With this new reference, we classify day28
reprogrammed iEPs, and long-term cultured iEPs (LT-iEPs). Capybara classifies 8.3 ± 4.7% of
day 28 reprogrammed iEPs (n = 20,532 cells) and 91.8 ± 7.49 % of LT-iEPs (n = 6,170 cells,
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two independent biological replicates) as post-injury BECs (Figure 2.17E-F). These results lead
us to perform experimental validation for this putative identity.

2.3.10

iEPs possesses characteristics of biliary epithelial cells
Under homeostasis, BECs are quiescent and arrange to form tubular, single-epithelial-

layered bile ducts in the liver. When the liver is injured, BECs enter active proliferation and play
a key role in regeneration (Kamimoto et al., 2016). Biliary epithelial cells isolated from the
injured liver can be cultured ex vivo, passaged, and maintained long-term (Okabe et al., 2009).
With support from the extracellular matrix, these cells form tubular or ductal structures in 3D-gel
culture, mimicking in vivo BEC morphology (L. Jin et al., 2013; Lewis et al., 2018). Thus, to
interrogate the BEC potential of iEPs, we cultured LT-iEPs, representing highest of injured BEC
identity, in a 3D-gel sandwich culture that promotes tubule formation in vitro (Ogawa et al.,
2015). We observed branching tubular structures after three days of culture and become more
evident by day 5. Via immunostaining, we observe significant upregulation of established BEC
markers, cytokeratin 19 (CK19), and epithelial cell adhesion molecule (EpCAM) by day 5
(Figure 2.18A-C). Moreover, side-by-side, we found that 2D-cultured LT-iEPs express Ck19
with reduced Epcam, recapitulating the reported behavior of injured BECs after expansion in
vitro for over 30 days (Okabe et al., 2009).
To further characterize 3D-cultured LT-iEPs, we performed single-cell RNA-sequencing
on day 5 gel-cultured branching iEPs and obtained a total of 14,047 cells from two independent
biological replicates. Application of Capybara on this dataset using the high-resolution reference
established in the previous section demonstrates the significant emergence of a normal BEC
population in 3D-cultured iEPs (14.3 ± 1.7%; P < 2.2E-16, randomization test). On the contrary,
classification of cells under 2D culture demonstrates a lack of normal BEC population but an
69
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injured Biliary Epithelial Cells.

enrichment for post-injury BECs (P < 2.2E-16, randomization test; Figure 2.18D-E).
Additionally, under 3D culture conditions, we observe a unique hybrid state between injured
BEC and normal BEC hybrid (Figure 2.18E, right). As normal BECs emerge in 3D-culture,
there is a significant increase of percentage of cells expressing Epcam (P < 2.2E-16,
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randomization test, Figure 2.18E), mirroring the results with the above immunostaining. In
addition, there is a significant reduction in the percentage of cells expressing Cyr61, a marker of
injured BECs (P < 2.2E-16; randomization test, Figure 2.18F) (Pepe-Mooney et al., 2019).
Moreover, these BEC-like cells express other specific BEC markers, such as Sox9 (Figure
2.18G). We further identified a set of specific BEC markers from literature (Verhulst et al.,
2019) and performed module score analysis, revealing higher BEC resemblance of the classified
BEC-like cells (Figure 2.18H).
These results support the resemblance of this relatively uncharacterized cell type, iEPs, to
in vivo biliary epithelial cells. Together, it highlights the application of Capybara to a relatively
uncharacterized reprogramming protocol, incorporating this analysis with our previous lineage
tracing studies to offer mechanistic insights into reprogramming, and to identify potential in vivo
correlates of iEPs, warranting further study.

2.4 Discussion
Here, we have presented Capybara, an unsupervised method to quantitatively assess cell
identity and fate transitions. A unique feature of Capybara is its ability to measure cell identity
on a continuum, allowing the establishment of the statistical framework to classify hybrid cell
states. Lineage tracing of myeloid differentiation demonstrates the multi-lineage potential of
cells classified as monocyte-neutrophil and basophil-mast hybrids. In addition, we found the
monocyte-neutrophil hybrids to be transcriptionally similar to a previously reported rare bistable
hybrid that can give rise to both monocyte and granulocyte fates (Olsson et al., 2016). Further,
we speculate that basophil-mast hybrids may represent a previously described rare basophil-mast
progenitor cell (BMCP). Previously, BMCPs are found to have hybrid transcriptional profile and
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have preferred differentiation toward the mast cell and basophil lineages (Dahlin et al., 2018).
Moreover, we validate the existence of atrial-ventricular cardiomyocyte hybrids in cardiac
reprogramming via RNA FISH and immunostaining, supporting the capacity of Capybara to
identify cells sharing features from multiple identities.
Occurring at low frequency with a transient nature, hybrid states have been relatively
poorly identified and characterized. High-throughput scRNA-seq brought new opportunities to
capture and evaluate hybrid states (MacLean et al., 2018). However, few approaches currently
exist to characterize hybrid identities. Though trajectory inference algorithms provide insights on
the continuous trajectory, it may overlook the transition states when the terminal fates are
undetermined or immature. Capybara represents a unique method in various cell differentiation
or reprogramming paradigms to uncover hybrid states that may represent novel progenitor cell
types or transitions between discrete identities. Hybrid cell states have been proposed to fulfill
vital roles in biological processes as reviewed in Chapter 1 (MacLean et al., 2018). Using
Capybara, we report wide-ranging hybrid states in the reprogramming paradigms we have
analyzed here. Our analysis in hematopoiesis reveals hybrids that represent rational cell state
transitions or reported bistable intermediates. Whereas in reprogramming paradigms, hybrids
states are rarely overlapping with known developmental progression, leading us to a hypothesis
that the trajectory of TF-mediated conversion involves non-physiological cell states to the target
cell identity. Alternatively, the diversity of hybrid states could be from heterogeneity in the
starting cell population, which often contains diverse cell types. Characterizing hybrids in this
context might provide insight into the origins of successfully reprogramming cells.
The benefits of unsupervised cell-type classification go beyond the characterization of
transition states, as we demonstrate via our analysis of several diverse cell fate engineering
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strategies. For example, we observed regional patterning dynamics in the TF-mediated
generation of cardiomyocytes and motor neurons. In the case of cardiomyocyte reprogramming,
atrial cardiomyocytes dominate ventricular cardiomyocytes. An atrial-ventricular hybrid suggests
that modulation in the protocol could potentially shift this balance. For instance, signaling factors
play pivotal roles in chamber-specification in early cardiac development. Previous protocols
where TGFb signaling is inhibited and Wnt activated yield mainly ventricular cardiomyocytes
(H. Wang et al., 2014), whereas protocols inhibiting TGFb and Wnt generate mostly atrial-like
cardiomyocytes, as we demonstrate here. Approaches to fine-tune this balance will be beneficial
to increasing production of atrial or ventricular cardiomyocytes for further disease and treatment
modeling. For motor neuron programming, our unbiased identification of a range of dorsalventral spinal neuron identities instructed the addition of signaling factors (RA and SAG) to
alleviate this patterning deficiency. The modulation with such factors yields over 4-fold more
motor neurons and increased specification of the resulting population. Finally, Capybara
identified injured BECs as a potential in vivo correlate for iEPs, a poorly characterized product of
reprogramming. Together, these observations highlight the broad application of Capybara to
generate quantitative observations, suggest modulation on reprogramming strategies, and reveal
the engineered cell identity and potential.
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2.5 Limitations of Capybara
It is crucial to note that the performance of Capybara relies on the selection of
appropriate reference datasets. We have designed the workflow with this limitation in mind,
where initial tissue-level classification identifies the most appropriate tissue-specific single-cell
reference to use. If an inappropriate reference is used, Capybara will classify cell identity as
‘unknown,’ as we demonstrate in our analysis of iEPs, which subsequently led us to a more
suitable reference. A strength of Capybara to note here is that references can be constructed from
a minimum of 30 cells, increasing the likelihood that rare cell types can be captured from
selected references. As more diverse single-cell datasets become publicly available, we
anticipate that this will support a much broader classification of cell identities. In addition, it is
worth noting that though Capybara can distinguish unknown progenitors from unknown terminal
fates, such classification is not to 100% accuracy due to the challenges in deconvolution of
distributions. With future distribution modeling in-depth, Capybara will support more accurate
classification of these two classes. Moreover, with expansion of complexity in the dataset,
Capybara shows a longer runtime due to the exponential increase of rounds of permutation as
increase of cell types and cell numbers. As parallelization being implemented in the pipeline, we
expect that this will be alleviated to have shorter runtime with increasing computing power.
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2.6 Materials and Methods
2.6.1 Key Resources Table
REAGENT or RESOURCE

SOURCE

IDENTIFIER

Mouse Monoclonal Anti-MYL7 Antibody (B-10)

Santa Cruz
Biotechnology

RRID:AB_1084827
2

Rabbit Monoclonal Anti-MYL2 Antibody

Abcam

RRID:AB_1056353
5

Rat Monoclonal Anti-Mouse CD326 (EpCAM)
Antibody

BD Biosciences

RRID:AB_394370

Rabbit Monoclonal Anti-Cytokeratin 19 (CK19)
Antibody

Abcam

RRID:AB_2281020

CD90.2 (Thy1.2) Monoclonal Antibody, FITC

Invitrogen

RRID:AB_273503

Alexa Fluor 546 Goat Anti-rabbit IgG

Invitrogen

RRID:AB_2534093

Alexa Fluor 488 Goat Anti-mouse IgG

Invitrogen

RRID:AB_2534088

Alexa Fluor 647 Goat Anti-rat IgG

Invitrogen

RRID:AB_141778

pMx-MGT

Wang et al., 2015

RRID:Addgene_111
810

pGCDNSam-Hnf4-t2a-Foxa1

Morris et al., 2014

pCL-Eco

Novus Biologicals

RRID:Addgene_123
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Stellar Competent Cells

Takara Bio

Cat #: 636763

Gibco

Cat #: 10082147

Antibodies

Bacterial and Virus Strains

Chemicals, Peptides, and Recombinant Proteins
Fetal bovine serum (FBS)
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Fibroblast Medium-2

ScienCell Research
Laboratories

Cat #: 2331

Matrigel (GFR Membrane Matrix)

Corning

Cat #: CB-40230

-mercaptoethanol

Life Technologies

Cat #: 21985023

X-tremeGENE9 Transfection Reagent

Sigma Aldrich

Cat #: 6365779001

XAV939

Cayman

Item #: 13031

SB431542

Cayman

Item #: 13596

CHIR99021

BioVision

Cat #: 1677

PD0325901

Sigma

Cat #: PZ0162

Leukemia Inhibitory Factor

Millipore

Cat #: LIF2050

Smoothened Agonist (SAG)

Millipore

Cat #: 566660

Epidermal Growth Factor

Sigma Aldrich

Cat #: E5160

Hepatocyte Growth Factor

Sigma Aldrich

Cat #: H9661

Doxycycline (Dox)

Sigma Aldrich

Cat #: D9891

L-Ascorbic Acid

Sigma Aldrich

Cat #: A8960

Insulin-Transferrin-Selenium-Ethanolamine (ITS-X)

Gibco

Cat #: 51500056

Gentle Cell Dissociation Reagent

STEMCELL
Technologies

Cat #: 100-0485

RNAscope Multiplex Fluorescent v2 kit

Advanced Cell
Diagnostics

Cat #: 323100

EasySep Mouse FITC Positive Selection Kit II

STEMCELL
Technologies

Cat #: 17668

Ampure XP SPRI Beads

Beckman

B23318

Chromium Single Cell 3’ Library and Gel Bead Kit v2

10x Genomics

PN-120237

Retinoic Acid (RA)

Critical Commercial Assays
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Chromium Single Cell 3’ Chip kit v2

10x Genomics

PN-120236

Chromium i7 Multiplex Kit

10x Genomics

PN-120262

Chromium Next GEM Chip G Single Cell Kit

10x Genomics

PN-1000127

Library Construction Kit

10x Genomics

PN-1000196

Chromium Next GEM Single Cell 3’ GEM Kit v3.1

10x Genomics

PN-1000130

Chromium Next GEM Single Cell 3’ Gel Bead Kit v3.1

10x Genomics

PN-1000129

Dual Index Kit TT Set A

10x Genomics

PN-1000215

scRNA-seq

This paper

GEO: GSE145251

Hematopoiesis Development

Paul et al., 2015

GEO: GSE72859
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2.6.2 Methods
Capybara Pipeline Overview: The Capybara pipeline comprises four major steps: 1) tissuelevel classification, 2) high-resolution custom reference generation and continuous identity
measurement, 3) initial classification into discrete, hybrid, or unknown identities, and 4) discrete
cell type classification and hybrid identity scoring. Capybara code and documentation are
available at: https://github.com/morris-lab/Capybara, along with detailed function descriptions
and tutorials.
Basis of Capybara: Quadratic Programming (Setup). Previous studies have measured
continuous changes in cell identity using Quadratic Programming (QP) (Biddy et al., 2018;
Treutlein et al., 2016), where The R package QuadProg was used for the calculation of QP
scores. In brief, the underlying assumption is that each single-cell transcriptome profile can exist
as a combination of fractional identities from all possible cell types, described as a linear
combination of gene expression profiles from different cell types. This assumption allows us to
model cell identity as a multivariate linear regression problem. For ease of biological
interpretation, constraints are placed on the coefficients: they are bound between 0 and 1, and the
sum of all coefficients does not exceed 1. These constraints limit the use of least squares
estimators in this scenario, while QP is an optimization approach that minimizes a quadratic
function under the given linear inequalities or equalities.

Let

denote the transcriptomic profile of genes g1, g2, …, gn for a query cell, and

denotes the reference dataset of the same set of genes by cell types t1, t2, …, tm. The goal is
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then to calculate the identity score vector

, such that the random error

is minimized, as

described below.

In addition to the fractional identity score matrix and the error term, each cell receives a
Lagrangian multiplier, gauging how much the solution is pushed toward the constraints.
Applying QP offers a quantitative evaluation of cell identity for each cell.

Basis of Capybara: Quadratic Programming (Data processing) Before QP, using raw count
matrices, we first perform log-normalization on both the reference and sample dataset. Let
be the matrix with each row representing a gene and each column denoting a cell or a cell type.
Let

denote the number of columns, and

of the matrix,

denote the number of rows. Then, for each column

,

The normalized matrix is then log-transformed with a base of 2 and pseudo-count of 1. The
reference dataset undergoes further scaling to ensure that gene expression levels between
datasets are comparable. We calculate the scaling factor as the ratio between

of the

reference and sample. Further, we filter the gene list of both matrices to include only those genes
shared between the reference and sample.
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Step 1: Tissue-level classification. The performance of Capybara hinges on the selection of an
appropriate single-cell reference to classify cell identity. Before assessing cell identity at singlecell resolution, we perform a tissue-level classification designed to restrict the number of
reference cell types included in downstream analysis, reducing excessive noise and dependencies
caused by correlation across tissues in the final single-cell reference. This tissue-level
classification is performed using bulk transcriptomics from ARCHS4, an exhaustive resource
platform comprising the majority of published RNA-seq datasets (Lachmann et al., 2018). To
achieve a relatively comprehensive and clean evaluation, we take a two-step approach: 1)
construct a clean bulk RNA-seq reference and 2) correlation-based tissue classification.
(1) Bulk Reference Construction
ARCHS4, a platform that contains most published RNA-seq and ChIP-seq datasets (Lachmann
et al., 2018), was mined for bulk RNA-seq data. ARCHS4 obtained raw datasets from the Gene
Expression Omnibus, then realigned and processed through a uniform pipeline. Using this data
bank, we first filtered the available datasets to retain only poly-A and total RNA-seq data from
C57BL/6 mice. We then calculated Pearson’s correlations on every sample pair from the same
tissue. The top 90 samples with the highest Pearson’s correlation scores for each of 30 tissues
comprised the final bulk reference. For tissues with less than 90 samples, we took the entire
sample set and randomly sampled with replacement to include 90 total samples. For the selected
90 samples for each tissue, we calculated the average reads per kilobase per million (RPKM) to
build the final tissue-level transcriptome profile, containing a total of 30 tissues. We evaluated
the quality of this bulk reference by calculating the identity scores of cells from manually
annotated single-cell atlases (MCA; (Han et al., 2018) and Tabula Muris; (Tabula Muris
Consortium et al., 2018)) based on this reconstructed reference. We randomly selected 90 cells
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from each tissue of MCA or Tabula Muris and performed QP using the bulk reference, where we
observe high scores when mapping the same tissue between single-cell and bulk datasets.
(2) Tissue-Level Classification
A potential concern of using QP to classify single cells directly is the correlation between similar
cell types from different tissues. In this scenario, it could be challenging to tease classification
results apart if high similarity to the correct cell type drives the high identity score. Thus, we first
perform classification at the tissue level to restrict the number of reference cell types in the
downstream analysis, reducing excessive noise and dependencies caused by correlation across
tissues in the final single-cell reference. In general, the three primary inputs of this step include
the single-cell reference (e.g., MCA), the sample single-cell dataset, and the constructed bulk
reference. Using the tissue reference, we calculate QP scores for the single-cell reference as well
as the sample, where we obtain two identity matrices. We then compute the Pearson’s
correlations of QP scores between each cell from the single-cell reference and each cell from the
sample. We use a threshold at the 90th percentile of the correlation matrix to binarize the
correlation matrix, where a cell-cell pair with a correlation that is greater than the threshold is
marked as 1; otherwise, 0. With the binarized matrix, we count the number of cells in each tissue
of the reference mapping to the sample. If there is a significant percentage of reference cells of a
tissue (over 70%) mapped, we record the tissue label. We then calculate the frequency of each
tissue label in the sample. Tissues with a frequency of at least 0.5% sample cells were selected to
proceed for further analysis at single-cell resolution. Here, it is worth noting that this tissue-level
classification removes most irrelevant tissues but still provides a broad range of tissue types, at
which point further downstream analysis removes non-relevant cell types (see 'Cardiomyocyte
Reprogramming Analysis,' below). Additionally, having prior information regarding the tissues
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involved can be beneficial to narrow down the tissue selection step, as exemplified by our
analysis of hematopoiesis and spinal cord below.

Step 2: Generation of high-resolution custom references and continuous identity
measurement. Having identified the potential tissues present in a sample from the tissue-level
classification, we next assemble a custom single-cell reference dataset containing the relevant
cell types to classify the sample cells accurately. An example of such a reference dataset is the
Mouse Cell Atlas (MCA; (Han et al., 2018)), which contains both fetal and adult mouse tissues.
For each tissue, it offers a detailed breakdown of its cell types, including the same cell type with
different marker genes, offering a high-resolution map of cell-type composition. This reference is
assembled based on manual annotation of the specific cell types in the tissue involved. A unique
feature of scRNA-seq is dropout - the failure to capture and detect known expressed genes and
other technical variation (Lun et al., 2016). Due to the highly sparse nature of scRNA-seq data,
an individual cell transcriptome may not provide a complete representation of a cell type. To
alleviate the effect of these technical variations, we construct pseudo-bulk references for each
cell type of each tissue. We sample 90 cells from each cell type for each tissue. For cell types
with more than 90 cells, we calculate Pearson’s correlations between each cell pair. Based on the
correlation matrices, we select the most correlated 45 cells to ensure homogeneity and the least
correlated 45 cells to ensure the capture of transcriptional diversity. Cell types that have fewer
than 90 cells, but more than 30 cells are sampled with replacement to achieve a total of 90 cells.
Summation of the counts of the selected 90 cells is used to construct the final high-resolution
reference, assuming homogeneity in the annotated population of the original single-cell
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reference. Application of QP using this 'high-resolution' reference generates a continuous
measurement of cell identity as a linear combination of all cell types within the reference.

Step 3: Initial discrete, hybrid and unknown classification. As aforementioned, the
application of QP generates the continuous scores, from which we calculate a deviance metric of
the scores from the expected score. In addition, QP provides two additional metrics: the error and
Lagrangian multiplier, together with the continuous scores. Using these three metrics together,
we evaluate the likelihood of a cell to have discrete, hybrid, or unknown identities, compared to
the scoring metric of reference cells. This step can be evaluated in two parts: 1) deviance, 2)
error, and Lagrangian multiplier.
(1) Deviance
The deviance is calculated via comparison between the identity scores to the expected scores
(

), assuming a cell is equally similar to every cell type in the reference. We

consider that cells with unique identities will have major deviations, while those with unknown
identities will have minor deviations from the expectation. Let

denote the score of a cell on

cell type . The deviance is then calculated as follows:

Assuming the reference cells are accurately annotated with discrete identities, we first calculate
the total deviance of each reference cell using the identity score matrix of the reference data. We
further model the total deviance from the reference cells as a normal distribution, serving as the
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reference distribution of discrete identity cells. Restricting the hybrid cells to have a maximum of
two identities, we establish an ideal distribution for the hybrid cells by shifting the density of
discrete identities by 2x standard deviation to the left. Lastly, the unknowns are expected to have
an even lower deviation than the hybrid cells. We then calculate the total deviance of each
sample cell in the same manner. With the established distributions, we obtain probability scores
from

the

evaluation

of

each

distribution
are

by

computing

considered

as

.
discrete.
are

Cells with

Cells
Cells

considered

with
with

hybrids.

are considered unknowns.

(2) Error & Lagrangian Multiplier
The selection of cells to build the high-resolution custom reference includes both highly
correlated and uncorrelated cells in the population of the corresponding cell type. Such a
selection scheme provides a multimodal distribution for the error and Lagrangian multiplier
metric, serving as background distributions for the extreme cases of matching and unmatching
cells. Based on the multimodal density, we build an ideal distribution for the test samples, where
the mean is the weighted mean of the mixed normal distribution, and the standard deviation is
the weighted standard deviation of the mixed distribution. We consider unknown cells will
establish higher error (on the right tail). In contrast, hybrid cells will have comparable levels of
error but a lower Lagrangian multiplier (on the left tail). In addition, unknowns can potentially
be distinguished into unknown progenitors vs. unknown end states by considering the
combination of the two distributions. As unknown end states take both higher error and
Lagrangian multiplier, unknown progenitors are considered to have a relatively high error, but
even lower Lagrangian multiplier compared to the hybrids. Yet, due to the challenges in
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deconvolving overlapping distributions, we could partially distinguish the two unknown cell
types leveraging the combination of the two metrics.

Step 4: Discrete cell type classification and hybrid identity scoring. While continuous identity
scores are informative, discrete cell-type assignment offers a more practical assessment of celltype composition for a biological system. One approach to call discrete cell types is to apply a
threshold to the calculated continuous scores. However, threshold selection and quality of the
custom high-resolution reference can bias cell type calling via this approach. To overcome this
limitation, we apply QP to score cells in the single-cell reference against the bulk reference. This
strategy accounts for reference quality, enabling background matrices to be generated, charting
the distributions of possible identity scores for each cell type. We then take a two-step approach
to give discrete and hybrid cell type classification: 1) empirical p-value calculation via
randomized testing, and 2) Mann-Whitney-based binarization and classification.
(1) Empirical P-Value Calculation via Randomized Testing
With the constructed single-cell reference, we apply QP to both the sample and reference
single-cell datasets to generate continuous measurements of cell identity. Let
identity score matrix of the reference data with a total of
denotes the score of reference cell on cell type . Let
of the sample data with a total of

cell types and

cell types and

denote the
cells, where

denote the identity score matrix

cells, where

denotes the score of

sample cell on cell type . We then carry out the following steps to calculate the empirical pvalues. (1) For each cell type in

, we randomly sampled 1000 times and constructed a
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background density of the identity scores,

. (2) For each

score in the identity matrices, we calculate the empirical p-value as follows:

where

if

is true; otherwise,

. (3) Next, we repeat steps (1) and (2) for a

total of 50 rounds, recording the empirical p-values matrix for each cell of both the reference and
the sample. The result of this step includes two lists of p-value matrices: one for the reference
and the other for the sample. For each cell, each column of the p-value matrix denotes a cell
type, while each row describes each round of 50.
(2) Binarization and Classification
From randomized testing, we construct two lists of empirical p-value matrices: one for all
sample cells,

, and the other for all reference cells,

. Using the list for all reference cells

together with its annotation data, we computed a benchmark empirical p-value for each cell type.
Specifically, the annotation data contains cell barcodes with their associated annotated cell types.
For each cell
values,

and its annotated cell type

, we identified the corresponding list of empirical p-

. As a result, we construct a possible range of p-values for each cell type, , from

which we generate the benchmark values. For each cell type , we eliminate the outlier p-values
and select the maximum p-value of the remaining cells as the final benchmark score,
. Outlier p-values are identified based on the definition of outliers in the
boxplot (outside of 1.5x the interquartile range above the third quantile or below the first
quantile).
Next, we move forward to evaluate the sample list with the initial classification results. If
the cell is initially considered as an unknown, it is skipped for this statistical framework
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evaluation. The length of the sample list, , is the number of sample cells. The
value matrix

in the list defines empirical p-value for the

reference cell type

under the

resampling background, where

empirical p-

sample cell belonging to
. We rank all

empirical p-values inside the matrix, from the lowest to the greatest, and break any tie by
averaging. The rank-sum for each column t of

is then calculated, and the cell type with the

lowest rank-sum, t*, is determined to be the putative identity for cell c. We then compare
to

to assign an identity for cell . To assign cells harboring hybrid identities,

recapitulating those identities, we perform a pairwise Mann–Whitney U test between the t*
column and other columns of

. For any cell type t’ with rank-sum that is not significantly

greater than the rank-sum of t* (significant level=0.05), we consider t’ to be one of multiple
identities of query c along with t*. Applying this process to each cell, we generated a binary
matrix with 1 = putative identities. Further, we generate a classification table with labeled cell
types for each cell barcode.
Transition Scoring. Cells with multiple identities (hybrid cells) label critical transition states in
different trajectories. Building on this concept, we also measure the strength and frequency of
connection to the discrete cell state, which provides a metric that we define as a 'transition score.'
The calculation of transition scores only involves cells with hybrid identities. In general, using
QP, each cell receives fractional identity scores for different cell types in the reference.
Interpreting QP as probabilities of the cell transitioning to each discrete cell identity, we use QP
scores as a measure of transition probability.
For a cell marked with multiple identities, we consider a transition between the cell to its
terminal cell state as events with the transition probability measured by QP scores
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, where i

denotes the cell and j denotes the cell state. Therefore, based on information theory, the
information of such transition event can be measured as

. We

further consider how much information the terminal cell state has received, which can be defined
as:

Thus, the total amount of information received for cell state j from n connected cells can be
computed as:

The measurement appears to be similar to Shannon’s entropy, while we note that with each cell
independently in transition, probabilities from all events do not necessarily add up to 1,
distinguishing it from a measure of entropy. Here, to demonstrate this metric, consider an
example as demonstrated in Figure 3F, where Cells 1 to 5 harbor multiple identities connecting
Cell State I to III. In this example scenario, the transition score for Cell State II can be calculated
as:

Using such measurement, we incorporate the frequency as well as the likelihood of connection
such that high information labels a discrete cell state associated with an abundance of dynamic
cell transitions.
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Benchmarking Capybara. To assess the efficacy and robustness of Capybara to classify cell
identity, here we validate each step and demonstrate its basic functionality. In the first step of the
Capybara pipeline, tissue-level classification, accuracy is pivotal as it helps reduce noise from
other cell types that are not present in the sample. We evaluate the validity of the tissue reference
transcriptome based on the identity scores of annotated single-cell atlases (Han et al., 2018;
Tabula Muris Consortium et al., 2018). We randomly selected 90 cells from each tissue of MCA
and Tabula Muris using the bulk reference, where we observed higher scores mapping of the
same tissue between single-cell and bulk.
Next, we assess the classification functionality of Capybara. In this step, we use a
benchmarking algorithm that was recently developed to compare a range of single-cell
classification approaches using an array of publicly available datasets (Abdelaal et al., 2019).
Briefly, we perform 10-fold cross-validation using various datasets. Here, the predictions from
the methods are assessed based on the area under the receiver operating characteristics
(AUROC) using the multiclass.roc function in R. Based on five human pancreatic datasets and
Allen Mouse Brain Atlas, the performance of Capybara indicates similar accuracy (rank 5) and
median F1 score (rank 4.2) with reasonable runtime when benchmarked against ten other
classifiers (Figure 2.4). In this automatic benchmarking method, 5-fold cross-validation provides
a relatively large training set (80%) compared to the test set (20%). A key feature of Capybara is
its flexible requirement in terms of training set size. We find that a minimum number of 90 cells
sampled from each cell type is required to perform accurate classification. For cell types with
fewer than 90 cells, we require a minimum of 30 cells, from which a 90-cell sample will be
drawn with replacement from the pool. Using this minimum number of cells, we evaluate our
performance using the Tabula Muris mouse cell atlas (Tabula Muris Consortium et al., 2018).
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Using AUROC scores and accuracy, we benchmark our method against two other classification
approaches, scmap (Kiselev et al., 2018) and SingleCellNet (Tan & Cahan, 2019). As a result,
we demonstrate the comparable performance of Capybara with excellent performance (AUROC
> 0.8).
Generation of simulated data. We use Splatter, an R-based simulation framework based on
Gamma-Poisson distribution, to simulate a single-cell dataset comprising distinct differentiation
paths (Zappia et al., 2017). We design the cell population to originate from a progenitor state
(P1) bifurcating toward two discrete states (E1: End State #1; P2: Progenitor State #2). P2
progenitor cells bifurcate further toward end states #2 and #3 (E2 and E3, respectively; Figure
1B, C). Using this simulated dataset, we assess if Capybara can 1) Capture cells with unique
identities; 2) Identify cells that do not correlate with any cell types in the reference; 3)
Characterize transition cells with multiple identities. E1, P2, and E2 cell populations were
defined as within 5% variability of the max pseudotime at each terminal. We construct a
reference using 90 of the most correlated and diverse cells from E1, P2, and E2 cell populations.
Cells in E1, P2, and E2 that did not contribute to the reference are used to test the efficacy of
accurate classification. The remaining cell populations are not included in the reference to test
how Capybara classifies cells with no correlates in the reference.
Capybara Analysis with Previously Published scRNA-seq data
(1) Paul et al. (2015) Mouse Hematopoiesis Analysis
We obtained the raw hematopoiesis count data from GSE72859 (Paul et al., 2015c). The data
was processed and clustered using SCANPY (Wolf et al., 2018) and PAGA (Wolf et al., 2019).
From processing, we included 3,451 genes in the dataset of 2,730 cells. We first perform tissue92

level classification with the bulk reference established using ARCHS4, as described in the
previous sections. From this, we identified three major relevant tissues: primary mesenchymal
stem cells (bone marrow mesenchyme), bone marrow, and bone marrow (c-Kit). Further
breakdown of these three major tissues using the MCA (X. Han et al., 2018) resulted in 49
different cell types. We constructed the high-resolution reference using these 49 cell types. 90
cells were selected from each cell type as described above and saved as the reference single-cell
dataset. Followed by preprocessing, we applied QP on the reference and sample single-cell
dataset, based on which we further categorized them to discrete, hybrid and unknown, calculated
empirical p-values, performed binarization and classification. We projected cells with single
identities onto the cluster embedding from PAGA. Cells with hybrid identities were isolated, and
we extracted the pseudotime for themselves and their terminal cell identities. We re-assessed
these multiple identity cells using their scores. If one of the identities scored near zero (score <
10E-3), we considered such identity as inaccurate and discarded it. In this process, we reevaluated transitioning cells, retaining only those cells with relatively higher shared identity
scores. For a hybrid identity to be considered usable, it needs to be represented by more than
0.5% of the sample population. Using this filtering, we alleviate potential transitions due to noise
but maintain the more putative transitions. Wilcoxon test was used to compare if the pseudotime
density differs comparing hybrids with their discrete identity parts.
(2) Weinreb et al. (2020) Mouse Hematopoiesis Lineage-Tracing Analysis
We obtained the normalized InDrop single-cell data, annotation, and SPRING embedding for
mouse hematopoiesis lineage-tracing dataset from https://github.com/AllonKleinLab/paper-data.
In this analysis, we mainly focused on the Lin- Sca+ cKit+ (LSK) population, containing a total of
72,946 cells. We constructed the high-resolution reference using 90 cells in each of the major
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day 6 differentiated cell types, including basophils, eosinophils, mast cells, monocytes, and
neutrophils. Considering the myeloid differentiation culture condition, we selected these five
populations as they are the continuous expanding populations from day 2 to day 6. Following
preprocessing, we generated the continuous identity score measurements for the remaining LSK
cells using QP, followed by initial classification, binarization, and classification. Leveraging the
lineage information in the dataset, we then identified clones that contained hybrid cells on day 4
to evaluate their siblings on day 4 and progeny on day 6. To compare with the hybrid-containing
clones, we also identified day 4 clones that are strictly represented by the discrete compartments
of the hybrids. For instance, while assessing monocyte-neutrophil hybrids, we compared the
siblings and progeny of day 4 clones strictly represented by monocytes or neutrophils.
Enrichment of populations was tested via randomization testing. Briefly, for the clones
representing the hybrid and its siblings, we randomly sampled the same number of cells as the
clones from the entire population and calculated the proportion of the cell type represented in the
sample. We iterated this process 10,000 times to establish a distribution. The likelihood of
proportions presented in the hybrid family was evaluated based on this density, providing
empirical p-values.
The raw count of the data was obtained by taking the reciprocal of the smallest non-zero
gene expression of each cell, following https://github.com/AllonKleinLab/paper-data/issues/7.
The data was then processed and clustered using SCANPY (Wolf et al., 2018) and PAGA (Wolf
et al., 2019), following the tutorials. Connectivity among clusters was obtained from PAGA
analysis. Assuming clusters connected to two differentiated fate clusters as potential hybrid
clusters, we evaluated if these cells were lineage restricted. From the connected cluster, we
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identified the day 4 cells and assessed their siblings and progeny. The enrichment of each
population is tested via randomization testing as described above.
(3) Pijuan-Sala et al. (2019) Mouse Gastrulation Transition Score Analysis
We obtained 10x scRNA-seq UMI count data and annotation of mouse gastrulation from
GSE87038 (Pijuan-Sala et al., 2019), containing a total of 139,331 cells. The dataset was
processed using Seurat (Butler et al., 2018; Satija et al., 2015). We performed classification
using all 23 tissues, composed of 361 cell types, in the adult MCA as a reference directly (X.
Han et al., 2018). We constructed the high-resolution reference using these annotated cells.
Following preprocessing, we generated the continuous identity score measurements for these
cells using QP, followed by initial classification, binarization, and classification. We then
performed Capybara transition scoring analysis for each sample, analyzing transition score
distributions of each annotated cell type from Pijuan-Sala et al.
(4) Stone et al. (2019) Cardiomyocyte Reprogramming Analysis
We obtained the 10x single-cell RNA-sequencing count data from GSE131328 (Stone et al.,
2019), containing a total of 30,729 cells. This dataset was processed using Seurat (Butler et al.,
2018; Satija et al., 2015) and clustered using UMAP. We used raw data from the filtered cells
and genes as input into the Capybara pipeline. We next performed tissue-level classification
using ARCHS4 (Lachmann et al., 2018), as described in previous sections, revealing four major
tissues, including neonatal skin, neonatal heart, fetal stomach, and fetal lung. Further breakdown
of these tissues using MCA (X. Han et al., 2018) contains 57 cell types. We constructed the highresolution reference using these annotated cells. Following preprocessing, we generated the
continuous identity score measures of these cells using QP, based on which we further performed
initial classification, binarization, and classification. We calculated the percentage of each
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identified cell type in the population. Additionally, we computed the transition scores for the cell
states involved in transitions. We performed transition score comparisons using a one-sided
Wilcoxon

test.

We

identified

region-specific

markers

from

MuscleDB

(http://muscledb.org/mouse/mRNA/).
(5) Briggs et al. (2017) In Vitro Spinal Cord Motor Neuron Derivation Analysis
We obtained 10x scRNA-seq UMI count data and annotation of developing mouse spinal cord
from https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-7320/ (Delile et al., 2019),
including a total of 38,976 cells. We removed unannotated cells and built a high-resolution
reference for each cell type at each developmental stage (E9.5 to E13.5), resulting in a total of
118 cell types (19 types for E9.5, 26 for E10.5, 26 for E11.5, 25 for E12.5, 22 for E13.5). We
also included embryonic stem cells from the MCA (X. Han et al., 2018). We obtained the InDrop
single-cell dataset for in vitro spinal cord motor neuron derivation from GSE97391 (Briggs et al.,
2017). The in vitro datasets were processed and clustered using Seurat (Butler et al., 2018; Satija
et al., 2015). From processing, we included 7,860 genes and 7,799 genes in the dataset of 1,984
cells and 2,720 cells in direct programming (DP) and direct differentiation (DD), respectively.
We analyzed ESCs from each protocol separately. Following preprocessing, we applied QP
using the high-resolution reference on four datasets, including two ESC populations, DP and DD.
Based on the identity score matrices, we categorized them into discrete, hybrid, and unknown,
calculated the empirical p-value matrices, performed binarization and classification. Cells with
discrete identities were separated to calculate the composition in the ventricular zone and mantle
zone. The ventricular zone also included the neural crest neurons and mesoderm lineage. Hybrid
cells were filtered and refined, as described in the above hematopoiesis section. With the QP
scores attached to each identity in the mixed set, we calculated the transition scores for the cell
96

states involved, as described in the transition scoring section. We compared transition scores
between different timepoint via a one-sided Wilcoxon test.
(6) Biddy et al. (2018) MEF to Induced Endoderm Progenitor Analysis
We processed scRNA-seq data of induced endoderm progenitor (iEP) reprogramming, as
previously described (Biddy et al., 2018). In brief, Scater was used to normalize (McCarthy et
al., 2017) the data across time points, and Seurat (Butler et al., 2018; Satija et al., 2015) was used
to integrate biological replicates, perform clustering, and visualize cells using t-SNE. We
performed tissue-level classification using ARCHS4 (Lachmann et al., 2018), as described in
previous sections, highlighting the involvement of 9 potential tissues, containing a total of 73 cell
types. Following the construction of a high-resolution reference, we performed preprocessing on
the reference and the sample, on which we then applied QP to generate the identity score
matrices. Further, we categorized them into discrete, hybrid, and unknown, calculated the pvalue matrices, and performed binarization and classification. We calculated the percent
composition of each cell type. Cells with hybrid identities were filtered as described in the above
hematopoiesis section, represented by more than 0.5% cells of the population.
We obtained scRNA-seq data of biliary epithelial cells (BECs) and hepatocytes, before
and after injury, from GSE125688 (Pepe-Mooney et al., 2019). We built a custom highresolution reference by incorporating additional tissues from the MCA: fetal liver, MEFs, and
embryonic mesenchyme. The long-term iEPs were cultured for 12 months before collection and
processing. We had previously used these cells to engraft mouse colon (Guo et al., 2019; Morris
et al., 2014). The long-term iEP dataset was processed, filtered, and clustered using Seurat,
resulting in 2,008 cells. We then constructed the high-resolution reference panel with 20 cell
types and performed preprocessing on the reference and single-cell sample. Application of QP
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using the processed reference and long-term iEP and iEP reprogramming datasets provides us the
continuous metric of identity scores, from which we carried out initial classification,
binarization, and classification. Gene expression was compared between groups via Wilcoxon
test.
10x alignment, digital gene expression matrix generation.
The

Cell

Ranger

v5.0.1

pipeline

(https://support.10xgenomics.com/single-cell-gene-

expression/software/downloads/latest) was used to align reads, process, and filter data generated
using 10x Chromium single-cell gene expression platform. Following this step, the default Cell
Ranger pipeline was implemented to generate the filtered output data for downstream analysis.
scRNA-seq Data Processing
To process and analyze scRNA-seq data, we used the R package, Seurat V4, following the
tutorial (https://satijalab.org/seurat/articles/pbmc3k_tutorial.html). Briefly, each sample was preprocessed based on RNA counts and mitochondria percentages and then normalized. The highly
variable genes were then identified, followed by scaling and dimensional reduction via PCA.
With the selected number of components, graph-based clustering and UMAP plotting were
further performed.
(1) Cardiac Reprogramming
When comparing our data with Stone et al., 2019, the data were integrated using canonical
correlation analysis and mutual nearest neighbor with the Seurat V4 pipeline (Butler et al., 2018;
Stuart et al., 2019). The similarity between the dataset was evaluated based on cosine similarity
between the cluster representation in the two datasets.
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(2) In Vitro Motor Neuron Programming and iEP Reprogramming
To evaluate reproducibility, datasets for each treatment were integrated across the two biological
replicates following the same process described above. The integrated Seurat objects were
further integrated to evaluate the effect of different treatment groups.
scRNA-seq Data Capybara Analysis
With the tissues identified from the corresponding publicly available dataset, we started from
step 2 of the Capybara pipeline for the single-cell RNA-sequencing data we generated for this
study. Using the raw counts, we performed preprocessing on the reference and the sample, on
which we then applied QP to generate the identity score matrices. Further, we categorized them
into discrete, hybrid, and unknown, calculated the p-value matrices, and performed binarization
and classification. We calculated the percent composition of each cell type. Cells with hybrid
identities were filtered as described in the above hematopoiesis section, represented by more than
0.5% cells of the population.

2.6.3 Experimental Methods
Reprogramming Virus Production
The retrovirus for cardiac and induced endoderm progenitor (iEP) reprogramming was freshly
prepared. 293T cells (RRID:CVCL_1926) were maintained and passaged in fibroblast media
(10% FBS, 1x penicillin-streptomycin, 1x -Mercaptoethanol, in DMEM). 293T cells were seeded
at a density of 3 million per 10-cm plate the day before transfection. The following day, the cells
were transfected with pMX-MGT (RRID:Addgene_111810) or pGCDN-Sam-Hnf4-t2a-Foxa1
with 5g of pCL-Eco (RRID:Addgene_12371), using X-tremeGENE 9 DNA transfection reagent
(Sigma, 6365779001) according to the manufacturer's instructions. Media was replaced with
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fresh fibroblast media the following day. Retrovirus was harvested the next day by taking the
supernatant from the transfected plate and filtered through a 45- m syringe filter. 500x protamine
sulfate was added to the viral media prior to transduction of the mouse cardiac fibroblasts
(cardiac) or mouse embryonic fibroblasts (iEP).
Cardiomyocyte Reprogramming
Direct cardiac reprogramming was performed using primary cardiac fibroblasts derived from a
postnatal day 2 CD1 Mouse (ScienCell, Catalog #M6300) following previously published
protocols (Ieda et al., 2010; Qian et al., 2013; Stone et al., 2019). Briefly, cardiac fibroblasts
(MCFs) were cultured overnight on gelatin-coated plates in Fibroblast Medium-2 (ScienCell,
Cat. #2331). MCFs were passaged 1-2 times, cultured for ~5 days for expansion, and prepared
for selection of Thy1+ (RRID:AB_273503) cells by MACS. After sorting, MCFs were plated at a
density around 100k~200k per 6-cm dish pre-treated overnight with gelatin (day -1). Thy1+
MCFs were infected with freshly harvested pMX-MGT retrovirus (L. Wang et al., 2015) (day 0).
The viral media was replaced with fresh cardiomyocyte media (10% M199, 10% FBS, 1%
NEAA, 1% sodium pyruvate, 1x penicillin-streptomycin, 1x Glutamax, in DMEM) containing
2.6M SB431542 (Cayman Chemical, Catalog #13031) or DMSO as a vehicle control (day 1).
5M XAV939 (Cayman Chemical, Catalog #13596) or DMSO was added to the plate without
media change (day +1). The media was replaced with fresh cardiomyocyte media two days after
the last addition of small molecule (day +3). Media was renewed every 2~3 days. The cells were
collected, filtered through a 70m strainer, resuspended in 1% BSA in PBS, and counted on Day
14 for scRNA-seq (see below).
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Immunostaining for day 14 Reprogrammed Cells in Cardiac Reprogramming
Mouse cardiac fibroblasts were generated as described above. On day 13 of the reprogramming
process, the cells were transferred to 4-Chamber Culture Slides (Falcon). On the next day, the
cells were rinsed with 1x DPBS and fixed in 4% paraformaldehyde for 20 minutes at room
temperature. The samples were then washed with 1x DPBS three times, permeabilized, and
blocked with blocking buffer (0.2% TritonX-100 and 3% FBS in DPBS) for an hour. The
primary antibodies, MYL2 (RRID:AB_10563535) and MYL7 (RRID:AB_10848272), were
diluted 1:250 (MYL2 and MYL7) in the blocking buffer. The blocking buffer was then removed
from the sample, and the primary antibodies were added. The samples were incubated with the
primary antibody at 4°C overnight (12hr). The samples were then washed for 5 minutes three
times. The secondary antibodies, Alexa Fluor 546 Goat Anti-rabbit IgG (RRID:AB_2534093)
and Alexa Fluor 488 Goat Anti-mouse (RRID:AB_2534088), were diluted 1:1000 in the
blocking buffer. The secondary antibodies were added and incubated at 4°C overnight (12hr).
The samples were washed again for 5 minutes, three times. 100 l of 300 nM DAPI (Invitrogen)
was added to each slide chamber and incubated at room temperature for 1 minute. The samples
were washed for 5 minutes three times. In the last wash, we aspirate all the DPBS and remove
the chamber from the slides. A coverslip was then applied with ProLong Gold Antifade
Mountant (Invitrogen). The slides were imaged using an Olympus FV1200 Confocal Microscope
with 10x, 20x, and 40x water objectives. The number of positive cells was counted in each
channel using ImageJ with “Analyze Particles” function. The total number of cells was
determined based on the DAPI counts.
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RNA Fluorescent in Situ Hybridization
On day 13 of mouse cardiac reprogramming (above), the cells were transferred to 4-Chamber
Culture Slides (Falcon). The next day, cells were rinsed with 1x DPBS and fixed with 10%
Neutral Buffered Formalin for 30 minutes at room temperature. RNAscope Multiplex
Fluorescent v2 kit (Advanced Cell Diagnostics) was used to perform RNA-FISH to probe Myh6
and Myh7 mRNA, following the protocol for cultured adherent cell samples. Briefly, the slides
were treated with hydrogen peroxide and RNAscope protease III (Advanced Cell Diagnostics).
Then, the slides were incubated to hybridize with the specified probes using the RNAscope
HybEZ II Oven (Advanced Cell Diagnostics). Probes were then amplified, and the HRP signal
was developed using the TSA Fluorescein Plus Evaluation Kit. Finally, DAPI (Advanced Cell
Diagnostics) staining was applied to the slide, and a coverslip was then applied with ProLong
Gold Antifade Mountant (Invitrogen). The slides were imaged using an Olympus FV1200
Confocal Microscope with 40x and 60x water objectives. Images were then analyzed using
computational quantification: RNA-FISH images were first processed through ImageJ to ensure
the same maximum intensity across images. Through ImageJ, individual cells were segmented
into smaller regions. All three channels of each selection were stored for further processing with
a custom R script to quantify intensity at single-cell resolution. Individual cells were read in as
individual matrices, where averaged green and red intensity were calculated and compared.
Motor Neuron Programming from mouse ESC
The NIL (Ngn2-Isl1-Lhx3)-V5 inducible ESC line was previously described (Mazzoni et al.,
2013b). All the inducible ESC lines were grown in 2-inhibitors medium (Advanced
DMEM/F12:Neurobasal (1:1) Medium (Gibco), supplemented with 2.5% ESC-grade fetal
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bovine serum (vol/vol, Corning), N2 (Gibco), B27 (Gibco), 2mM L-glutamine (Gibco), 0.1 mM
β-mercaptoethanol (Gibco), 1000 U/ml leukemia inhibitory factor (Millipore), 3µM CHIR
(BioVision) and 1 µM PD0325901 (Sigma). To obtain Embryoid bodies (EBs) ESC were
trypsinized (Gibco) and 3 x 105 cells were plated in each 100 mm dish in AK medium
(Advanced DMEM/F12:Neurobasal (1:1) Medium, 10% Knockout SR (vol/vol) (Gibco),
Pen/Strep (Gibco), 2mM L-glutamine and 0.1 mM 2-mercaptoethanol) (day -2). After 48 hr,
EBs were passed 1:2, and the inducible cassette was induced by adding 3 µg/ml of Doxycycline
(Sigma) and/or 1 μM all-trans retinoic acid and/or 0.5 μM smoothened agonist (SAG) (Millipore,
566660). Differentiating EBs were washed three times with PBS, dissociated with Trypsin, and
pipetted into single-cell suspensions. After 48 hr, cells were preserved in methanol (Alles et al.,
2017) before processing for single-cell profiling (below).
Long-term iEP culture
Mouse

Embryonic

Fibroblasts

were

derived

from

the

C57BL/6J

strain

(RRID:IMSR_JAX:000664). All animal procedures were based on animal care guidelines
approved by the Institutional Animal Care and Use Committee. Mouse embryonic fibroblasts
were reprogrammed to iHeps/iEPs, as in Sekiya and Suzuki (2011). Briefly, fibroblasts were
prepared from E13.5 embryos and serially transduced with polyethylene glycol concentrated
Hnf4 -t2a-Foxa1, followed by culture on gelatin for two weeks in hepato-medium (DMEM:F12, supplemented with 10% FBS, 1 mg/ml insulin (Sigma-Aldrich), dexamethasone (SigmaAldrich), 10 mM nicotinamide (Sigma-Aldrich), 2 mM L-glutamine, 50 mM -mercaptoethanol
(Life Technologies), and penicillin/streptomycin, containing 20 ng/ml hepatocyte growth factor
(Sigma-Aldrich), and 20 ng/ml epidermal growth factor (Sigma-Aldrich)), after which the
emerging iEPs were cultured on collagen and passaged twice per week for three months.
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Matrigel Sandwich Culture of Long-term iEPs
We adapted the culturing methods in Ogawa et al., 2015 and Okabe et al., 2009. Briefly, 70%
Matrigel in DMEM was added as a bottom layer to the plate, 96-well glass-bottom plate (20 l) or
glass-bottom 35mm -Dish (100 l; iBidi) or 6-well plate (100 l). The bottom layer was allowed to
solidify at 37°C for 30 minutes. Long-term iEPs were dissociated using 0.05% Trypsin-EDTA
(diluted from 0.25%; Gibco, Cat #: 25200056). The cells were resuspended in pre-chilled OVMmedium (William’s E medium, supplemented with 10% FBS, dexamethasone, 10 mM
nicotinamide, 2 mM L-glutamine, 0.2 mM ascorbic acid, 20 mM HEPES, 1%
penicillin/streptomycin, 1% sodium pyruvate, 0.15% of 7.5% sodium bicarbonate, 14 mM
glucose, containing 1x ITS-X (Gibco), 20 ng/ml hepatocyte growth factor (Sigma-Aldrich), and
20 ng/ml epidermal growth factor (Sigma-Aldrich)). The top layer was prepared with 40%
Matrigel, with1.2mg/ml Collagen Type I (Gibco, stock of 3mg/ml), mixed with 20k cells for
each well of 96-well plate, or 80k for each well of a 6-well plate. After 30 minutes, the top layer
was added to the plate and allowed to solidify and set in the incubator for 45 minutes. After the
top layer solidified, pre-warmed OVM medium was added. The medium was changed every
other day. After five days of gel culture, the cells were imaged and processed for single-cell
RNA-sequencing.
iEP Preparation from Matrigel Culture for Single-Cell Profiling
Cells in 3D gel-culture were dissociated using a combination of Type I Collagenase (Gibco; 100
l of 500 mg/ml Type I Collagenase in 1 ml of OVM) and 1ml of Gentle cell dissociation reagent
(STEMCELL Technologies). Briefly, the medium was carefully pipetted off, and 1 ml of enzyme
mix was added to each well of the 6-well plate. The plate was incubated at 37°C for 10 minutes.
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The partially dissociated gel was collected into a 15-ml Falcon tube, further mixed on a rocker
for 15 minutes at room temperature. The cells were then pelleted at 300xg for 5 minutes and
washed with 1ml HBSS. The solution was passed through a 27-gauge needle using a 3 ml
syringe. The cells were counted, centrifuged, resuspended in 0.04% BSA in 1x DPBS, and
passed through a 70 m cell strainer before loading onto the 10x Chromium Single Cell Chip.
Immunofluorescence Staining of Branching iEPs
3D-cultured iEPs were cultured in 96-well glass-bottom plate or glass-bottom 35mm -Dish for
imaging. The cells ready for immunostaining was washed with 1x DPBS three times and fixed
overnight in 4% paraformaldehyde at 4°C. The fixed sample was then washed twice with 1x
DPBS for 15 minutes, permeabilized, and blocked with blocking buffer (0.2% TritonX-100 and
3% FBS in DPBS) for 10 minutes at room temperature. The primary antibodies, EpCAM
(RRID:AB_394370) and CK19 (RRID:AB_2281020), were diluted at 1:100 (EpCAM) and
1:200 (CK19) in the blocking buffer. The samples were incubated with the primary antibodies at
4°C overnight (12hr). The sample was then washed for 15 minutes three times. Secondary
antibodies Alexa Fluor 546 Goat Anti-rabbit (RRID:AB_2534093), and Alexa Fluor 647 Goat
Anti-rat IgG (RRID:AB_141778), were diluted 1:500 (Alexa Fluor 546 and Alexa Fluor 647) in
the blocking buffer. 50 l of 300 nM DAPI (Invitrogen) was added with the secondary antibodies
and incubated at 4°C overnight (12hr). The samples were washed again for 15 minutes three
times. Cells in 96-wells were imaged as 3D z-stack images using Zeiss LSM 880 Confocal with
Airyscan with 40x air objective. Samples in the 35-mm dish were transferred to a slide, covered
with a coverslip with ProLong Gold Antifade Mountant (Invitrogen), and imaged using an
Olympus FV1200 Confocal Microscope with 40x water objective. Representative images were
chosen.
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Single-cell profiling
For single-cell library preparation on the 10x Genomics platform, we used: the Chromium Single
Cell 3′ Library & Gel Bead Kit v2 (PN-120237), Chromium Single Cell 3′ Chip kit v2 (PN120236), and Chromium i7 Multiplex Kit (PN-120262), according to the manufacturer’s
instructions in the Chromium Single Cell 3′ Reagents Kits V2 User Guide. Prior to cell capture,
methanol-fixed cells were placed on ice, then spun at 3000rpm for 5 minutes at 4°C, followed by
resuspension and rehydration in PBS, according to Alles et al., 2017. 17,000 cells were loaded
per lane of the chip, aiming to capture 10,000 single-cell transcriptomes. The resulting cDNA
libraries were quantified on an Agilent Tapestation and sequenced on an Illumina HiSeq 2500.
For analysis of cardiomyocyte reprogramming, The Chromium Single Cell 3’ (v2) Reagent Kits
(PN-120237, PN-120236, PN-120262) were used to prepare single-cell RNA-seq libraries,
according to manufacturer’s guidelines. Libraries were pooled and sequenced on an Illumina
NextSeq 550. For motor neuron programming, prior to loading the 10x chip, methanol-fixed
cells were counted, spun, resuspended in 1% BSA in PBS, and counted again, according to 10x
Genomics methanol fixation protocol. The Chromium Single Cell 3’ (v2) Reagent Kits (PN120237, PN-120236, PN-120262) were used to prepare single-cell RNA-seq libraries, according
to manufacturer’s guidelines. Libraries were pooled and sequenced on an Illumina NextSeq 550.

106

2.7 Detailed Figure Legends
Figure 2.1: Previous Applications of Quadratic Programming (QP). (A) Continuous identity
score measuring at different time points during MEF to iEP reprogramming using previously
available microarray data (Sekiya & Suzuki, 2011). (B) Using the identity scores, single-cell data
was labelled from fibroblast state to the reprogrammed states. (C) Continuous identity score
measuring of epithelial cells from the small intestine using a reference constructed from a singlecell survey of the epithelium of mouse intestine (Haber et al., 2017). (D) Using the identity
scores, single-cell data was labelled of different cell populations in the intestine. (E-F) Gradual
identity measures of hematopoietic stem/progenitor cell development from fetal to adult state.
(G) Continuous identity score measuring at different time point during fibroblast to neuron
reprogramming with microRNAs.
Figure 2.2: Overview of the Capybara Workflow. Four major steps of the Capybara
workflow: 1) tissue-level classification; 2) continuous identity measurement; 3) initial
classification; 4) discrete cell type classification. In brief, we first perform tissue-level
classification to restrict the number of reference cell types in the downstream analysis. We
further identify the correlated tissues in a single-cell atlas, such as the Mouse Cell Atlas (MCA;
(Han et al., 2018)). Using only the highly correlated tissues, we build a high-resolution reference.
Application of quadratic programming (QP) provides a continuous measure of cell identity as a
linear combination of all cell types within the reference. With the quality metrics from QP, we
perform an initial classification to categorize the sample cells into discrete, hybrid, or unknown
identities. Lastly, cells with discrete or hybrid identities are mapped to their corresponding cell
types using a statistical framework.
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Figure 2.3: QP Metric Demonstration and Tissue-Level Reference Validation. (A)
Distributions of quadratic programming metrics, including error, Lagrangian multiplier, and
deviance. Black line represents the distribution of these metrics in the reference. Other lines
represent the ideal distributions for discrete, hybrid, and unknown, which are modeled based on
the reference metrics. Assuming each cell in the reference has a discrete identity, the ideal
distribution of deviance for discrete cells is modeled based on the reference identity scores. The
ideal distribution of deviance for hybrid is constructed as 2 standard deviations shifted to the left
from the one for discrete, and the deviance distribution for unknown is 2-standard-deviation
shifted to the left from the one for hybrid. (B) Correlation heatmap of bulk expression between
each pair of the 30 identified tissues from ARCHS4. The bulk expression is the logged reads per
kilobase per million (RPKM). The RPKM was calculated as the average of the 90 samples
selected for each tissue (See Methods). The color of each square denotes the correlation between
tissues, where a lighter color indicates a higher correlation.
Figure 2.4: Benchmarking of Capybara using Established Pipeline and in-house CrossValidation. (A) Evaluation using five human pancreatic datasets and the Allen Mouse Brain
atlas against ten other classifiers, using an established benchmarking pipeline (Abdelaal et al.,
2019). The performance of the classification was evaluated by the area under the receiver
operating characteristic (AUROC) and the mean total time in seconds. The color of each square
labels the assessment of each aspect. (B) Cross-validation using Tabula Muris processed with
10x droplet-based or Smart-seq2 technologies. In this evaluation, 90 cells were sampled from
each cell type of each tissue to construct the high-resolution reference. Sample cells used for
reference construction were used as training sets for scMap and SingleCellNet. The remaining
cells were used as test samples. The performance was evaluated by AUROC scores.
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Figure 2.5: Validation of Capybara for Datasets generated from Different Single-Cell
Platforms. Cross-platform validation between Baron et al., 2016 (InDrop) and Muraro et al.,
2016 (CEL-Seq2). Left: Proportions of cells mapping between Capybara classification and the
original annotation. A lighter color indicates a higher percentage agreement. Right: Lognormalized expression levels of marker genes across classified cell types, calculated using
Seurat. The marker genes were identified from Baron et al., 2016. Gamma cells: PPY, SERTM1,
CARTPT; Activated stellate cells: PDGFRA; Acinar cells: REG3A, PRSS1, CPA1; Ductal cells:
KRT19.
Figure 2.6: Simulation Study for Proof of Concept. (A) Design of the simulation study with
Splatter. Differentiation of single cells is simulated from the progenitor state to two end states.
Further, from end-state #2, cell differentiation into two other end states is simulated. Red Node:
Test cells; Black Node: Cells to build the reference. (B) Pseudotime presentation of the
simulated single-cell dataset with different states marked in circles. (C) Expected classification
outcomes using the simulated single-cell dataset. (D) Heatmap comparing the result from
Capybara to the ground truth as designed with color showing percentage matched. The transition
state is mapped with a hybrid classification; end states are mapped with corresponding discrete
identities; unknown cell types are correctly identified. (E) Classification of the simulated dataset
(described in Figure 1) using scMap with cell or cluster mapping. The color of each square labels
the percentage of the actual annotation mapped to each scMap annotation.
Figure 2.7: Application of Capybara to Classify Hematopoietic Cell Identity. We first
applied Capybara analysis to a well-characterized cell differentiation paradigm: hematopoiesis.
(A) Stepwise cell-type classification of an existing hematopoiesis dataset (Paul et al., 2015),
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consisting of 2,730 myeloid progenitors. 1) Tissue-level classification identifies three major
tissues, including bone marrow, primary mesenchymal stem cells, and peripheral blood; 2) Using
the higher resolution MCA reference, the main cell types correspond to two primary tissues:
bone marrow and peripheral blood; 3) Initial classification places cells into discrete, hybrid, and
unknown identity categories; 4) Cells are mapped to discrete and hybrid cell types. ‘Prog’:
Progenitor; ‘MPP/HSPC’: Multipotent Progenitors/Hematopoietic Stem and Progenitor Cell.
‘Other’: includes basophils, eosinophil progenitors, B cell progenitors, macrophages, dendritic
cells, and NK cells. (B) PAGA embedding of the myeloid progenitor dataset. ‘FA’: Force Atlas.
(I) Manual annotation of clusters, based on Paul et al., 2015 and Wolf et al., 2019. ‘DC’:
Dendritic Cell; ‘MEP’: Megakaryocyte and Erythroid Progenitor; ‘Ery’: Erythroid; ‘Lymph’:
Lymphoid; ‘GMP’: Granulocyte and Monocyte Progenitor. (II) Projection of the major
Capybara-classified populations. (C) Heatmap comparing Capybara classifications to the manual
annotations. Color denotes the percentage matched. (D) Comparison of log-normalized
expression between classified cell types and other cells. The following genes are used as key
markers for different populations: MPPs: Cd34; Megakaryocytes: Itga2b; Neutrophils: Cebpe;
Monocytes: Csf1r; Erythrocytes: Car2. A Wilcoxon test was used for significance testing (****:
P <=0.0001).
Figure 2.8: Evaluation of Hematopoietic Hybrid Cells against Pseudotime. (A) Diffusion
pseudotime analysis projected onto the PAGA embedding. (B) Pseudotime for each cell type.
MPP/HSPC classified cells, representing early cell states in the hematopoietic lineage, are
associated with the lowest pseudotime values. (C) Projection of the major hybrid population,
‘erythrocyte progenitor–erythroblasts,’ along with discrete erythrocyte progenitors and
erythroblasts onto the erythroid lineage. (D) Comparison of pseudotime between the hybrid and
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discrete identities shown in (C). (E) Top: Projection of the classified hybrid cell populations on
the PAGA-guided clustering, along with their corresponding discrete identities. Bottom:
Comparison of pseudotime between hybrids and their discrete identity counterparts. A Wilcoxon
test was used for significance testing. (F) PAGA-guided clustering of the Paul et al. dataset,
consisting of a total of 2,730 myeloid progenitors enriched from mouse bone marrow, revealing a
total of 24 clusters. PAGA connectivity links the clusters containing hybrid cells, as expected,
but does not pinpoint the hybrid state. (G) Correlation between log (PAGA connectivity scores)
and log (transition scores).
Figure 2.9: Evaluation of hybrid cells using ground-truth lineage tracing. (A) Schematic of
the Weinreb 2020 hematopoietic lineage-tracing dataset. Hematopoietic progenitor cells were
isolated, barcoded at Day 0, and first collected for scRNA-seq at Day 2. The cells were then
cultured under myeloid differentiation conditions and collected at Days 4 and 6 for scRNA-seq.
The barcode captured from the single-cell transcriptome allows the capture of clonally related
cells. Thus, we can test whether hybrid cells possess significant multi-lineage potential using this
dataset. (B) Major hybrid populations identified by Capybara. (C) Cell-type composition of cells
clonally related to major hybrid cell types. Upper row: Cell-type distribution of the overall
population. Lower rows: Average cell-type breakdown for all clonal relatives of each major
hybrid cell population. For example, clonal relatives of Monocyte-neutrophil hybrids are
significantly enriched for discrete Neutrophil, Monocyte, and hybrid Monocyte-neutrophil
populations (*: P <= 0.05, n.s.: P > 0.05, randomization test; 24 +/- 4 cells per clone, 10 clones,
243 cells). (D) State-fate analysis: Detailed breakdown of populations across timepoints. We
identified clones composed of discrete or hybrid identities at Day 4 and assessed the cell-type
composition of their differentiated clonal relatives at Day 6. The top two rows represent the day
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6 clonal relatives derived from day 4 lineage-restricted clones. The bottom row represents day 6
clonal relatives derived from day 4 clones containing hybrid cells. Significant population
enrichment is assessed using a randomization test (*: P <= 0.05). (E) SPRING projection of cells
related to monocyte- or neutrophil-restricted clones and monocyte-neutrophil hybrid clones.
Figure 2.10: Discrete Identities in Ground-Truth Lineage Tracing Dataset and Comparison
to Previous Identified bistable states. A) Manual annotation of the major differentiated cell
populations identified from the Weinreb et al., 2020 hematopoiesis lineage tracing dataset,
projected onto the SPRING embedding. (B) Comparison between Capybara classification and
the manual annotation. We selected the major differentiated myeloid cell types, including
basophils, eosinophils, mast cells, monocytes, and neutrophils, as a reference. Cell types not
included in the reference are correctly identified as ‘Unknown.’ 95.1% of cells with unknown
identities are labeled as undifferentiated in the original Weinreb et al. annotation. The color of
each square denotes the percentage agreement between the manual and Capybara-based
annotations. (C) Integrative analysis of monocyte-neutrophil hybrids, monocytes, neutrophils
(identified by Capybara), and IG2 and GMP cells (identified in Olsson et al., 2016). IG2 cells
have the potential to differentiate into monocytes or granulocytes. To evaluate monocyteneutrophil hybrids, we used Seurat V4 to integrate monocytes, neutrophils, and monocyteneutrophil hybrids with the IG2 and GMP population, showing the overlap between monocyteneutrophil hybrids and the IG2 population. (D) The color of each square denotes the percentage
of each population in each cluster. (E) Cosine similarity of percentage cluster representations
across all populations, showing the highest similarity between monocyte-neutrophil hybrids and
the IG2 population. (F) Left: PAGA-guided clustering of the Weinreb dataset, revealing a total of
15 clusters, along with calculated connectivity between these clusters. Right: Projection of
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Weinreb annotations onto the PAGA-guided clustering and lineage analysis. We identified
cluster 3 as discrete monocytes, cluster 7 as discrete neutrophils, cluster 8 as discrete basophils,
and cluster 14 as discrete mast cells. The most connected clusters were then identified based on
the connectivity plot to test if they are lineage-restricted using clonal data. A randomization test
was used for testing the significant enrichment of populations on day 6 (*: P <=0.05)
Figure 2.11: Transition Scores and Its Validation. (A) Schematic of the principles underlying
Capybara’s transition metric. Squares represent discrete cell identities. Circles represent cells
with hybrid identities.

represents the probability of cell i transitioning to cell type j. Then, we

calculate the transition score of each cell type as the accumulated information received from each
cell connection. (B) Demonstration of transition scores using the mouse gastrulation atlas
(Pijuan-Sala et al., 2019), embryonic stem cell (ESC) dataset (Briggs et al., 2017), and
cardiomyocyte dataset (Stone et al., 2019). Transition scores decrease as development progresses
during mouse gastrulation. ESCs under maintenance conditions demonstrate low transition
scores as they are not actively differentiating. On the other hand, cardiomyocytes show low
transition scores as they are terminally differentiated. (****: P <= 0.0001, ***: P <= 0.001, **: P
<= 0.01, *: P <= 0.05, Wilcoxon test). (C) Comparison between RNA velocity and Capybara
transition scores in cardiac reprogramming (Stone et al., 2019). RNA velocity vectors projected
onto the UMAP embedding (Square: area containing a small number of moving vectors; Circle:
area containing a large number of moving vectors). Middle: Transition scores projected onto the
UMAP embedding (Square: area corresponding to the RNA velocity plot showing low transition
scores; Circle: area corresponding to the RNA velocity plot showing high transition scores). (D)
correlation between log (velocity vector counts) and log (transition scores).
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Figure 2.12: Capybara Analysis of Direct Cardiac Reprogramming. (A) Stone et al., 2019
experimental design: Cardiac fibroblasts were harvested from neonatal mice. Three transcription
factors, Mef2c, Gata4, and Tbx5 (MGT), were overexpressed via retroviral transduction (Day 1), followed by the addition of TGFb inhibitor (Day 0) and Wnt inhibitor (Day 1).
Reprogrammed cells were collected on days -1, 1, 2, 3, 7, and 14 for scRNA-seq. (B) Initial
tissue-level classification of this dataset reveals four major tissues, which the high-resolution
atlas restricts to two major tissues with the higher-resolution reference. (C) Discrete, hybrid and
unknown cell composition. Top: Capybara classified cell type composition over the time course.
The dot size is proportional to the discrete population size. Bottom: Hybrid cell identities of cells
after 14 days of reprogramming. (D) UMAP plot of the cardiac reprogramming dataset. Top:
Collection time points projected onto the UMAP embedding; Bottom: Projection of the two
major target populations: atrial and ventricular cardiomyocytes. (E) Normalized gene expression
of cardiac markers labeling atrial vs. ventricular cardiomyocytes (****: P <=0.0001, Wilcoxon
test).
Figure 2.13: Transition Scores and Hybrid Identities of Direct Cardiac Reprogramming.
(A) Transition scores across the cardiac reprogramming process (****: P <= 0.0001, ***: P <=
0.001, **: P <= 0.01, *: P <= 0.05, Wilcoxon test). (B) Breakdown of cell types listed as “Other”
in Figure 4. (C) Detailed hybrid cell-type breakdown for each time point of the cardiac
reprogramming time course. (D) Integration of 10x dataset generated in this study with days 7
and 14 from the Stone et al., 2019 dataset, Cosine similarity = 0.804 between the independent
studies. Bottom right: Projection of the two major cardiomyocyte populations, atrial and
ventricular cardiomyocytes, onto the integrated UMAP. (E) Detailed cell type and hybrid
classification of our in-house reprogramming dataset (n = 5,107 cells, two independent biological
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replicates). Note that in our experiment, the day 14 cells were not sorted for the cardiac reporter
gene used in Stone et al., 2019. Left: Discrete cell-type composition. Right: Hybrid cell-type
composition.
Figure 2.14: Experimental Validation of Hybrid Cells using RNA FISH and
immunostaining. (A) Normalized gene expression of Actc1 and Tnnc1 in the classified cells in
the scRNA-seq data. (B) RNA FISH of cells expressing only Myh7 or Myh6. (C) RNA FISH for
Myl4 (atrial) and Actc1, Tnnc1 (ventricular) showing discrete and hybrid cells. Scale bars =
10mm. (D) Negative staining controls for RNA FISH and immunostaining. (E)
Immunofluorescence for MYL7 (atrial) and MYL2 (ventricular) proteins showing cells
expressing a single protein (discrete) or co-expressing both proteins (hybrids). (F) Left:
Quantification of discrete cells identified from immunostaining and scRNA-seq. MYL7expressing cells are enriched relative to MYL2-expressing cells, confirming the atrial/ventricular
bias observed from scRNA-seq data. Right: Hybrid cell percentages measured by RNA FISH,
immunofluorescence, and scRNA-seq.
Figure 2.15: Capybara Analysis of Spinal Motor Neuron Differentiation and Programming
(Briggs et al 2017). (A) Differentiation vs. direct programming of motor neurons (MNs) from
ESCs (Briggs et al., 2017). (B) Spinal cord domains and regions included in the reference atlas.
(C) Capybara classification steps: with prior knowledge that these protocols aim to generate
spinal motor neurons, we selected a single-cell spinal cord development atlas (Delile et al., 2019)
as the high-resolution reference, omitting the general tissue selection step. We identified the
major embryonic development stages corresponding to each protocol. (D) Cell type composition
over the differentiation and programming time courses. Dot size is proportional to the discrete
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population size. (E) UMAP plot of this dataset, divided by protocol (Direct Programming: DP;
Directed Differentiation: DD). Top: Projection of time points onto the UMAP embedding.
Bottom: Projection of major discrete cell types, as identified via Capybara analysis, onto the
UMAP embedding. (F) Transition scores for each protocol across experimental time points
(****: P <=0.0001, n.s. = not significant, Wilcoxon test). (G) Major hybrid populations in the
direct programming and differentiation protocols. For each time point, we show the percentage
of each hybrid type.
Figure 2.16: Experimental Validation with Modulation of Retinoic Acid and Sonic
Hedgehog in MN Reprogramming. (A) UMAP plot of the integrated datasets generated in this
study, including four samples with different treatment groups. The major Capybara classification
is labelled for each cluster. (B) All discrete and hybrid cell type compositions for each treatment
group. (C) Top: Experimental design in this study. After 48 hr of embryoid body (EB) formation,
we induced the original reprogramming cocktail (Ngn2, Isl1, Lhx3: NIL) with retinoic acid (RA)
and/or smoothened agonist (SAG). Day 4 cells were collected for scRNA-seq (Cells profiled: TF
only: 2,926; TF + Shh: 3,340; TF + RA: 2,828; TF + RA +Shh: 8,042; two independent
biological replicates per condition). Bottom: Differentiated spinal cord neuron composition and
percentage breakdown of dorsal-ventral populations for each treatment group (*: P <= 0.05,
****: P <= 0.0001, randomization test). (D) UMAP plot of MN and dorsal populations
comparing TF-only to TF + RA groups. (E) Major hybrid populations across treatment groups
(****: P <= 0.0001, *: P <= 0.05; Two sample Chi-squared test). (F) Expression of the dorsal
marker, Pou4f1, and motor neuron marker, Mnx1, comparing this study to the in vivo study
(Delile et al., 2019). (G) Quantification of co-expressing cells in across treatment groups and in
vivo (****: P <= 0.0001; Two sample Chi-squared test)
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Figure 2.17: Capybara Analysis of fibroblast to induced Endoderm Progenitor (iEP)
Reprogramming. (A) MEF to iEP reprogramming (Biddy et al., 2018). (B) Tissue-level
classification of this dataset reveals seven major tissues. With the high-resolution reference, the
relevant tissues narrow down to three major tissues. (C) Top: Discrete cell type composition over
the time course. Dot size is proportional to the discrete population size. Bottom: Hybrid cell
identity proportions of cells after 28 days of reprogramming. (D) Cell composition with a
developmental atlas (Han et al., 2020; Nowotschin et al., 2019) or a combined regenerative liver
atlas (Han et al., 2018; Pepe-Mooney et al., 2019). (E) Cell type composition of day 28 and longterm cultured iEPs (n = 20,532 and 2,008 cells). (F) Cell-type classification using an expanded
reference with embryonic populations. We selected a foregut organogenesis atlas (Han et al.,
2020) and a gut tube development atlas (Nowotschin et al., 2018). We combined the two
references and performed Capybara analysis. 99.9% of cells were classified as ‘unknown.’ We
then combined this endoderm development atlas with the regenerative liver atlas, where the iEPs
were primarily classified as injured BECs. (C) Hybrid populations in day 28 and long-term iEPs.
Figure 2.18: Experimental Validation of iEPs resembling injured Biliary Epithelial Cells.
(A) Imaging of 2D and 3D-cultured iEPs. Left: Bright-field images and DAPI field of composite
z-stack images. Right: Immunofluorescence images of DAPI, CK19, and EpCAM staining. (B)
3D-rendering of a microscopy z-stack for 3D-cultured iEPs stained for DAPI, EpCAM, and
CK19, demonstrating branching. (C) Quantification of the percentage of positively stained cells,
with MEFs as a negative control (n = two independent biological replicates, two technical
replicates each). (D) UMAP plot of our integrated 2D and 3D single-cell datasets with classified
cell types labeled (Two independent biological replicates: n = 9,348 and 4,699 cells). (E)
Discrete and hybrid cell type composition of iEPs in 2D and 3D cultures. (*: P <= 0.05,
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randomization test). (F) Percentage of 2D- and 3D-cultured iEPs expressing Epcam, Cyr61 (P <=
0.0001; Two sample Chi-squared test). (G) Expression of other BEC markers on the UMAP plot,
including Krt19, Sox9, and Cftr. (H) Module scores comparing identified injured BECs,
MEF/Stromal cells (LT-iEP Dataset), and primary BECs (Pepe-Mooney et al., 2019). BEC
markers used for module scores are identified from Verhulst et al., 2019.
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3.1 Abstract
The Waddington landscape depicts development as a unidirectional descent from a
pluripotent state, down valleys toward defined cell identities. Lineage reprogramming, such as
direct cardiac conversion, crosses the barrier between valleys, bypassing progenitor or stem cell
states. These cell fate engineering strategies hold much promise for generation of clinically
valuable cell types from mature somatic cells. However, current reprogramming protocols are
inefficient, marked by low conversion rates and failure to fully recapitulate the properties of
target cells. Insights into the mechanisms of reprogramming and trajectories leading to
undesired, off-target identities will improve the efficiency and fidelity of this process.
Cardiac reprogramming from non-myocyte donor cells to cardiomyocytes via exogenous
expression of transcription factors (TFs), provides a promising approach to repair damaged heart
tissue. Despite recent advances in cardiac reprogramming, its inefficiency and low fidelity
hinders the clinical use of the resulting engineered cells. Application of single-cell technologies
together with epigenetic analyses has provided valuable insight into the reprogramming process.
However, properties such as reprogramming trajectory – i.e., the transition of cells toward target
or off-target identities, are often inferred from gene expression alone thus key information on the
progression of cell fate conversion remains unknown. This is an important area of study, as
lineage can provide answers to key questions in cardiac reprogramming, such as: 1) what
molecular changes accompany transition states on the trajectory? 2) Are conversion trajectories
stochastically or deterministically determined? Here, we apply methodologies in the Morris lab
to resolve lineage relationships using CellTagging to find key regulatory transcription factors
with CellOracle and evaluate the effect of small molecules on patterning biases using Capybara.
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3.2 Introduction
Heart disease is a leading cause of death worldwide. One of the key pathologies
contributing to cardiovascular disease is the loss of functional cardiomyocytes, whose postmitotic nature limits regenerative potential (Ieda et al., 2010; Qian et al., 2012; Song et al.,
2012). Induced pluripotent stem cell (iPSC) reprogramming from somatic cells opened broad
opportunities in direct differentiation of mature cardiomyocytes from a stem-cell like state
(Takahashi & Yamanaka, 2006). Yet, the inefficient conversion to iPSCs along with limited
differentiation to cardiomyocytes produces a heterogeneous population, hindering the clinical
utility of these cells (Ieda et al., 2010). Recent advances in direct lineage reprogramming from
somatic cells enable the generation of cardiomyocyte-like cells from fibroblasts with
overexpression of three key transcription factors - Gata4, Mef2c and Tbx5 (GMT) (Ieda et al.,
2010; Qian et al., 2013; Song et al., 2012; Srivastava & Ieda, 2012). As a major building block of
the heart making up of 50% of composition, cardiac fibroblasts have promise as an endogenous
source of cells for reprogramming in vivo (Ieda et al., 2010; Qian et al., 2012). Though there
have been continuous improvements in cardiac reprogramming protocols, the underlying
molecular mechanisms driving this process remain unclear. Recent studies have elucidated
important features of this cell fate conversion (de Soysa et al., 2019; Liu et al., 2017; Stone et al.,
2019; Y. Zhou et al., 2019). Single-cell transcriptomics has revealed that cells during early
conversion transit through a bifurcation, with one route leading to reprogramming while the
other becomes refractory to cardiac conversion (Y. Zhou et al., 2019). In support of this, in joint
epigenetic and single-cell analysis, transition cells are found to determine their terminal fate in
the first 24-48hr and take one of two paths, either to a cardiac destination or to a non-cardiac
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identity resembling fibroblast or vascular developmental cell states (Stone et al., 2019). Analysis
of chromatin landscape changes illustrates enhancers activated at early transition resemble
mostly neonatal cardiac development, gradually moving toward postnatal and adult stages. This
demonstrates that early reprogrammed cells adopt an immature identity, mimicking embryonic
development, before specification and activation of mature cardiac enhancers toward an adult
fate (Hashimoto et al., 2019).
Most current studies rely on enrichment of reprogrammed cells using an a-Myosin
Heavy Chain (a-MHC) reporter gene (Gulick et al., 1991), building a restricted lineage rather
than a comprehensive map, where off-target identities and interactions between non-myocyte and
reprogrammed cells may reside. Moreover, current trajectories leading to reprogrammed and offtarget identities are inferred from gene expression. Therefore, the molecular mechanisms
underlying these trajectories are also inferred. A “ground truth” map of lineage, connecting cell
ancestry via heritable cell labeling, has not been constructed for cardiac reprogramming,
representing a critical gap in knowledge for direct cardiac conversion. Unraveling this
comprehensive lineage map will help us gauge in vivo delivery of transcription factors or small
molecules as putative drugs and to understand potential obstacles to generating functional
cardiac tissue. As aforementioned, a key driver of cardiovascular disease is the loss or defect in
functional cardiomyocytes, which could potentially be rescued via in vivo regeneration.
To construct the “ground-truth” lineage map of this reprogramming process, we leverage
CellTagging (Biddy et al., 2018; Kong et al., 2020), joint with single-cell sequencing across
different time points to establish trajectories. Further, we apply nascent computational tools,
including CellOracle (Kamimoto et al., 2020) and Capybara, developed in the Morris lab to
identify potential transcription factors that could potentially promote or block successful
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reprogramming outcomes. Lastly, via joint profiling of lineage, transcriptome, and chromatin
accessibility, we attempt to characterize and compare the origins of successfully converted cells
and learn the diverse outcomes from clonally related siblings during direct cardiac conversion.

3.3 Results
3.3.1 CellTagging: Simultaneous Capture of Lineage and Transcriptomics
The rapid advancement of single-cell technologies opens broad opportunities in
uncovering heterogeneity and mechanisms at a single-cell resolution. Yet, during a single-cell
experiment, lineage relationships between cells are destroyed, hindering the mechanistic
understanding of continuous biological processes, such as reprogramming. To reveal such
relationships, we developed CellTagging, a combinatorial cell barcoding approach, enabling
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parallel capture of clonal history and transcriptional changes with single-cell RNA sequencing.
In brief, CellTagging labels the cells with an 8-nt heritable lentiviral-delivered barcode,
where sequencing cell barcoding during biological processes allows us to construct a multilevel
lineage tree (Figure 3.1A). Each delivery uses a distinct CellTag library that differs from each
other based on a short motif right before the random CellTag region. This design allows us to
demultiplex the cells after sequencing. We applied CellTagging to the direct reprogramming of
mouse embryonic fibroblast to induced endoderm progenitors (iEPs). As this epithelial-like cell
population has been shown to have both intestinal and hepatic potentials (Morris et al., 2014;
Sekiya & Suzuki, 2011), it serves as a prototypical example of direct reprogramming,
representing low efficiency and fidelity (Cahan et al., 2014; Guo & Morris, 2017; Morris et al.,
2014).
In this experiment, initial CellTag library CellTagMEF was transduced into MEFs. After
expansion for two days post transduction, the MEFs were split into two replicates for
independent reprogramming via overexpression of transcription factors, Hnf4 and Foxa1
according to previously reported protocols (Morris et al., 2014; Sekiya & Suzuki, 2011). At the
end of 60-hour of transcription factor delivery, CellTagD3, a second barcode library, was
delivered with a third round of CellTag delivery, CellTagD13, on day 13. During the time course
of this reprogramming, a portion of cells was collected and fixed in methanol every three days in
early reprogramming days (before d15) and every 7 days during the later days (day 21 and day
28), while the remaining cells were replated for continued expansion and reprogramming.
Single-cell RNA-seq was employed on all collected and fixed cells at the end of the experiments,
following the 10x Genomics protocol.
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In total, we recovered over 100k cells during this direct reprogramming protocol with
CellTag barcoding information and transcriptomic profiles. The CellTag information was
extracted, binarized, filtered, and processed for final computation of clonal or lineage
relationships. Using randomized testing with this lineage information, we identified bifurcation
trajectories with two terminals – one to successful conversion, expressing Apoa1 and Cdh1, and
the other to a “dead-end”, where fibroblast gene expression is retained (Figure 3.1B). In
addition, when investigating early CellTag labels, we found that clonally related cells from the
same fibroblast ancestor populations, tend to follow the same trajectory of reprogramming,
revealing early initiation of deterministic commitment to these trajectories.
Construction of distinct trajectories led us to explore potential regulators that can enhance
reprogramming, where we found that expression of a putative methyltransferase, Mettl7a1, was
identified to associate with successful reprogramming. Previously, it has been reported that
METTL3, which catalyzes N6-methyladenosine (m6A) modification of mRNA, plays a key role
in stem-cell differentiation and reprogramming to pluripotency (Batista et al., 2014; T. Chen et
al., 2015). We performed MEF to iEP reprogramming experiment with the addition of Mettl7a1
into the cocktail and subjected the cells on day 14 to colony formation assays and single-cell
RNA-sequencing. Colony formation assays demonstrate a two-fold increase in E-cadherinpositive colonies by day 14. Analysis of single-cell RNA-sequencing revealed higher expression
of Apoa1 and higher similarity to the successfully reprogrammed cells identified in the previous
time course experiment (Biddy et al., 2018).
To enable more streamlined discoveries using CellTagging, we developed a lineage
reconstruction pipeline, CellTagR (https://github.com/morris-lab), to analyze CellTag data
(Biddy et al., 2018; Kong et al., 2020a). In brief, CellTagR supports two different parts to
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analyze CellTag. First, post generation of CellTag library, its complexity needs be accessed via
sequencing to further produce an allow list for downstream design of the experiment and analysis
of single-cell RNA-sequencing data. CellTags were extracted from FASTQ files, counted, and
sorted to provide an allow list (Figure 3.2A). The allow list provides instruction for the design of
the experiment to ensure the complexity of the single-cell CellTag library. Then, after generation
of the single-cell RNA sequencing data, CellTags were extracted from filtered alignment files
and further subject to UMI quantification and count matrix generation. The data was then
filtered, binarized, corrected for errors, filtered with the allow list and metrics, and lastly used for
clone calling and lineage construction (Figure 3.2B).

Figure Error! No text of specified style in document..20: Overview of CellTagR pipeline and
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In an effort to alleviate batch effects introduced by differing sample preparation,
CellTagging has been adapted for multiplexing of samples for high-throughput single-cell RNAsequencing. In brief, different CellTag barcodes can be delivered to distinct populations,
enabling the separation via barcodes in the downstream analysis post-sequencing. In this manner,
samples can be pooled for preparation and single-cell RNA-sequencing. CellTag information
was extracted similarly as described above. With such information, we employed similar
classification strategy as Capybara in the downstream analysis to classify cells into different
groups based on their CellTag profile (Figure 3.2C). Using genetically distinct populations,
CellTag Index-based multiplexing was shown to be accurate and efficient. In addition, as
CellTags are heritable and lentivirus-delivered, CellTag Indexing demonstrates efficacy for longterm live cell multiplexing, supporting cell tracking in a competitive transplant assay in vivo
(Guo et al., 2019).
Together, CellTagging has enabled us to build a quantitative map of direct iEP
reprogramming and empowered us to identify key regulators to enhance reprogramming
efficiency and fidelity. Next, we sought to deploy this system in the direct cardiac
reprogramming system to build a comprehensive lineage map during this process.

3.3.2 Successful recapitulation of direct lineage reprogramming with CellTag
delivery
To deploy CellTagging in cardiomyocyte reprogramming, we started to establish the
reprogramming protocol in the lab, following previous established protocols (Qian et al., 2013).
Cardiac fibroblasts were harvested from neonatal mouse hearts using an explant protocol
(Methods). The cells attached and expanded for 7 days prior to the reprogramming experiment.
We first sought to test via immunostaining to ensure successful recapitulation of this
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reprogramming protocol in the lab. Transcription factors (TFs), Mef2c, Gata4, and Tbx5 (MGT),
were retrovirally delivered into the cells, followed by the reprogramming period of 28 days with
media change every two to three days. On day 28, we fixed the cells and performed
immunostaining labeling cardiac troponin, a regulatory protein in cardiac muscle cells (Sharma
et al., 2004). Utilizing confocal microscopy, we identified positive cells only in samples infected
with the TFs (Figure 3.3), supporting successful conversion of cells from fibroblast to
cardiomyocytes.
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Next, we applied a similar CellTagging experimental scheme as aforementioned to the
conversion of cardiomyocytes. Three days prior to introduction of TFs, the cells were stained and
replated from the explant culture, followed by infection of CellTag V1 library on the next day
(day -2). After expansion for 48-hr post transduction, the reprogramming cocktail was introduced
according to previously reported protocols (Qian et al., 2013). CellTag V2, the second barcode
library, was delivered on day 10 with a third round of CellTag delivery, CellTag V3, on day 21.
During the process, the cells were collected, and methanol fixed at day 0, 13 and 27, to perform a
pilot single-cell experiment using the 10x Genomics platform (Figure 3.5A) (Zheng et al.,
129

2017), where we obtained a total of 3,418 cells (Day0: 1,517; Day 13: 618; Day 27: 1,283) after
quality metric filtering. Preliminary clustering analysis using Seurat reveals 14 clusters in total
(Figure 3.4A). We identified fibroblast markers, Col1a2 and Tbx20, as well as cardiomyocyte
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markers, Tnnt2 and Des, in distinct clusters (Figure 3.4B). Interestingly, we observe most of the
cells expressing cardiac gene signatures occur on day 13 with decreasing percentages on day 27,
reflecting a possible refractory path as previously reported in Zhou et al. Additional
immunofluorescence using sarcomeric a-actinin antibody of these cells shows striation and
sarcomere structure (Figure 3.4C, Top). Moreover, we evaluate CellTag expression by
identification of GFP+ cells in culture (Figure 3.4D). Along with imaging, we performed initial
lineage analysis, demonstrating our ability to capture CellTag expression in this reprogramming
process with average of over 95% of cells captured to have at least one UMI count and over 78%
with 2 or more counts (Figure 3.4E, F). This further enabled successful clone and lineage
detection in the system (Figure 3.4C, Bottom).
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3.3.3 CellTag lineage analysis mainly reveals trajectory toward off-target cell
types
Next, we sought to further explore the lineage of this reprogramming process leveraging
this preliminary dataset. As this dataset captures a time course of continuous reprogramming, we
turned to use partition-based graph abstraction (PAGA; (Wolf et al., 2019)), supporting a betterconnected embedding. Similar to Seurat outcomes, PAGA identifies a total of 14 clusters with
cells from distinct time points distributed across clusters (Figure 3.5B). To evaluate lineage
outcomes, we first annotate clusters that represents successfully reprogrammed cardiomyocytes
and other off-target cell types. As discussed in previous subsection, we identified distinct clusters
expressing fibroblast signatures or cardiac signatures (Figure 3.5C). Moreover, using the
reference established for Stone et al dataset in Chapter 1, we applied Capybara on this new
dataset to distinguish clusters. Continuous scoring reveals enriched atrial cardiomyocyte identity
scores in cluster 10 and enriched cardiac muscle cell scores in cluster 1, 2, and 12 (Figure 3.5E).
Further cell-type classification identifies 20.4% hybrid cells with the remaining being classified
as discrete populations. We further assigned cell-type labels to the clusters based on the
dominant cell-type represented, leading to the identification of atrial cardiomyocytes in cluster
10 and cardiac muscle cells in cluster 1. Intriguingly, we also recognized a population labelled as
brown adipose tissue, mirroring previous findings in Chapter 1 (Figure 3.5F).
With the identified target population, we performed randomized testing to assess major
clones (more than 10 cells) that were significantly enriched for or depleted of induced
cardiomyocytes (Figure 3.6A). Interestingly, the test uncovers zero enriched clones with seven
depleted clones (p value < 0.05), in which less than 5% of cells coincide with the reprogrammed
populations. The major depleted source population largely occupies cluster 0 and 3, representing
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mainly cells from day 0, which infers a potential directionality from cluster 0 and 3 toward
cluster 4 and 5. Indeed, leveraging diffusion pseudotime analysis, we found a low pseudotime
profile in cluster 0 and 3 and relatively higher pseudotime in cluster 4 and 5, supporting more
“differentiated” states (Figure 3.6B-D).

Figure Error! No text of specified style in document..23: Further Analysis of the Preliminary
Data using SCANPY and PAGA.
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Furthermore, we interrogated potential reasons why there is no identified enriched clones.
Though large proportion of the cells received qualitied CellTags, we found that the cells
associated with a clone were biased toward the off-target lineage, largely overlapping with the
categorized iCM depleted clones (Figure 3.6B-C). Further, compared to day 0 and day 27, we

Figure Error! No text of specified style in document..24: Identification of Enriched
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captured at least 50% fewer cells on day 13, where major reprogrammed cardiomyocytes reside
(contains 69.1% of atrial cardiomyocyte population). We speculate that this could be due to the
post-mitotic nature of cardiomyocytes, where once reprogrammed, the cells would halt
proliferation. As previously reported, the number of reprogrammed cardiomyocytes achieve its
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peak by day 14 (Qian et al., 2013), explaining the potential capture of all reprogrammed cells at
day 13 without their clonally related cells left in culture. This concern potentially can be
addressed via restriction of the initial fibroblast population size and careful selection of
collection time points, coupled with sequencing more cells to optimize clone detection.
Alternatively, this could be alleviated via changing the reprogramming source cell type to an
immortalized MEF-T cell line (Vaseghi et al., 2016), where cells do not exit cell cycle as much
as primary fibroblasts once reprogrammed. Despite the concern of immaturity of the
reprogrammed cells, this cell line could serve as a good model to dissect lineages and
mechanisms in this reprogramming process.
In a nutshell, CellTagging enabled us to distinguish the trajectory to the off-target cell
types. Though this experiment did not bring detailed information regarding the lineage, it
supports the compatibility of CellTagging with the system and instructs high-level information
regarding experimental design and time point of CellTag delivery. Future adaptation and
adjustment of the experimental design could support better capture of the clonal dynamics and
lineage relationships.

3.3.4 Probing cell-type dynamics with potential modulation leverage
Capybara
Additional small molecules, such as TGFb- and Wnt-inhibitors (Y. Fu et al., 2015;
Mohamed et al., 2017; Zhao et al., 2015), have been demonstrated to improve the efficiency of
reprogramming, relative to conversion with Gata4, Mef2c, and Tbx5 (MGT) alone. In Chapter 1,
we utilized Capybara to probe the cell types during reprogramming with MGT and small
molecules (SM), where we observe an atrial (76%) vs. ventricular (7.7%) bias in resulting cell
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types. As TGFb and Wnt signaling play key roles in chamber specification in early development
of the heart, it has been previously shown that TGFb inhibition and Wnt agonism yields mostly
ventricular cardiomyocytes (H. Wang et al., 2014). We hypothesize that the TGFb and Wnt
inhibitors (SB431542, and XAV939, respectively) applied in the Stone et al., protocol could be
potentially responsible for the generation of mostly atrial-like cardiomyocytes that we observed.
To test this hypothesis, we collected cells for scRNA-seq, without sorting, yielding a total
of 11,215 cells from two biological replicates (+SM: 5,107; -SM: 6,108) (Figure 3.7A).
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Figure Error! No text of specified style in document..25: Capybara Analysis
comparing Cardiac Reprogramming with or without small molecules.
Integration with days 7 and 14 of the Stone et al., data demonstrates successful recapitulation of
the protocol (cosine similarity between Day 7 from Stone et al. and +SM samples = 0.71
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(Replicate #1); 0.89 (Replicate #2)). Capybara analysis reveals that the addition of SM to the
GMT cocktail produces relatively higher percentages of cardiomyocytes (+SM: 25.3 ± 1.06%, SM: 24.0 ± 0.7%; P = 0.057, randomized test). Breaking down the atrial and ventricular
cardiomyocytes reveals that the addition of SM produces a higher ratio of atrial to ventricular
cardiomyocytes (P = 0.0287, randomization test; Figure 3.7B-C). Confirming this observation,
we observed a significant increase in atrial genes, such as Myl7 (P=0.021, Wilcoxon rank sum
test), and decrease in ventricular genes, such as Myl12a (P=0.00061, Wilcoxon rank sum test), in
the presence of SM (Figure 3.7D). Together, this offers support to the hypothesis that small
molecules in reprogramming play a role in altering region specification.
In addition to small molecules, other factors, such as transcription factors (Akt1 and
Hand2) (Hashimoto et al., 2019; H. Zhou et al., 2015) and microRNA (miR-133) (Jayawardena
et al., 2012), have been demonstrated to improve the efficiency and fidelity of reprogramming.
Next, we sought to look for potential transcriptional regulators that plays vital parts during this
reprogramming process.

3.3.5 CellOracle reveals two transcription factors as key regulators during
direct cardiac reprogramming
During reprogramming, transcriptional regulators play key roles in “wiring” cells to their
destined cell fate. Identification of such factors can largely facilitate the derivation or
differentiation toward their terminal fate. Traditionally, transcription factors were identified via
differential gene expression analysis and screened via experimental approach (Ieda et al., 2010;
Song et al., 2012; Takahashi & Yamanaka, 2006). Here, we turned to in silico approach, using
CellOracle, to identify key transcriptional regulators and simulate potential outcomes from
knockout or overexpression.
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CellOracle reconstructs gene regulatory networks (GRNs) from scRNA-seq profiles.
Integrated with chromatin accessibility information, this approach utilizes regularized linear
regression to build statistical models for predicting gene expression, the strength of gene-gene
interactions, inferring regulatory factors to maintain or reprogram cell identity. Beyond GRN
prediction, it provides functionality to simulate expression profile shift once the expression of the
transcript factor is altered (Kamimoto et al., 2020).
We first examined the time course reprogramming dataset generated in the preliminary
experiment. With the data preprocessed, we constructed GRN models for each of the 14 clusters
identified, representing cardiomyocyte fates (cluster 1 and 10) as well as other off-target cell
types with the starting population labeled in cluster 0 and 3 (smooth muscle/mesenchymal).
Ranking of the degree centrality of the top 30 TFs in cluster 1 and cluster 10 suggests a potential
factor, Klf5 (Figure 3.8B). KLF5 has previously been reported as significant in cardiovascular
remodeling upon injury. During embryonic development, it is expressed abundantly, yet
downregulated as development progress. Nonetheless, upon injury, Klf5 expression is reinduced
to activate downstream wound repair response and remodeling (Nagai et al., 2005). Together
with pseudotime (Figure 3.8A) and CellOracle gradient vectors, we observe the inferred normal
trajectory from cluster 0 and 3 toward different other branches (Figure 3.8C). We performed
perturbation simulation of Klf5 to evaluate the potential effect of it on this reprogramming
system. The perturbation results reveal that upon knockout, the transitions to cardiac fate are
blocked while transitions toward fibroblast fate is promoted (Figure 3.8E). On the contrary,
overexpression simulation shows promotion toward the cardiomyocyte fate with blocked
fibroblast transitions (Figure 3.8F), suggesting overexpression of Klf5 in joint with the MGT
cocktail could potentially improve this direct lineage reprogramming.
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Figure Error! No text of specified style in document..26: CellOracle Analysis of the
preliminary time course single-cell dataset.
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Next, we sought to assess the reprogramming dataset that profiles the reprogramming
process initiated with a modified cocktail (MGT + SM). We reanalyzed the data using PAGA
(Wolf et al., 2019) to obtain a better-connected embedding, yielding a total of 13 clusters
(Figure 3.9). Based on Capybara annotation, we labeled the clusters with the most dominant fate

Figure Error! No text of specified style in
document..27: SCANPY and PAGA analysis
of the dataset with small molecule treatment.

within each cluster and identified cluster 3, 4 and 10 as reprogrammed clusters. Using similar
approaches as described above, ranking of the degree centrality of the top 30 TFs in cluster 3, 4,
and 10 suggests potential factors, including Klf5 and Atf3 (Figure 3.10B). Previously, it has been
reported that Atf3 is a key regulator for ventricular remodeling to protect the heart from
hypertensive stress. The major source of Atf3 response resides in the cardiac fibroblasts, which is
the source of reprogramming in this protocol (Y. Li et al., 2017). Similar to Klf5, pseudotime
(Figure 3.10A) and CellOracle gradient vector inferred that the normal trajectory starts from
cluster 1 toward different other branches (Figure 3.10C). Further perturbation simulation of Atf3
reveals that upon knockout, the transitions to all cardiac fates are blocked while transitions
toward the fibroblastic fate is promoted (Figure 3.10E). Interestingly, overexpression simulation
shows promotion toward one subpopulation of cardiomyocyte fates (cluster 4) yet with blocked
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fibroblast and other cardiac fates (cluster 3) transitions (Figure 3.10F), suggesting Atf3 as a
potentially more specific driver factor in determination of fates.

Figure Error! No text of specified style in document..28: CellOracle Analysis of
the dataset with small molecules.
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Overall, leveraging GRN analysis, I have pinpointed putative transcriptional regulators,
overexpression of which could promote the efficiency and fidelity of reprogramming.
Intriguingly, both Klf5 and Atf3 have been found to serve important roles in cardiovascular
remodeling when exposed to injury or stress, suggesting potential similarity between in vitro
reprogramming and in vivo cardiac repair process.

3.3.6 Lineage tracing with immortalized MEF-T cell line uncovers two
overlapping putative trajectories in transcriptional profiles
We route back to the big-picture scope of this project to construct a comprehensive
lineage map of cardiac reprogramming. To alleviate the previously identified concerns, we
moved on to use the inducible MEF-T cell line. In brief, this cell line is constructed from primary
cells harvested from transgenic mice, which harbors the reporter under the a-MHC promoter as
aforementioned (Gulick et al., 1991). The three transcription factors, MGT, are integrated into
the genome in a polycistronic manner and regulated under a Tetracycline inducible promoter.
Once doxycycline is introduced, MGT TFs are overexpressed, initiating reprogramming. As the
cells initiate cardiac program, they start to express the GFP reporter protein, serving as a
benchmark for successful reprogramming. SV40 large T antigen was retrovirally delivered into
the primary cells, followed by selection, to establish the immortalized cell line (Vaseghi et al.,
2016). As these cells are more prolific than primary MEFs and the reprogramming outcomes are
less mature (Stone et al., 2019; Vaseghi et al., 2016), we consider it could help alleviate the
concerns as cells become non-proliferative. In addition, doxycycline induces a peak
reprogramming within three days post-initiation (Vaseghi et al., 2016), enabling us to probe the
initiation and reprogramming in a short time frame.
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Figure Error! No text of specified style in document..29: State-Fate Experiment (RNA Profile).

Inspired by the state-fate experiment performed in hematopoiesis (Weinreb et al., 2020),
we designed a similar experiment in the direct cardiac reprogramming, profiling the state
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samples at day 2 and fate samples at day 5 post induction of doxycycline. Accompanying this
design is the advancement in the CellTagging system (CellTag-AR), where the 8-nt random
barcode is replaced with an 18-nt barcode, enabling higher library complexity and lower MOIs.
In addition, CellTagging has been adapted to capture lineage in concurrent with single-cell assay
for transposase-accessible chromatin sequencing (scATAC-seq) (Kunal Jindal, unpublished,
manuscript in preparation). Here, ~10,000 cells were plated (0hr) and transduced with CellTagAR library 12 hr later with doxycycline induction. The virus was removed 12 hours later, with
replacement of fresh media containing doxycycline. Doxycycline was maintained and replaced
every day in culture for ~3 days to initiate reprogramming, where the GFP reporter signal was
observed by day 2 (data not shown). We collected and counted cells on day 2, two-thirds of
which were prepared for single-cell sequencing with the remaining replated for continual
expansion. The collected cells were further split for two assays, scRNA-seq and scATAC-seq.
After an additional three-day expansion, we collected all the cells at day 5 and subjected them to
similar protocols as day 2. Having the cells sharing the same CellTag-AR infection enables us to
join RNA and ATAC data together by lineage (Figure 3.11A).
Post-sequencing, the RNA data was subject to CellRanger analysis to align, filter, and
generate the count matrices. Through scRNA-seq, we obtained a total of 72,834 cells (Day 2:
18,702; Day 5: 54,132) post QC metrics through Seurat analysis. Application of integration with
Seurat V4 reveals 12 clusters with even distribution of cells from day 2 and day 5 (Figure
3.11B-C). These clusters dynamically express fibroblastic and cardiac marker genes (Figure
3.11D). To have a better idea of identity shifts, we constructed a reference based on the sorted
day 14 (iCM) and initial day -1 populations (fibroblast) in Stone et al. Referencing against this
dataset, we assigned identity scores to these cells via QP and found the iCM scores to be
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enriched in cluster 6 while fibroblast scores to be evenly distributed across all other clusters
(Figure 3.11E). Based on the expression level of Col1a2, we speculate cluster 5 is the source of
fibroblasts. Notably, the iCM scores peak around 0.6 compared to day 14 sorted population in
Stone et al, suggesting immaturity in these reprogrammed cells.
Next, we turned our focus to CellTag clonal information. A total of 47,671 RNA and
ATAC cells were captured as in clones with at least 2 cells in a clone. From RNA clonal
information only, 31,111 RNA cells (Day 2: 7,823; Day 5: 23,288) were identified as in clones
with overall even distributions across the clusters (Figure 3.12A). Here, following the interest in
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looking at different time points, we mainly investigate the state-fate clones in this RNA dataset,
defined as clones containing cells from day 2 and day 5. Within a total of 12,460 clones, we
found 3,477 state-fate (SF) clones. With the identified target population (cluster 6), we
performed randomized testing to assess major SF clones (more than 10 cells) that were
significantly enriched for or depleted of induced cardiomyocytes, uncovering nine enriched
clones with 25 depleted clones (p value < 0.1). 14~16% of the cells in the enriched clones are
transcriptionally similar to the identified successfully reprogrammed cluster (cluster 6). The
major depleted source population represents 0% of cells in the clone to become reprogrammed,
largely locating in cluster 0 and 10 (Figure 3.12B). The dominant depleted clones reflect our
pilot experiment with serial infection of CellTags. It is worth noting that there is a significant
overlap of distribution of the cells identified in the reprogrammed enriched or depleted clones,
suggesting similarity in expression profiles of these cells, which further support the immaturity
of these reprogrammed cells

3.3.7 Lineage tracing with immortalized MEF-T cell line uncovers two
distinctive putative trajectories in chromatin landscapes
Next, we sought to chart the dynamics on the chromatin landscape during this
reprogramming protocol. In addition to transcriptional remodeling, direct lineage reprogramming
involves significant shifts in chromatin landscape. For instance, in TF-mediated lineage
reprogramming, pioneer transcription factors, who can open heterochromatin, alter the chromatin
landscape with facilitation from additional co-factors. The chromatin remodeling then drives the
transcriptional shift to the expression profile of the target cell types (Guo & Morris, 2017). In
cardiac conversion, it has been found that the transcriptional remodeling involves a rapid gain of
the cardiac program, yet with gradual loss of the fibroblast profile (Liu et al., 2017; Stone et al.,
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2019; Y. Zhou et al., 2019). In effort to chart chromatin remodeling in cardiac reprogramming, a
recent study leveraging scATAC-seq reveals key regulatory factors, including Fos and Tcf21,
during early stages of the process, providing invaluable insights in epigenomic remodeling (H.
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Wang et al., 2022).
After we obtained the sequencing data, the ATAC data was subject to CellRanger-atac
analysis to align, filter, and generate the fragment counts. Through scATAC-seq, we obtained a
total of 52,365 cells (Day 2: 20,476; Day 5: 31,889) post QC metrics through ArchR analysis
(Granja et al., 2021). Clustering via ArchR reveals 11 clusters with distribution of cells from day
2 mainly occupies the top and those from day 5 lays on the bottom (Figure 3.13A-B). We further
compute imputed gene activity scores using ArchR, where we observe these clusters distinctively
have high activity scores for fibroblastic and cardiac marker genes (Figure 3.13C). To better
pinpoint the identities of each cluster, we further perform differential peak analysis, followed by
motif enrichment analysis, where we found significant enrichment of previously reported
fibroblastic motif, such as Fos and Bach2, in cluster 5 and 6. On the other hand, we found
enrichment of cardiac motifs, such as Mef2c and Tead4, in cluster 8 and 10. To further confirm
the cluster identities, we performed GREAT analysis, a tool that predict functions of cisregulatory regions, to assign biological meanings to these regions (McLean et al., 2010), where
we found cluster 5 and 6 to be significantly enriched for vascular and immune development. In
addition to being fibroblastic, cluster 5 and 6 mirrors previous findings of vascular off-target
during this reprogramming ((Stone et al., 2019) (Figure 3.14A). Annotation of cluster 8 and 10
reveals significant enrichment of muscle and cardiac cell development as well as muscle fiber
organization, supporting these two clusters as reprogrammed clusters (Figure 3.14B). Further
comparison of these differential peaks to the binding profile of Mef2c, Gata4, and Tbx5
highlights cluster 8-11 as enriched for these binding sites (Figure 3.14C).
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Figure Error! No text of specified style in document..14: GREAT analysis and Comparison
to Chip-seq Peaks.
Considering cluster 10 is composed mainly of day 5 fate cells, we consider this cluster as
the cluster harboring successfully reprogrammed cells. We next performed similar randomized
test using the ATAC clonal and lineage information. From ATAC clonal information only,
16,560 ATAC cells (Day 2: 5,157; Day 5: 11,403) were identified as in clones with overall even
distributions across the clusters (Figure 3.15A). Again, we mainly investigate the state-fate
clones in this dataset, where we found 1,305 state-fate (SF) clones out of 9,653 total clones. With
the identified target population (cluster 10), we performed randomized testing to assess major SF
clones (more than 10 cells) that were significantly enriched for or depleted of induced
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cardiomyocytes, uncovering eight enriched clones with eight depleted clones (p value < 0.1).
30~50% of the cells in the enriched clones coincide with the identified successfully
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reprogrammed cluster (cluster 10). The major depleted source population represents 0% of cells
in the clone to become reprogrammed, largely locating in cluster 5 and 6 (Figure 3.15B-C). It is
worth noting that, compared the RNA lineages identified, there is a more distinct distribution of
the cells identified in the reprogrammed enriched or depleted clones, suggesting distinctions in
their epigenetic landscape to define the two fates. Interestingly, in the depleted clones, we
observe clones that remained within the region of cluster 5 and 6 across the two time points as
well as clones that traversed cluster 8 to cluster 5/6. As mentioned above, cluster 8 demonstrates
strong cardiac profile. This observation mirrors the previous identified refractory trajectory in
this reprogramming protocol (Stone et al., 2019; Y. Zhou et al., 2019).
Taking RNA and ATAC together, we demonstrate the rich information presented in
combination of lineage, transcriptome, and chromatin landscape. We speculate that the observed
more distinct trajectories in the epigenome suggests that the chromatin remodeling has already
occurred while the more overlapping trajectories in transcriptome profile reveals the delay in
transcriptional remodeling.

3.4 Discussion
In this Chapter, we report the application of our in-house tools on a new direct lineage
reprogramming protocol to generate cardiomyocytes. In the pilot experiment, with serial delivery
of CellTags, we showcase the compatibility of the CellTag lineage tracing system with this new
reprogramming system. In addition, we learn the behavior of these cells, which instruct our
future experimental design to take these factors into account.
Brief investigation of atrial-ventricular regionalization with or without small molecules
suggests potential patterning events introduced via these modulations. This result requires further
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validation as our small molecule treatment group did not show as significant fold increase as
previously described in producing cardiomyocytes (Mohamed et al., 2017). We speculate a
potential reason that the construct we used for MGT infection is previously optimized and
ordered in a polycistronic manner. This construct has previously been shown to significantly
increase production of reprogrammed cardiomyocytes, compared to separate transduction of the
M, G, T factors (L. Wang et al., 2015), resulting in our observed higher cardiomyocyte rates in
the control groups.
In order to identify key transcriptional regulators in this system, we employed CellOracle
analysis to construct gene regulatory networks and identified two potential key factors, Klf5 and
Atf3. Both factors have been previously reported to play vital roles in cardiovascular remodeling
in response to injury and hypertensive stress (Y. Li et al., 2017; Nagai et al., 2005). Perturbation
simulation with CellOracle demonstrates that knockout of either one of the factors will block
transitions to successful reprogrammed cells. Yet, overexpression of either one will promote
transition to more cardiomyocyte-like cell states. In addition, we speculate that overexpression of
Atf3 could lead us to a specific cardiac cell type, blocking possibilities to other cardiac fates.
This analysis opens new hypothesis for testing to promote the efficiency and fidelity of
reprogramming.
Refocusing on the blueprint of this project to identify the comprehensive lineage map, we
perform state-fate experiment to capture lineage information together with transcriptome profiles
or chromatin landscapes. Leveraging nascent CellTag-AR development, we identified two
putative trajectories in both assays – one toward successfully reprogrammed and the other to
fibroblastic states. This mirrors our previous discoveries in MEF to iEP reprogramming, where
we observed a successfully reprogrammed vs a ‘dead-end’ trajectory. In addition, it reflects
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previous reported refractory lineage inferred via RNA velocity (Stone et al., 2019; Y. Zhou et al.,
2019). Comparing RNA and ATAC trajectories, we observe a more distinct separation between
the two directions from the ATAC clonal information than the more overlapping trajectories in
RNA. We speculate that this demonstrates the upstream chromatin remodeling has occurred to
turn off fibroblastic program while the downstream transcriptional remodeling is gradually
losing their fibroblast expression profile. Indeed, it has been previously reported that the cells
acquire a cardiac expression profile rapidly with a gradual loss of their starting transcriptional
profiles (Liu et al., 2017; Stone et al., 2019; Y. Zhou et al., 2019).
Through this preliminary analysis, we present this rich dataset profiling both
transcriptional and chromatin landscape and demonstrate our ability to track cells in this system.
This opens broad opportunities to probe changes occurring in the transcriptome and chromatin
level, further providing mechanistic insight in reprogramming to improve cell fate engineering
strategies.

3.5 Materials and Methods
3.5.1 Cell Culture
Immortalized mouse embryonic fibroblast cell line was a kind gift from the laboratory of Dr.
Li Qian at University of North Carolina, Chapel Hill. The cells were maintained and passaged
according to its protocol (Vaseghi et al., 2016) in Dulbecco’s Modified Eagle Medium (Gibco)
supplemented with 10% Fetal Bovine Serum (Gibco), 1% penicillin/streptomycin (Gibco), and
55 M 2-mercaptoethanol (Gibco).
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3.5.2 Mice
Mice used for cardiac fibroblast explant experiment were of C57BL/6J background (The
Jackson Laboratory #000664). All animal care procedures were approved by Washington
University Institutional Animal Care and Use Committee.

3.5.3 Cardiac Fibroblast Explant Culture
The cardiac fibroblasts were derived via an explant culture, following previous protocol
(Qian et al., 2013). In brief, explant media was prepared with Iscove’s Modified Dulbecco’s
Medium (IMDM) supplemented with 20% Fetal Bovine Serum (Gibco), 1%
penicillin/streptomycin (Gibco), and 55 M 2-mercaptoethanol (Gibco). hearts were harvested
from P0-P3 mice, rinsed with 1x DPBS (Gibco) for 3 times, and minced to small pieces around
0.5 mm3 in size. The tissue pieces were plated on a 0.1% gelatin-coated 6-well plate with
minimum explant media (~0.5 to 1 ml to barely cover the bottom). The plate was incubated at
37°C, 5% CO2 in an incubator for 2 hours to allow the tissue pieces to attach on the bottom of
the plate. Post the 2-hour incubation, 2-ml fresh and pre-warmed explant media was added to
each well. The plate was then incubated at 37°C, 5% CO2 in an incubator for 3 days without
disturbance. After the 3 days, medium was changed every three to four days or till medium
becomes yellow. Explanted fibroblast was harvested with trypsin, followed by passing through a
70- m cell strainer, on day 7 post initiation of the explant culture. The resulting cells were
counted and replated on 0.1% gelatin coated plates at a density of 500k/10-cm dish to be used for
reprogramming the next day.
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3.5.4 Reprogramming Virus Production
The

retrovirus

for

cardiac

reprogramming

was

freshly

prepared.

293T

cells

(RRID:CVCL_1926) were maintained and passaged in fibroblast media (10% FBS, 1x
penicillin-streptomycin, 1x -Mercaptoethanol, in DMEM). 293T cells were seeded at a density of
3 million per 10-cm plate the day before transfection. The following day, the cells were
transfected

with

pMX-MGT

(RRID:Addgene_12371),

using

(RRID:Addgene_111810)
X-tremeGENE

9

DNA

with

5g

transfection

of

pCL-Eco

reagent

(Sigma,

6365779001) according to the manufacturer's instructions. Media was replaced with fresh
fibroblast media the following day. Retrovirus was harvested the next day by taking the
supernatant from the transfected plate and filtered through a 45- m syringe filter. 500x protamine
sulfate was added to the viral media prior to transduction of the mouse cardiac fibroblast.

3.5.5 Cardiomyocyte Reprogramming with Primary Cells
Direct cardiac reprogramming was performed using primary cardiac fibroblasts derived
from the cardiac fibroblast explant culture. Briefly, cardiac fibroblasts (MCFs) were harvested
after seven days of the explant culture and cultured overnight on gelatin-coated plates in MEF
media (DMEM supplemented with 10% FBS, 1% penicillin/streptomycin, and 55 M 2mercaptoethanol). MCFs were plated at a density around 500k per 10-cm dish pre-treated with
0.1% gelatin solution for 20~30 minutes. MCFs were infected with freshly harvested pMX-MGT
retrovirus (L. Wang et al., 2015) (day 0). The viral media was replaced with fresh cardiomyocyte
media (10% M199, 10% FBS, 1% NEAA, 1% sodium pyruvate, 1x penicillin-streptomycin, 1x
Glutamax, in DMEM). In the small molecule comparison experiment, the cardiomyocyte media
was supplemented with 2.6M SB431542 (Cayman Chemical, Catalog #13031) or DMSO as a
vehicle control (day 1). 5M XAV939 (Cayman Chemical, Catalog #13596) or DMSO was added
154

to the plate without media change (day +1) for the small molecule group. The media was
replaced with fresh cardiomyocyte media two days after the last addition of small molecule (day
+3). Media was renewed every 2~3 days. The cells were collected, filtered through a 70-m
strainer, resuspended in 1% BSA in PBS, and counted on day 0, day 13, and day 27 for scRNAseq (see below).

3.5.6 Cardiomyocyte Reprogramming with inducible Fibroblast Cell Line
Direct cardiac reprogramming was performed using the immortalized inducible fibroblast
cell line (MEF-T iMGT) (Vaseghi et al., 2016). Briefly, MEF-T iMGT was maintained on
gelatin-coated plates in MEF media (DMEM supplemented with 10% FBS, 1%
penicillin/streptomycin, and 55 M 2-mercaptoethanol). 12-hour prior to reprogramming
initiation, MEF-T iMGT cells were replated at a density around 10k per well on a 48-well plate
with 0.1% gelatin solution for 20~30 minutes. The cells were allowed to attach for ~12hrs. The
media was aspirated and replaced with cardiomyocyte media with CellTag-AR virus and 1 g/ml
doxycycline. The viral media was replaced with fresh cardiomyocyte media (10% M199, 10%
FBS, 1% NEAA, 1% sodium pyruvate, 1x penicillin-streptomycin, 1x Glutamax, in DMEM),
containing 1 g/ml doxycycline. Doxycycline was maintained in culture for three days and
replaced with new treatment every day. The cells were collected, filtered through a 70-m
strainer, resuspended in 1% BSA in PBS, and counted on day 2 and day 5 for scRNA-seq.

3.5.7 Immunostaining for day 28 Reprogrammed Cells in Cardiac
Reprogramming
Mouse cardiac fibroblasts were generated as described above. On day 27 of the
reprogramming process, the cells were transferred to 4-Chamber Culture Slides (Falcon). On the
next day, the cells were rinsed with 1x DPBS and fixed in 4% paraformaldehyde for 20 minutes
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at room temperature. The samples were then washed with 1x DPBS three times, permeabilized,
and blocked with blocking buffer (0.1% TritonX-100 and 5% BSA in DPBS) for an hour. The
primary antibodies, Cardiac Troponin T (RRID:AB_11000742) and -Actinin (Sigma-Aldrich,
Product No. A7811), were diluted 1:500 (cTnT) and 1:800 (ACTN2) in the 1% BSA in DPBS.
The blocking buffer was then removed from the sample, and 250 l of diluted primary antibodies
was added to two different wells. The samples were incubated with the primary antibody at 4°C
overnight (12~16 hrs). The samples were then washed for 5 minutes three times. The secondary
antibodies, Alexa Fluor 568 Goat Anti-mouse IgG (RRID:AB_2534072), were diluted 1:1000 in
the blocking buffer. The secondary antibodies were added and incubated at room temperature for
1 hour in the dark on a rocker. The samples were washed again for 5 minutes, three times. 100 l
of 300 nM DAPI (Invitrogen) was added to each slide chamber and incubated at room
temperature for 1 minute. The samples were washed for 5 minutes once. The final wash with
DPBS was aspirated and the chamber was removed from the slides. A coverslip was then applied
with ProLong Gold Antifade Mountant (Invitrogen). The slides were imaged using an Olympus
FV1200 Confocal Microscope with 60x water objectives.

3.5.8 CellTag Lentivirus Production
293T cells (RRID:CVCL_1926) were maintained and passaged in fibroblast media (10%
FBS, 1x penicillin-streptomycin, 1x -Mercaptoethanol, in DMEM). 293T cells were seeded at a
density of 3 million per 10-cm plate the day before transfection. CellTag virus was produced by
transfecting 293T cells with lentiviral pSMAL vector and packaging plasmids pCMV-dR8.2
dvpr (Addgene plasmid 8455) and pCMV-VSV-G (Addgene plasmid 8454) using X-tremeGENE
9 (Sigma, 6365779001). Media was replaced with fresh fibroblast media the following day.
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Virus was collected 48 and 72 hours after transfection by filtering the supernatant through a
0.45-m syringe filter.

3.5.9 CellTag Transduction
The CellTag virus containing supernatant as collected above was used immediately or kept
at 4°C for up to a week. Prior to transduction, 500x protamine sulfate was added to the viral
media. Media was aspirated from the cells to be transduced. The viral media was immediately
added to the cells and left on the plate for a 24-hour transduction period. This transduction was
performed on day -2 with V1 library, day 10 with V2 library, and day 21 with V3 library for the
primary fibroblast reprogramming or day 0 with CellTag-AR library for inducible MEFs.

3.5.10 Single-Cell RNA Profiling
For single-cell library preparation on the 10x Genomics platform, we used: the Chromium
Single Cell 3′ Library & Gel Bead Kit v2 (PN-120237), Chromium Single Cell 3′ Chip kit v2
(PN-120236), and Chromium i7 Multiplex Kit (PN-120262), according to the manufacturer’s
instructions in the Chromium Single Cell 3′ Reagents Kits V2 User Guide. Prior to cell capture,
methanol-fixed cells were placed on ice, then spun at 3000rpm for 5 minutes at 4°C, followed by
resuspension and rehydration in PBS, according to Alles et al., 2017. 17,000 cells were loaded
per lane of the chip, aiming to capture 10,000 single-cell transcriptomes. The resulting cDNA
libraries were quantified on an Agilent Tapestation and sequenced on an Illumina HiSeq 2500.
For analysis of cardiomyocyte reprogramming, The Chromium Single Cell 3’ (v2) Reagent Kits
(PN-120237, PN-120236, PN-120262) were used to prepare single-cell RNA-seq libraries,
according to manufacturer’s guidelines. Libraries were pooled and sequenced on an Illumina
NextSeq 550. For motor neuron programming, prior to loading the 10x chip, methanol-fixed
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cells were counted, spun, resuspended in 1% BSA in PBS, and counted again, according to 10x
Genomics methanol fixation protocol. The Chromium Single Cell 3’ (v2) Reagent Kits (PN120237, PN-120236, PN-120262) were used to prepare single-cell RNA-seq libraries, according
to manufacturer’s guidelines. Libraries were pooled and sequenced on an Illumina NextSeq 550.

3.5.11 Single-Cell ATAC Profiling
For single-cell ATAC library preparation on the 10x Genomics platform, we used: the
Chromium Next GEM Single Cell ATAC Library & Gel Bead Kit v1.1 (PN-1000175),
Chromium Next GEM Chip H Single Cell Kit v1.1 (PN-1000161), and Single Index Kit N Set A
(PN-1000212), according to the manufacturer’s instructions in the Chromium Next GEM Single
Cell ATAC Reagents Kits v1.1 User Guide. Briefly, the cells were harvested, counted, and
subjected to nuclei isolation and light fixation with 4% paraformaldehyde for 4 minutes at room
temperature, followed by tagmentation of accessible genome in the nuclei. An in-situ reverse
transcription step was performed on the nuclei prior loading the chip for better capture of the
CellTag-AR barcodes. After the reverse transcription, the nuclei were resuspended and spun at
600xg for 10 min at 4°C. Supernatant was partly removed with measured amount left for loading
on the 10x scATAC Chip. 20,000 cells were processed to generate nuclei for loading per lane of
the chip, aiming to capture 10,000 single-nuclei accessible genome. The GEM generated from
the chip was further prepared to generate the final libraries, according to the manufacturer’s
instructions. The resulting libraries were quantified on an Agilent Tapestation and sequenced on
an Illumina NextSeq 550.
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3.5.12 Single-Cell RNA Sequencing Analysis
The Cell Ranger v6.0 pipeline (https://support.10xgenomics.com/single-cell-geneexpression/software/downloads/latest) was used to align reads, process, and filter data generated
using 10x Chromium single-cell gene expression platform. Following this step, the default Cell
Ranger pipeline was implemented to generate the filtered output data for downstream analysis.
To process and analyze scRNA-seq data, we used the R package, Seurat V4, following the
tutorial (https://satijalab.org/seurat/articles/pbmc3k_tutorial.html). Briefly, each sample was preprocessed based on RNA counts and mitochondria percentages and then normalized. The highly
variable genes were then identified, followed by scaling and dimensional reduction via PCA.
With the selected number of components, graph-based clustering and UMAP plotting were
further performed.

3.5.13 CellOracle Gene Regulatory Network Analysis
To analyze the scRNA-seq data through CellOracle, the data was processed through
SCANPY standard pipeline (https://scanpy.readthedocs.io/en/stable/) (Wolf et al., 2018). The
single-cell data was processed through similar preprocessing, filtering, and clustering as
described above. The data was then subject to trajectory inference using PAGA (Wolf et al.,
2019). The Anndata result from this processing was passed into CellOracle. Gene regulatory
network models were constructed on a cluster-by-cluster basis and enabled network analysis of
each individual cluster to identify top rank transcription factors. Leveraging the in-silico
perturbation function with GRNs in CellOracle, the data was the altered to have a gene knocked
out or overexpressed. Knockout set the expression level to zero where overexpression set the
expression level to the max expression level of that gene in the system. The perturbation was
then visualized with gradient vectors and perturbation scores.
159

3.5.14 CellTag Data Analysis
For CellTag V1, V2, and V3, CellTag information was analyzed as aforementioned (Biddy
et al., 2018; Kong et al., 2020). In brief, the CellTags were extracted from aligned bam files,
followed by UMI counting to generate the count matrix. With the count matrix, the data was
further binarized, passed through an allow list, and QC metric filtered. Finally, Jaccard analysis
was performed on the filtered matrix and further graph-based method was used to identify
clonally related cells. For CellTag-AR, similar approaches were adapted for extraction, filtering
of the data, and clone calling. The clone calling process using CellTag-AR leverage an additional
step to break down sparse clones using graph cliques.

3.5.15 Randomized Test for Trajectory Discovery
To identify clones enriched or depleted of iCM generation, we applied similar strategies as
previously described (Biddy et al., 2018). Briefly, randomized testing to evaluate whether each
clone (of at least 10 cells) has a similar percentage of fully reprogrammed cells relative to a
randomly selected population of the same size. The percentage of reprogrammed cells is defined
as the proportion of cells within each group found in the reprogrammed cluster, as defined by
Seurat together with Capybara and marker gene scores. Let N represent the number of cells in
each clone and M represent the remaining cell population size. We pool the two groups of cells
(size=N+M) and resample N random cells, without replacement, from the pooled cells (N+M)/N
times such that every possible separation with ending groups of size N and M can be sampled
and captured. During this process, the percentage is calculated based on the N randomly sampled
cells. With the percentage calculated, P values can be evaluated based on the proportion of
randomly sampled cells with a percentage greater than or equal to the null percentage.
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3.6 Detailed Figure Legends
Figure 3.1: Overview of CellTagging System and Previous Discovery in MEF to iEP
Reprogramming. (A) Top: Schematic of the CellTagging barcode cell label, including a GFP
with an 8-nt random barcode integrated into its 3’-UTR. Bottom: Outline of CellTagging and
trace method for reconstruction of lineage during reprogramming. (B) Application of the lineage
tracing approach to MEF to iEP reprogramming uncovers two distinct trajectory – one toward
successfully reprogrammed outcome (Bottom) and one toward an off-target cell type (Top).
Figure 3.2: Overview of CellTagR Pipeline and CellTag Indexing Strategy. (A) Pipeline to
assess library complexity after sequencing of the CellTag barcode library, prior to application to
biological systems. (B) Pipeline for CellTag data extraction, filtering, and clone calling post
single-cell RNA sequencing. (C) Schematic of CellTag Indexing Strategy, where unique
barcodes are delivered to different populations. Post single-cell sequencing, the barcodes were
extracted, normalized, filtered, and provide a classification of the samples toward their labelled
population categories.
Figure 3.3: Immunostaining of Cardiac Troponin Protein. Top Row: Negative control group
staining fibroblast. Bottom Row: Staining of the protein in cells 28 days after cardiomyocyte
reprogramming was initiated.
Figure 3.4: Preliminary single-cell RNA-sequencing analysis. (A) Left: Clustering of the data
using Seurat, presenting a total of 14 clusters. Right: the distribution of cells from different time
points on the UMAP embedding. (B) Expression of key markers. Cardiac fibroblast: Tbx20 and
Col1a2. Cardiomyocyte: Tnnt2 and Des. (C) Top: Immunofluorescent experiment staining for a161

actinin. Red: a-actinin. Bottom: primary lineage analysis using single-cell data, in which each
center node labels for a clone for each version of CellTag libraries and each branch node denote
a cell in the clone. D) CellTag expression gauged by GFP expression. E) Overall distribution of
CellTag counts captured after filtering. F) Percentages of cells captured with 1+ or 2+ CellTags.
Figure 3.5: Further Analysis of the Preliminary Data using SCANPY and PAGA. (A)
Schematic of the experiment. (B) Left: PAGA embedding of the time course reprogramming
dataset. ‘FA’: Force Atlas. Right: Distribution of cells from different time points on the PAGA
embedding. (C) Expression of additional key markers. Cardiac fibroblast: Postn, Tcf21, and
Tbx20. Cardiomyocyte: Tnnt2, Tnnc1, and Des. (D) Overall distribution of CellTag counts
captured after filtering. (E) Cardiomyocyte and fibroblast identity score distribution on the FA
plot. (F) Clusters labelled with dominant cell-type classified by Capybara.
Figure 3.6: Identification of Enriched vs Depleted Clones. (A) P-values of major clones tested
(>10 cells) using randomized test. (B) Distribution of cells that have clonally related siblings. (C)
Overlay of the iCM depleted clones on the FA plot. It demonstrates the depleted clone initiates at
the source fibroblast population and move to the off-target branch. (D) Projection of pseudotime
of these cells to guide the directionality of cell identity shift.
Figure 3.7: Capybara Analysis comparing Cardiac Reprogramming with or without small
molecules. (A) Schematic for the design of the experiment. (B) Comparison of the atrial to
ventricular cardiomyocyte ratio between the small molecule and no small molecule treatment.
An increase of this ratio was observed with the addition of small molecules (P=0.0287,
randomized test). (C) Overlay of Capybara classification on the integrated space of our dataset
with Stone et al dataset. (D) Log-normalized expression profile of atrial and ventricular markers
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between the two treatment groups. Differential enrichment or depletion of the expression is
tested by Wilcoxon rank sum test (*: P <= 0.05; **: P <= 0.01; ***: P <= 0.001; ****: P <=
0.0001)
Figure 3.8: CellOracle Analysis of the Preliminary Time Course Single-Cell Dataset. (A)
Diffusion pseudotime calculated via PAGA. (B) Degree centrality for the top 30 TFs in cluster 1
and 10, suggesting a putative factor Klf5. (C) Inferred gradient vector under normal development
from CellOracle, indicating potential directionality of the cell movement in this dataset. (D) Lognormalized Klf5 expression projected on the FA plot. (E) CellOracle knockout simulation of
Klf5, showing transitions toward cardiac fate is blocked. (F) CellOracle overexpression
simulation of Klf5, showing promoted transition to cardiomyocytes. Blue region: negative
perturbation score, transitions toward this region are blocked. Red region: positive perturbation
score, transitions toward this direction are promoted.
Figure 3.9: SCANPY and PAGA analysis of the dataset with small molecule treatment.
PAGA embedding of the time course reprogramming dataset, representing a total of 13 clusters.
‘FA’: Force Atlas.
Figure 3.10: CellOracle Analysis of the Dataset with small molecules. (A) Diffusion
pseudotime calculated via PAGA. (B) Degree centrality for the top 30 TFs in cluster 3, 4 and 10,
suggesting a putative factor Atf3. (C) Inferred gradient vector under normal development from
CellOracle, indicating potential directionality of the cell movement in this dataset. (D) Lognormalized Atf3expression projected on the FA plot. (E) CellOracle knockout simulation of Atf3,
showing transitions toward cardiac fate is blocked. (F) CellOracle overexpression simulation of
Atf3, showing promoted transition to cardiomyocytes. Blue region: negative perturbation score,
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transitions toward this region are blocked. Red region: positive perturbation score, transitions
toward this direction are promoted.
Figure 3.11: State-Fate Experiment (RNA Profile). (A) Schematic of the experimental design.
(B) The samples were processed and integrated via Seurat V4, representing a total of 12 clusters.
(C) Distribution of cells from different time points on the UMAP projection, showing even
distribution across the clusters. (D) Expression of key markers. Fibroblast: Col1a2 and S100a4.
Cardiomyocyte: Tnnt2 and Tnnc1. (E) Cardiomyocyte and fibroblast identity score distribution
on the UMAP plot, referencing the Stone et al. dataset.
Figure 3.12: Identification of Enriched or Depleted Clones based on Transcriptional
Lineage. (A) Distribution of cells that have clonally related siblings, split by time points,
showing even clonal relationship across the clusters and days (B) Overlay of the iCM enriched
clones on the UMAP plot. (D) Overlay of the iCM depleted clones on the UMAP plot.
Figure 3.13: State-Fate Experiment (ATAC Profile). (A) The samples were processed and
aggregated via ArchR, representing a total of 12 clusters. (B) Distribution of cells from different
time points on the UMAP projection, showing major occupation of day 2 cells on the top and day
5 cells on the bottom. (C) Imputed gene activity scores of key markers as previously reported (H.
Wang et al., 2022). Fibroblast: Postn, Dcn and Dsp. Cardiomyocyte: Ryr2, Myom2, and Actc1.
(D) Percentage of day 2 and day 5 cells in each cluster. (E) Motif enrichment identified in the
differentially accessible peaks for each cluster.
Figure 3.14: GREAT analysis and Comparison to Chip-seq Peaks. (A) Predicted annotation
for the genomic regions differentially accessible for Cluster 5 and 6. GREAT analysis predict
functional annotation for genomic regions. We note most annotations to be related to immune
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response and vascular development. (B) Predicted annotation for the genomic regions
differentially accessible for Cluster 8 and 10. We note most annotations to be related to muscle
and cardiac development as well as muscle structure organization. (C) Comparison of differential
peaks to Chip-seq data of Mef2c, Gata4, and Tbx5, suggesting cells in Cluster 8-11 have
accessible peaks for these three reprogramming TFs.
Figure 3.15: Identification of Enriched or Depleted Clones based on Chromatin Landscape.
(A) Distribution of cells that have clonally related siblings, split by time points, showing even
clonal relationship across the clusters (B) Top: projection of the cells in enriched (left) or
depleted (right) clones on the UMAP. Light purple: Day 2 cells, Dark purple: Day 5 cells. Each
colored path marks a different clone. Bottom: Overlay of the iCM enriched (left) or depleted
(right) clones on the UMAP plot. The arrows are the inferred the direction of movement based
on the paths marked by the clones, sourcing from day 2 cells to day 5 cells.
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Chapter 4: Closing Remarks and Future
Directions
In this dissertation, we aim to unravel population heterogeneity in a complex and continuous
biological system via development and application of computational and experimental tools, with
a focus on reprogramming. The findings of this work, both preliminary and published, advance
the field by providing a valuable tool with a unique focus on the hybrid cells and a rich dataset
that captures lineage together with transcriptome profiles as well as chromatin landscapes. The
discoveries with the application of nascent tools in the Morris lab opens opportunities to answer
broad range of questions for continued advancement of the field and research. In this final
chapter, we briefly pinpoint interesting questions for future pursuit from this work.
Can we distinguish different types of hybrid cells? In Chapter 2, we present our work,
Capybara, in effort to capture transition cells during continual biological processes. It enabled us
to observe rare intermediates in different dynamic systems. Yet, as transition cells have been
proposed to play diverse roles (MacLean et al., 2018), an interesting problem to pursue is further
separation and characterization of these transition cells. For instance, the transition population
can mark a bistable state toward two terminal fates or a transient state from one progenitor state
to a terminal fate. A potential approach to isolate such population is to consider the stability of
the identified hybrid state. A bistable state would demonstrate higher stability compared to a
transient state. In addition, as we carefully note that hybrid cells identified in Capybara do not
imply directionality, incorporation of trajectory inference or velocity metric could facilitate the
identification of directionality of flow in these identified intermediate states.

167

In Chapter 3, we showcase the joint application of nascent tools in the Morris lab to
reveal cell type dynamics and mechanistic insights in direct cardiac reprogramming. Particularly,
we reveal two putative trajectories of this reprogramming – one toward successfully
reprogrammed state vs. the other toward the fibroblastic fate. The preliminary analysis describes
the overarching picture of the lineage map. Taking a deeper dive, we can ask the following
questions to further identify changes that define fates.
From fate to state, where are the reprogrammed cells originating from? It has been
previously reported that the dynamic cell types in the heterogeneous starting population have
different reprogramming efficiency (Biddy et al., 2018; Mahmoudi et al., 2019). Leveraging this
state-fate dataset, we can trace from the fate cells to their originating states. Further comparison
of their gene expression profile and chromatin landscape can lead us to identify conserved
expression or accessible chromatin regions that could be key to a restricted fate. Identification of
such can lead to discovery of key regulatory genes in specific fate decision.
From state to fate, do the cells diverge? Previously, we have identified that cell fate
decision is stochastic yet becomes deterministic early during reprogramming, leading to
restricted lineages (Biddy et al., 2018). Here, we can follow the state cells to their fate cells to
assess if we observe similar lineage restriction as we previously observed. If the cells in a clone
diverge, additional comparisons between the bifurcation cluster and fate clusters can highlight
key transition transcriptional state and chromatin landscape. In this manner, we can further
assess if the chromatin has already been remodeled prior to transcriptional changes. Such
analysis can further refine our lineage maps for this reprogramming protocol and pinpoint
bifurcation dynamics in the system.
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Are successfully reprogrammed clones identified with transcription profile also
considered successful in chromatin landscape? As described in Chapter 3, we observe more
distinctive trajectories from the chromatin landscape point of view compared to expression
profiles, reflecting the slow transcriptional remodeling. In addition, in the ATAC lineages, we
identified a potential trajectory to depleted clones from an early reprogrammed cluster. Hence, it
would be intriguing to explore if their RNA siblings have also lost the cardiac profile with a
regain of fibroblastic fate. Considering the delay between upstream chromatin shift to
downstream transcriptome modification, this can help identify key accessible genomic regions
that are responsible for this refractory lineage.
With the basic lineage map, how is the map altered upon modulation with other
factors, such as signaling molecules and other regulatory factors? Previously, it has been
shown that other factors can enhance efficiency and fidelity of reprogramming (Mohamed et al.,
2017; Hashimoto et al., 2019; Zhou et al., 2015; Jayawardena et al., 2012). Additional functional
studies reveal the different roles of the factors in alteration of the chromatin landscape and
transcriptional space (Hashimoto et al., 2019). From a lineage perspective, we could ask the
question if the lineage is shifted, and the bifurcation observed in this study disappears. State-fate
experiments with this modulation can be further employed to identify lineage changes and find
key drivers of these changes. In addition, alternation in the lineage map can help pinpoint the
factors could achieve both high efficiency and fidelity during reprogramming.
Can we improve the efficiency and fidelity of cardiac reprogramming more? This is a
long-standing question in the field of direct cell fate engineering (Guo & Morris, 2017). Utilizing
CellOracle (Kamimoto et al., 2020), we highlight two putative transcription factors that could
potentially increase the generation of cardiomyocytes in vitro. These factors can be tested and
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evaluated in vitro by performing a reprogramming experiment with the traditional cocktail in
joint with the new factors. The resulting cells can be evaluated via qRT-PCR or single-cell
sequencing for full profile and immunostaining for structural representation of cardiomyocytes.
In a nutshell, the tool and data presented in this dissertation provide important findings to
the field of cell fate engineering. In addition, it laid the foundation for exploration in
understanding the mechanisms of in vitro regeneration strategies, further improving them closer
to future application in medicine.
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